~~(a)~~

(a)

All or a portion of this investment has an unfunded commitment ~~as of February 29, 2020.~~

~~(b) As of February 29, 2020, the investment was in default and on non-accrual status.~~

~~(c) Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 29, 2020.~~

~~LIBOR—London Interbank Offered Rate~~

~~1W USD LIBOR—The 1 week USD LIBOR rate~~ as of February 29, 2020 (see Note 6 in Notes to financial statements).

(b)

As of February 29, 2020, the investment was ~~1.57%.~~

~~1M USD LIBOR—The 1 month USD LIBOR rate~~in default and on non-accrual status.

(c)

Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 29, ~~2020 was 1.52%.~~

~~2M USD LIBOR—The 2 month USD LIBOR rate as of February 29, 2020 was 1.50%.~~

~~3M USD LIBOR—The 3 month USD LIBOR rate as of February 29, 2020 was 1.46%.~~

~~6M USD LIBOR—The 6 month USD LIBOR rate as of February 29, 2020 was 1.40%.~~

~~Prime—The Prime Rate as of February 29, 2020 was 4.75%.~~

2020.

LIBOR—London Interbank Offered Rate

1W USD LIBOR—The 1 week USD LIBOR rate as of February 29, 2020 was 1.57%.

1M USD LIBOR—The 1 month USD LIBOR rate as of February 29, 2020 was 1.52%.

2M USD LIBOR—The 2 month USD LIBOR rate as of February 29, 2020 was 1.50%.

3M USD LIBOR—The 3 month USD LIBOR rate as of February 29, 2020 was 1.46%.

6M USD LIBOR—The 6 month USD LIBOR rate as of February 29, 2020 was 1.40%.

Prime—The Prime Rate as of February 29, 2020 was 4.75%.

Note 5. Income Taxes

SIA-Avionte, Inc., SIA-GH, Inc., SIA-MAC, Inc., SIA-PP Inc., SIA-TG, Inc., SIA-TT, Inc., SIA-Vector, Inc. and SIA-VR, Inc., each 100% owned by the Company, are each filing standalone C Corporation tax returns for federal and state purposes. As separately regarded entities for tax purposes, these entities are taxed at normal corporate rates. For tax purposes, any distributions by the entities to the parent company would generally need to be distributed to the Company’s shareholders. Generally, such distributions of the entities’ income to the Company’s shareholders will be considered as qualified dividends for tax purposes. The entities taxable net income will differ from U.S. GAAP net income because of deferred tax temporary differences adjustments arising from net operating losses and unrealized appreciation and ~~deprecation~~depreciation of securities held. Deferred tax assets and liabilities are measured using enacted corporate federal and state tax rates expected to apply to taxable income in the years in which those net operating losses are utilized and the unrealized gains and losses are realized. Deferred tax assets and deferred tax liabilities are netted off by entity, as allowed. The recoverability of deferred tax assets is assessed and a valuation allowance is recorded to the extent that it is more likely than not that any portion of the deferred tax asset will not be realized on the basis of a history of operating losses combined with insufficient projected taxable income or other taxable events in the taxable blockers.

The Company may distribute a portion of its realized net long term capital gains in excess of realized net short term capital losses to its stockholders, but may also decide to retain a portion, or all, of its net capital gains and elect to pay federal tax on the net capital gain, potentially in the form of a “deemed distribution” to its stockholders. Income tax (provision) relating to an election to retain its net capital gains, including in the form of a deemed distribution, is included as a component of income tax provision and income tax (provision) on realized gains on investments, depending on the character of the underlying taxable income (ordinary or capital gains), on the consolidated statements of operations. During the three months ended November 30, 2020, the Company paid federal tax of $3.9 million on the undistributed net gains it elected to retain for the tax year ended February 29, 2020.

Deferred tax assets and liabilities, and related valuation allowance as of ~~May 31,~~November 30, 2020 and February 29, 2020 were as follows:


	May 31, 2020			February 29, 2020			November 30, 2020			February 29, 2020
Total deferred tax assets	$	1,924,689		$	1,744,879		$	(1,965,687	)	$	1,744,879
Total deferred tax liabilities		(1,144,746	)		(1,412,486	)		1,471,324			(1,412,486	)
Valuation allowance on net deferred tax assets		(1,850,621	)		(1,679,756	)		1,928,869			(1,679,756	)

Net deferred tax liability	$	(1,070,678	)	$	(1,347,363	)	$	1,434,505		$	(1,347,363	)

As of ~~May 31,~~November 30, 2020, the valuation allowance on deferred tax assets was $1.9 million, which represents the federal and state tax effect of net operating losses and unrealized losses that we do not believe we will realize through future taxable income. Any adjustments to the Company’s valuation allowance will depend on estimates of future taxable income and will be made in the period such determination is made.

Net deferred tax (benefit) expense for the three months ended May 31, 2020 includes $(0.3) million net change in unrealized appreciation (depreciation) on investments and $(0.01) million net change in total operating expense, in the consolidated statement of operations, respectively.

Net deferred tax (benefit) expense for the three months ended ~~May 31, 2019~~November 30, 2020 includes ~~$0.02~~$0.2 million net change in unrealized appreciation (depreciation) on investments and $0.0 million net change in total operating expense, in the consolidated statement of operations, respectively. Net deferred tax (benefit) expense for the three months ended November 30, 2019 includes $1.1 million net change in unrealized appreciation (depreciation) on investments and $(1.0) million net change in total operating expense, in the consolidated statement of operations, respectively.

Net deferred tax (benefit) expense for the nine months ended November 30, 2020 includes $0.1 million net change in unrealized appreciation (depreciation) on investments and $0.0 million net change in total operating expense, in the consolidated statement of operations, respectively. Net deferred tax (benefit) expense for the nine months ended November 30, 2019 includes $1.8 million net change in unrealized appreciation (depreciation) on investments and $(1.5) million net change in total operating expense, in the consolidated statement of operations, respectively.

Deferred tax temporary differences may include differences for state taxes and joint venture interests.

Federal and state income tax provisions (benefits) on investments for three and nine months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019:

   May 31, 2020    May 31, 2019
Current

Federal
   $ —      $ —
State
   —      —




Net current expense
   —      —




Deferred

Federal
   (245,474 )    13,290
State
   (31,211 )    9,776




Net deferred expense
   (276,685 )    23,066




Net tax provision
   $ (276,685 )    $ 23,066

	For the three months ended				For the nine months ended
	November 30, 2020		November 30, 2019		November 30, 2020		November 30, 2019
Current
Federal	$	-	$	-	$	-	$	-
State		-		-		-		-
Net current expense		-		-		-		-
Deferred
Federal		195,652		38,486		24,814		252,303
State		44,153		22,033		62,328		69,621
Net deferred expense		239,805		60,519		87,142		321,924
Net tax provision	$	239,805	$	60,519	$	87,142	$	321,924

Note 6. Agreements and Related Party Transactions

Investment Advisory and Management Agreement

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement was two years, with automatic, one-year renewals at the end of each year, subject to certain approvals by our board of directors and/or the Company’s stockholders. On July 7, 2020, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive management fee.

Base Management Fee and Incentive Management Fee

The base management fee of 1.75% per year is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters. The base management fee is paid quarterly following the filing of the most recent 10-Q.

The incentive management fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no claw back of amounts previously paid if subsequent quarters are below the quarterly hurdle rate, and there is no delay of payment if prior quarters are below the quarterly hurdle rate.

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis on each investment in the Company’s portfolio, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, the Company incurred ~~$2.2~~$2.3 million and ~~$1.8~~$2.1 million in base management fees, respectively. For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, the Company incurred ~~$1.4~~$1.2 million and ~~$1.2~~$1.5 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, the Company accrued an expense of $1.1 million and an expense of $1.6 million in incentive fees related to capital gains.

For the nine months ended November 30, 2020 and November 30, 2019, the Company incurred $6.7 million and $6.0 million in base management fees, respectively. For the nine months ended November 30, 2020 and November 30, 2019, the Company incurred $4.0 million and $4.1 million in incentive fees related to pre-incentive fee net investment income, respectively. For the nine months ended November 30, 2020 and November 30, 2019, the Company accrued a (benefit) of ~~$(3.3)~~$(2.0) million and an expense of ~~$1.0~~$3.2 million in incentive fees related to capital ~~gains.~~gains, respectively.

The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of ~~May 31,~~November 30, 2020, the base management fees accrual was ~~$2.2~~$2.3 million and the incentive fees accrual was ~~$1.4~~$2.5 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 29, 2020, the base management fees accrual was $2.1 million and the incentive fees accrual was $13.7 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

Administration Agreement

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement was two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company was capped at $1.0 million for the initial two-year term of the Administration

Agreement and subsequent renewals. On July 8, 2015, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company thereunder, which had not been increased since the inception of the agreement, to $1.3 million. On July 7, 2016, our board of directors approved the renewal of the Administration Agreement for an additional one-year term. On October 5, 2016, our board of directors determined to increase the cap on the payment or reimbursement of expenses by the Company under the Administration Agreement, from $1.3 million to $1.5 million, effective November 1, 2016. On July 11, 2017, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $1.5 million to $1.75 million, effective August 1, 2017. On July 9, 2018, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $1.75 million to $2.0 million, effective August 1, 2018. On July 9, 2019, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $2.0 million to $2.225 million effective August 1, 2019. On July 7, 2020, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $2.225 million to $2.775 million effective August 1, 2020.

For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, we recognized $0.7 million and $0.6 million in administrator expenses, respectively, pertaining to bookkeeping, record keeping and ~~$0.5~~other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. For the nine months ended November 30, 2020 and November 30, 2019, we recognized $1.9 million and $1.6 million in administrator expenses, respectively, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of ~~May 31,~~November 30, 2020, ~~$0.4~~$0.3 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. As of February 29, 2020, $0.5 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities.

Saratoga CLO

On August 7, 2018, the Company entered into an unsecured loan agreement with CLO 2013-1 Warehouse, a wholly-owned subsidiary of Saratoga CLO, pursuant to which CLO 2013-1 Warehouse may borrow from time to time up to ~~$20~~$25 million from the Company in order to provide capital necessary to support warehouse activities. The CLO 2013-1 Warehouse Loan, which expired on February 7, 2020, bears interest at an annual rate of 3M USD LIBOR + 7.5%.

On December 14, 2018, the Company completed the third refinancing and issuance of the 2013-1 Reset CLO Notes. This refinancing, among other things, extended the Saratoga CLO reinvestment period to January 2021, and extended its legal maturity to January 2030. A non-call period ending January 2020 was also added. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $300 million in assets to approximately $500 million. As part of this refinancing and upsizing, the Company invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $2.5 million in aggregate principal amount of the Class F-R-2 Notes tranche and $7.5 million in aggregate principal amount of the Class G-R-2 Notes tranche at par. Concurrently, the existing $4.5 million of Class F notes and $20.0 million CLO 2013-1 Warehouse Loan were repaid. The Company also paid $2.0 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO and was reimbursed by the Saratoga CLO for these costs during the year ended February 29, 2020.

For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, we recognized management fee income of $0.6 million and $0.6 million, respectively, related to the Saratoga CLO.

For the nine months ended November 30, 2020 and November 30, 2019, we recognized management fee income of $1.9 million and $1.9 million, respectively, related to the Saratoga CLO.

In conjunction with the third refinancing and issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to receive an incentive management fee from Saratoga CLO. See Note 4 for additional information.

On February 11, 2020, the Company entered into an unsecured loan agreement with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, ~~Loan with CLO 2013-1 Warehouse 2,~~Ltd., a wholly-owned subsidiary of Saratoga Investment Corp. CLO ~~pursuant~~2013-1, Ltd. Pursuant to which CLO 2013-1 Warehouse 2 may borrow from time to time up to $20.0 million from the Company in order to provide capital necessary to support warehouse activities. ~~The~~On October 23, 2020, the CLO 2013-1 Warehouse 2 Loan was increased to $25.0 million availability, which was immediately fully drawn and, which expires on August 20, ~~2021, bears~~2021. The interest rate was also amended to be based on a pricing grid, starting at an annual rate of 3M USD LIBOR + ~~7.5%~~4.46%. As of ~~May 31,~~November 30, 2020, ~~the aggregate principal amount of~~ the Company’s investment in the CLO 2013-1 Warehouse 2 ~~Loan was $5.0 million, which~~ had a fair value of ~~$4.0~~ $24.8 million.

For the ~~three~~nine months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, the Company neither bought nor sold any investments from the Saratoga CLO.

Note 7. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage, or, if we obtain the required approvals from our independent directors and/or stockholders, 150.0%. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing. Our asset coverage ratio, as defined in the 1940 Act, was ~~569.4%~~377.3% as of ~~May 31,~~November 30, 2020 and 607.1% as of February 29, 2020. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our non-interested board of directors approved of our becoming subject to a minimum asset coverage ratio of 150.0% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150.0% asset coverage ratio became effective on April 16, 2019.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral were used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility ~~(the “Credit Facility”)~~ with Madison Capital Funding LLC (the “Credit Facility”), in each case, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended the Credit Facility to, among other things:

~~expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;~~

●

expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;

●

extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and

●

remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

~~remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.~~

On September 17, 2014, we entered into a second amendment to the Credit Facility to, among other things:

~~extend the commitment termination date from February 24, 2015 to September 17, 2017;~~

●

extend the commitment termination date from February 24, 2015 to September 17, 2017;

~~extend the maturity date of the Credit Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);~~

●

extend the maturity date of the Credit Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

~~reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and~~

●

reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

●

reduce the floor on base rate borrowings from 3.00% to 2.25%, and on LIBOR borrowings from 2.00% to 1.25%.

~~reduce the floor on base rate borrowings from 3.00% to 2.25%, and on LIBOR borrowings from 2.00% to 1.25%.~~

On May 18, 2017, we entered into a third amendment to the Credit Facility to, among other things:

~~extend the commitment termination date from September 17, 2017 to September 17, 2020;~~

●

extend the commitment termination date from September 17, 2017 to September 17, 2020;

~~extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025 (unless terminated sooner upon certain events);~~

●

extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025 (unless terminated sooner upon certain events);

~~reduce the floor on base rate borrowings from 2.25% to 2.00%;~~

●

reduce the floor on base rate borrowings from 2.25% to 2.00%;

~~reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and~~

●

reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and

●

reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.

~~reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.~~

On April 24, 2020, we entered into a fourth amendment to the Credit Facility to, among other things:

● permit certain amendments related to the Paycheck Protection Program (“Permitted PPP Amendment”) to Loan Asset Documents;

●

exclude certain debt and interest amounts allowed by the Permitted PPP Amendments from certain calculations related to Net Leverage Ratio, Interest Coverage Ratio and EBITDA; and

●

exclude such Permitted PPP Amendments from constituting a Material Modification.

On September 14, 2020, we entered into a fifth amendment to the ~~Paycheck Protection Program (“Permitted PPP Amendment”)~~Credit Facility to, ~~Loan Asset Documents;~~among other things:

~~exclude certain debt and interest amounts allowed by the Permitted PPP Amendments from certain calculations related to Net Leverage Ratio, Interest Coverage Ratio and EBITDA; and~~

●

extend the commitment termination date of the Credit Facility from September 17, 2020 to September 17, 2021, with no change to the maturity date of September 17, 2025.

●

provide for the transition away from the LIBOR Rate in the market, and

~~exclude such Permitted PPP Amendments from constituting a Material Modification.~~

●

expand the definition of Eligible Loan Asset to allow investments with certain recurring revenue features to qualify as Collateral and be included in the borrowing base.

In addition to any fees or other amounts payable under the terms of the Credit Facility, ~~agreement with Madison Capital Funding LLC,~~ an administrative agent fee per annum equal to $0.1 million is payable in equal monthly installments in arrears.

As of ~~May 31,~~November 30, 2020 and February 29, 2020, there were no outstanding borrowings under the Credit Facility. During the applicable periods, the Company was in compliance with all of the limitations and requirements of the Credit Facility. Financing costs of ~~$3.1~~$3.3 million related to the Credit Facility have been capitalized and are being amortized over the term of the facility.

For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, we recorded $0.1 million and $0.1 million of interest expense related to the Credit Facility, respectively, which includes commitment and administrative agent fees. For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, we recorded ~~$0.02~~$0.03 million and $0.02 million of amortization of deferred financing costs related to the Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During ~~both~~ the three ~~month periods~~months ended ~~May 31, 2020 and May 31,~~November 30, 2019, ~~there was no~~the weighted average interest rate on the outstanding borrowings under the Credit ~~Facility.~~Facility was 6.72%, and the average dollar amount of outstanding borrowings under the Credit Facility was $2.1 million.

For the nine months ended November 30, 2020 and November 30, 2019, we recorded $0.3 million and $0.4 million of interest expense related to the Credit Facility, respectively, which includes commitment and administrative agent fees. For the nine months ended November 30, 2020 and November 30, 2019, we recorded $0.08 million and $0.07 million of amortization of deferred financing costs related to the Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2019, the weighted average interest rate on the outstanding borrowings under the Credit Facility was 6.67%, and the average dollar amount of outstanding borrowings under the Credit Facility was $0.8 million.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight-year term, consisting of a three-year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing one-month LIBOR rate and 1.00%, plus an applicable margin of 4.75%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.00%, and the applicable margin over such alternative base rate is 3.75%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Credit Facility for the duration of the Revolving Period.

Our borrowing base under the Credit Facility was ~~$36.8~~$46.4 million subject to the Credit Facility cap of $45.0 million at ~~May 31,~~November 30, 2020. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”). Accordingly, the ~~May 31,~~November 30, 2020 borrowing base relies upon the valuations set forth in the ~~Annual~~Quarterly Report on Form ~~10-K~~10-Q for the ~~year~~period ended ~~February 29,~~August 31, 2020. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

Our wholly-owned SBIC subsidiaries are able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA.

On August 14, 2019, the Company’s wholly-owned subsidiary, SBIC II LP, received an SBIC license from the SBA. The new license provides up to $175.0 million in additional long-term capital in the form of SBA debentures. As a result of the 2016 omnibus spending bill signed into law in December 2015, the maximum amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding was increased from $225.0 million to $350.0 million. With this license approval, Saratoga ~~will~~can grow its SBA relationship from $150.0 million to $325.0 million of committed capital.

As of ~~May 31,~~November 30, 2020, we have funded SBIC LP and SBIC II LP with an aggregate total of equity capital of $75.0 million and ~~$50.0~~$69.0 million, respectively, and have ~~$170.0~~$176.0 million in SBA-guaranteed debentures outstanding, of which $150.0 million is held in SBIC LP and ~~$20.0~~$26.0 million held in SBIC II LP. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP and SBIC II LP may borrow to a maximum of $150.0 million and $175.0 million, respectively, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $19.5 million and have average annual fully taxed net income not exceeding $6.5 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ~~‘‘smaller’’~~“smaller” concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBIC LP and SBIC II LP are subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC II LP will receive SBA-guaranteed debenture funding, which is dependent upon SBIC II LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP and SBIC II LP assets over our stockholders and debtholders in the event we liquidate SBIC LP and SBIC II LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP and SBIC II LP upon an event of default.

The Company received exemptive relief from the SEC to permit it to exclude the debt of SBIC subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows the Company increased flexibility under the asset coverage test by permitting it to borrow up to $325.0 million more than it would otherwise be able to absent the receipt of this exemptive relief. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, the non-interested board of directors of the Company approved of the Company becoming subject to a minimum asset coverage ratio of 150.0% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150.0% asset coverage ratio became effective on April 16, 2019.

As noted above, as of ~~May 31,~~November 30, 2020, there was ~~$170.0~~$176.0 million of SBA debentures outstanding and as of February 29, 2020, there was $150.0 million of SBA debentures outstanding. The carrying amount of the amount outstanding of SBA debentures approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy. Financing costs of $5.0 million and ~~$1.2~~$1.3 million related to the SBA debentures issued by SBIC LP and SBIC II LP, respectively, have been capitalized and are being amortized over the term of the commitment and drawdown.

For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, we recorded ~~$1.2~~$1.3 million and $1.2 million of interest expense related to the SBA debentures, respectively. For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, we recorded $0.2 million and $0.1 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019 on the outstanding borrowings of the SBA debentures was ~~3.16%~~2.97% and ~~3.25%~~3.21%, respectively. During the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, the average dollar amount of SBA debentures outstanding was ~~$157.4~~$170.3 million and $150.0 million, respectively.

For the nine months ended November 30, 2020 and November 30, 2019, we recorded $3.8 million and $3.6 million of interest expense related to the SBA debentures, respectively. For the nine months ended November 30, 2020 and November 30, 2019, we recorded $0.5 million and $0.4 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the nine months ended November 30, 2020 and November 30, 2019 on the outstanding borrowings of the SBA debentures was 4.57% and 3.24%, respectively. During the nine months ended November 30, 2020 and November 30, 2019, the average dollar amount of SBA debentures outstanding was $165.9 million and $150.0 million, respectively.

In December 2015, the 2016 omnibus spending bill approved by Congress and signed into law by the President increased the amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding from $225.0 million to $350.0 million, subject to SBA approval. SBA regulations previously limited the amount of SBA-guaranteed debentures that an SBIC may issue to $150.0 million when it has at least $75.0 million in regulatory capital but this has increased to $175.0 million for new licenses when it has at least $87.5 million in regulatory capital. Affiliated SBICs are permitted to issue up to a combined maximum amount of $350.0 million in SBA-guaranteed debentures when they have at least $175.0 million in combined regulatory capital.

Notes

In May ~~10,~~ 2013, the Company issued ~~$42.0~~$48.3 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “2020 Notes”). The 2020 Notes will mature on May 31, 2020, and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at the Company’s option. Interest will be payable quarterly beginning August 15, 2013. On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the 2020 Notes, pursuant to the full exercise of the underwriters’ option to purchase additional 2020 Notes. The 2020 Notes were redeemed in full on January 13, ~~2017.~~2017 and are no longer listed on the NYSE.

On May 29, 2015, the Company entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which the Company may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. Prior to the 2020 Notes being redeemed in full, the Company had sold 539,725 bonds with a principal of $13.5 million at an average price of $25.31 for aggregate net proceeds of $13.4 million (net of transaction costs).

On December 21, 2016, the Company issued $74.5 million in aggregate principal amount of our 6.75% fixed-rate notes due 2023 (the “2023 Notes”) for net proceeds of $71.7 million after deducting underwriting commissions of approximately $2.3 million and offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 2023 Notes is paid quarterly in arrears on March 15, June 15, September 15 and December 15, at a rate of 6.75% per year, beginning March 30, 2017. The 2023 Notes mature on December 30, 2023, and commencing December 21, 2019, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used to repay all of the outstanding indebtedness under the 2020 Notes, which amounted to $61.8 million, and for general corporate purposes in accordance with our investment objective and strategies.

On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes. The 2023 Notes were listed on the NYSE under the trading symbol “SAB” with a par value of $25.00 per share, and have been delisted following the redemption.

On August 28, 2018, the Company issued $40.0 million in aggregate principal amount of our 6.25% fixed-rate notes due 2025 (the ~~“2025~~“6.25% 2025 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.3 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $5.0 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest on the 6.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning November 30, 2018. The 6.25% 2025 Notes mature on August 31, 2025 and commencing August 28, 2021, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes.

On February 5, 2019, the Company completed a re-opening and up-sizing of its existing 6.25% 2025 Notes by issuing an additional $20.0 million in aggregate principal amount for net proceeds of $19.2 million after deducting underwriting commissions of approximately $0.6 million and discount of $0.2 million. Offering costs incurred were approximately $0.2 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $2.5 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate, interest payment dates and maturity remain unchanged from the existing 6.25% 2025 Notes issued in August 2018. The net proceeds from this offering were used for general corporate purposes in accordance with our investment objective and strategies. The financing costs and discount of $1.0 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes.

As of ~~May 31,~~November 30, 2020, the total 6.25% 2025 Notes outstanding was $60.0 million. The 6.25% 2025 Notes are listed on the NYSE under the trading symbol “SAF” with a par value of $25.00 per share.

As of ~~May 31,~~November 30, 2020, the carrying amount and fair value of the 6.25% 2025 Notes was $60.0 million and ~~$56.5~~$62.0 million, respectively. The fair value of the 6.25% 2025 Notes, which isare publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 29, 2020, the carrying amount and fair value of the 6.25% 2025 Notes was $60.0 million and $60.6 million, respectively.

For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, we recorded $0.9 million and $0.9 million, respectively, of interest expense and $0.1 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 6.25% 2025 ~~Notes.~~ Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, the average dollar amount of 6.25% 2025 Notes outstanding was $60.0 million and $60.0 million, respectively.

For the nine months ended November 30, 2020 and November 30, 2019, we recorded $2.8 million and $2.8 million, respectively, of interest expense and $0.3 million and $0.3 million, respectively, of amortization of deferred financing costs related to the 6.25% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2020 and November 30, 2019, the average dollar amount of 6.25% 2025 Notes outstanding was $60.0 million and $60.0 million, respectively.

As discussed above, during the fourth quarter of 2020 fiscal year, the Company redeemed $74.45 million in aggregate principal amount of issued outstanding 2023 Notes.

For the three and nine months ended ~~May 31,~~November 30, 2019, we recorded $1.3 million and $3.8 million, respectively, of interest expense and $0.1 million and $0.3 million, respectively, of amortization of deferred financing costs related to the 2023 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of ~~operations.~~options. During the three and nine months ended ~~May 31,~~November 30, 2019 the average dollar amount of 2023 Notes outstanding was $74.5 million and $74.5 million respectively.

On June 24, 2020, the Company issued $37.5 million in aggregate principal amount of our 7.25% fixed-rate notes due 2025 (the “7.25% 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.3 million. On July 6, 2020, the underwriters exercised their option in full to purchase an additional $5.625 million in aggregate principal amount of its 7.25% 2025 Notes. Net proceeds to the Company were $5.4 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 7.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.25% per year, beginning August 31, 2020. The 7.25% 2025 Notes mature on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and are being amortized over the term of the 7.25% 2025 Notes.

As of November 30, 2020, the total 7.25% Notes 2025 outstanding was $43.1 million. The 7.25% 2025 Notes are listed on the NYSE under the trading symbol “SAK” with a par value of $25.00 per share.

As of November 30, 2020, the carrying amount and fair value of the 7.25% 2025 Notes was $43.1 million and $45.0 million, respectively. The fair value of the 7.25% 2025 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 29, 2020, the carrying amount and fair value of the 7.25% 2025 Notes was $0.0 million and $0.0 million, respectively.

For the three and nine months ended November 30, 2020, we recorded $0.8 million and $1.4 million, respectively, of interest expense and $0.08 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 7.25% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations options. During the three and nine months ended November 30, 2020 the average dollar amount of 7.25% 2025 Notes outstanding was $43.1 million and $43.1 million respectively.

On July 9, 2020, the Company issued $5.0 million aggregate principal amount of our 7.75% fixed-rate Notes due in 2025 (the “7.75% Notes 2025”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% Notes 2025 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year, beginning August 31, 2020. The 7.75% Notes 2025 mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% Notes 2025 have been capitalized and are being amortized over the term of the Notes.

As of November 30, 2020, the total 7.75% Notes 2025 outstanding was $5.0 million The 7.75% 2025 Notes are not listed and have a par value of $25.00 per share. As of November 30, 2020, there was $5.0 million of 7.75% 2025 Notes outstanding and as of February 29, 2020, there was $0.0 million outstanding. The carrying amount of the amount outstanding of 7.75% 2025 Notes approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy.

For the three and nine months ended November 30, 2020, we recorded $0.1 million and $0.2 million, respectively, of interest expense and $0.0 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 7.75% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three and nine months ended November 30, 2020 the average dollar amount of 7.75% 2025 Notes outstanding was $5.0 million and $5.0 million respectively.

Senior Securities

Information about our senior securities is shown in the following table as of ~~May 31,~~November 30, 2020 for the fiscal year periods indicated in the table, unless otherwise noted.

SENIOR SECURITIES

(dollar amounts in thousands, except per share data)


Class and Year (1)(2)		Total Amount Outstanding Exclusive of Treasury Securities(3)		Asset Coverage per Unit(4)		Involuntary Liquidating Preference per Share(5)		Average Market Value per Share(6)			Total Amount Outstanding Exclusive of Treasury Securities(3)		Asset Coverage per Unit(4)		Involuntary Liquidating Preference per Share(5)		Average Market Value per Share(6)
		(in thousands)									(in thousands)
Credit Facility with Madison Capital Funding	Credit Facility with Madison Capital Funding
Fiscal year 2021 (as of May 31, 2020)		$	—	$	5,694		—		N/A
Fiscal year 2021 (as of November 30, 2020)											$	-	$	3,773		-		N/A
Fiscal year 2020 (as of February 29, 2020)		$	—	$	6,071		—		N/A		$	-	$	6,071		-		N/A
Fiscal year 2019 (as of February 28, 2019)		$	—	$	2,345		—		N/A		$	-	$	2,345		-		N/A
Fiscal year 2018 (as of February 28, 2018)		$	—	$	2,930		—		N/A		$	-	$	2,930		-		N/A
Fiscal year 2017 (as of February 28, 2017)		$	—	$	2,710		—		N/A		$	-	$	2,710		-		N/A
Fiscal year 2016 (as of February 29, 2016)		$	—	$	3,025		—		N/A		$	-	$	3,025		-		N/A
Fiscal year 2015 (as of February 28, 2015)		$	9,600	$	3,117		—		N/A		$	9,600	$	3,117		-		N/A
Fiscal year 2014 (as of February 28, 2014)		$	—	$	3,348		—		N/A		$	-	$	3,348		-		N/A
Fiscal year 2013 (as of February 28, 2013)		$	24,300	$	5,421		—		N/A		$	24,300	$	5,421		-		N/A
Fiscal year 2012 (as of February 29, 2012)		$	20,000	$	5,834		—		N/A		$	20,000	$	5,834		-		N/A
Fiscal year 2011 (as of February 28, 2011)		$	4,500	$	20,077		—		N/A		$	4,500	$	20,077		-		N/A
Fiscal year 2010 (as of February 28, 2010)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2009 (as of February 28, 2009)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2008 (as of February 29, 2008)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2007 (as of February 28, 2007)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
7.50% Notes due 2020(7)
7.50% Notes due 2020(7)
Fiscal year 2017 (as of February 28, 2017)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2016 (as of February 29, 2016)		$	61,793	$	3,025		—	$	25.24	(8)	$	61,793	$	3,025		-	$	25.24	(8)
Fiscal year 2015 (as of February 28, 2015)		$	48,300	$	3,117		—	$	25.46	(8)	$	48,300	$	3,117		-	$	25.46	(8)
Fiscal year 2014 (as of February 28, 2014)		$	48,300	$	3,348		—	$	25.18	(8)	$	48,300	$	3,348		-	$	25.18	(8)
Fiscal year 2013 (as of February 28, 2013)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2012 (as of February 29, 2012)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2011 (as of February 28, 2011)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2010 (as of February 28, 2010)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2009 (as of February 28, 2009)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2008 (as of February 29, 2008)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2007 (as of February 28, 2007)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
6.75% Notes due 2023(9)
6.75% Notes due 2023(9)
Fiscal year 2020 (as of February 29, 2020)		$	—	$	—		—		N/A		$	-	$	-		-		N/A
Fiscal year 2019 (as of February 28, 2019)		$	74,451	$	2,345		—	$	25.74	(10)	$	74,451	$	2,345		-	$	25.74	(10)
Fiscal year 2018 (as of February 28, 2018)		$	74,451	$	2,930		—	$	26.05	(10)	$	74,451	$	2,930		-	$	26.05	(10)
Fiscal year 2017 (as of February 28, 2017)		$	74,451	$	2,710		—	$	25.89	(10)	$	74,451	$	2,710		-	$	25.89	(10)
6.25% Notes due 2025
Fiscal year 2021 (as of May 31, 2020)		$	60,000	$	5,694		—	$	22.15	(11)
Fiscal year 2021 (as of November 30, 2020)											$	60,000	$	3,773		-	$	23.87	(11)
Fiscal year 2020 (as of February 29, 2020)		$	60,000	$	6,071		—	$	25.75	(11)	$	60,000	$	6,071		-	$	25.75	(11)
Fiscal year 2019 (as of February 28, 2019)		$	60,000	$	2,345		—	$	24.97	(11)	$	60,000	$	2,345		-	$	24.97	(11)

7.25% Notes due 2025
Fiscal year 2021 (as of November 30, 2020)											$	43,125	$	3,773		-	$	25.53	(11)
7.75% Notes due 2025
Fiscal year 2021 (as of November 30, 2020)											$	5,000	$	3,773		-	$	25.00	(12)

(1)

We have excluded our SBA-guaranteed debentures from this table because the SEC has granted us exemptive relief that permits us to exclude such debentures from the definition of senior securities in the ~~200%~~150% asset coverage ratio we are required to maintain under the 1940 Act.

(2)

This table does not include the senior securities of our predecessor entity, GSC Investment Corp., relating to a revolving securitized credit facility with Deutsche Bank, in light of the fact that the Company was under different management during the time that such credit facility was outstanding.

(3)

Total amount of senior securities outstanding at the end of the period presented.

(4)

Asset coverage per unit is the ratio of our total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness, calculated on a total basis.

(5)

The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The “—” indicates information which the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.

(6)

Not applicable for credit facility because not registered for public trading.

(7)

On January 13, 2017, the Company redeemed in full its 2020 Notes. The Company used a portion of the net proceeds from the 2023 Notes offering, which was completed in December 2016, to redeem the 2020 Notes in full.

(8)

Based on the average daily trading price of the 2020 Notes on the NYSE.

(9)

On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.45 million, respectively, in aggregate principal amount of the $74.45 million in aggregate principal amount of issued and outstanding 2023 Notes.

(10)

Based on the average daily trading price of the 2023 Notes on the NYSE.

(11)

Based on the average daily trading price of the 2025 Notes on the NYSE.

(12)

The carrying value of this unlisted security approximates its fair value, based on a waterfall analysis showing adequate collateral coverage.

Note 8. Commitments and Contingencies

Contractual Obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at ~~May 31,~~November 30, 2020:


			Payment Due by Period
	Total		Less Than 1 Year		1 - 3 Years		3 - 5 Years		More Than 5 Years				Payment Due by Period
Long-Term Debt Obligations	Total		Less Than 1 Year		1 - 3 Years		3 - 5 Years		More Than 5 Years		Total		Less Than 1 Year		1 - 3 Years		3 - 5 Years		More Than 5 Years
	($ in thousands)										($ in thousands)
Revolving credit facility	$	—	$	—	$	—	$	—	$	—	$	-	$	-	$	-	$	-	$	-
SBA debentures		170,000		—		40,000		39,000		91,000		176,000		-		40,000		39,000		97,000
2025 Notes		60,000		—		—		—		60,000

6.25% 2025 Notes												60,000		-		-		60,000		-
7.25% 2025 Notes												43,125		-		-		43,125		-
7.75% 2025 Notes												5,000				-		5,000		-
Total Long-Term Debt Obligations	$	230,000	$	—	$	40,000	$	39,000	$	151,000	$	284,125	$	-	$	40,000	$	147,125	$	97,000

Off-Balance Sheet Arrangements

As of ~~May 31,~~November 30, 2020 and February 29, 2020, the Company’s off-balance sheet arrangements consisted of ~~$48.3~~$49.8 million and $64.1 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

A summary of the unfunded commitments outstanding as of ~~May 31,~~November 30, 2020 and February 29, 2020 is shown in the table below (dollars in thousands):


	May 31, 2020		February 29, 2020		November 30, 2020		February 29, 2020
At Company’s discretion
CLEO Communications Holding, LLC					$	630	$	-
inMotionNow, Inc.	$	3,000	$	3,000		-		3,000
Omatic Software, LLC		—		1,000		-		1,000
Passageways, Inc.		5,000		5,000		5,000		5,000
PDDS Buyer, LLC		3,000		5,000		-		5,000
Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd.		15,000		17,500		-		17,500
Top Gun Pressure Washing, LLC		3,175		5,000		3,175		5,000
Village Realty Holdings LLC		10,000		10,000		10,000		10,000
						18,805		46,500
		39,175		46,500

At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required
ArbiterSports, LLC		—		1,000		-		1,000
Axiom Purchaser, Inc.		—		1,000		-		1,000
CoConstruct, LLC		—		3,500		6,500		3,500
Davisware, LLC		1,022		2,000		1,022		2,000
GoReact		2,000		2,000		2,000		2,000
Granite Comfort, LP						8,000		-
HemaTerra Holding Company, LLC		2,000		4,000		2,000		4,000
New England Dental Partners						7,445		-
Passageways, Inc.		3,000		3,000		3,000		3,000
Procurement Partners, LLC						1,000		-
Village Realty Holdings LLC		1,124		1,124		-		1,124
						30,967		17,624
		9,146		17,624

Total	$	48,321	$	64,124	$	49,772	$	64,124

Note 9. Directors Fees

The independent directors receive an annual fee of ~~$60,000.~~$70,000. They also receive ~~$2,500~~$3,000 plus reimbursement of reasonable out-of- pocket expenses incurred in connection with attending each board meeting and receive ~~$1,000~~$1,500 plus reimbursement of reasonable out-of- pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of ~~$10,000~~$12,500 and the chairman of each other committee receives an annual fee of ~~$5,000~~$6,000 for their additional services in these

capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, we incurred ~~$0.1~~$0.06 million and ~~$0.1~~$0.06 million for directors’ fees and expenses, respectively. For the nine months ended November 30, 2020 and November 30, 2019, we incurred $0.2 million and $0.2 million for directors’ fees and expenses, respectively. As of ~~May 31,~~November 30, 2020 and February 29, 2020, ~~$0.1~~$0.04 million and $0.06 million in directors’ fees and expenses were accrued and unpaid, respectively. As of ~~May 31,~~November 30, 2020, we had not issued any common stock to our directors as compensation for their services.

Note 10. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial ~~statements.~~statements (the “Share Repurchase Plan”). On October 7, 2015, ~~the Company’s~~our board of directors extended the ~~open market share repurchase plan~~Share Repurchase Plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. On October 5, 2016, ~~the Company’s~~our board of directors extended the ~~open market share repurchase plan~~Share Repurchase Plan for another year to October 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. On October 10, 2017, January 8, 2019 and January 7, 2020, ~~the Company’s~~our board of directors extended the ~~open market share repurchase plan~~Share Repurchase Plan for another year to October 15, 2018, January 15, 2020 and January 15, 2021, respectively, each time leaving the number of shares unchanged at 600,000 shares of its common stock. On May 4, 2020, ~~the Board~~our board of ~~Directors~~directors increased the ~~share repurchase plan~~Share Repurchase Plan to 1.3 million shares of common stock. On January 5, 2021, our board of directors extended the Share Repurchase Plan for another year to January 15, 2022, leaving the number of shares unchanged at 1.3 million shares of common stock. As of ~~May 31,~~November 30, 2020, the Company purchased ~~218,491~~358,812 shares of common stock, at the average price of ~~$16.87~~$17.14 for approximately ~~$3.7~~$6.2 million pursuant to ~~this repurchase plan.~~the Share Repurchase Plan. During the three months ended ~~May 31,~~November 30, 2020, ~~there was no activity related~~the Company purchased 50,000 shares of common stock, at the average price of $18.28 for approximately $0.9 million pursuant to the ~~repurchase plan.~~Share Repurchase Plan. During the nine months ended November 30, 2020, the Company purchased 140,321 shares of common stock, at the average price of $17.56 for approximately $2.5 million pursuant to the Share Repurchase Plan.

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. As of ~~May 31,~~November 30, 2020, the Company sold 3,992,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs). During the ~~three~~nine months ended ~~May 31,~~November 30, 2020, there was no activity related to the ATM offering.

On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised.

					Capital			Total
	Common Stock				in Excess			Distributable
	Shares		Amount		of Par Value			Earnings (Loss)			Net Assets
Balance at February 28, 2019		7,657,156	$	7,657	$	203,552,800		$	(22,685,270	)	$	180,875,187
Increase (Decrease) from Operations:
Net investment income		-		-		-			3,680,788			3,680,788
Net realized gain (loss) from investments		-		-		-			-			-
Net change in unrealized appreciation (depreciation) on investments		-		-		-			3,989,130			3,989,130
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			(20,930	)		(20,930	)
Decrease from Shareholder Distributions:
Distributions of investment income – net		-		-		-			(4,176,132	)		(4,176,132	)
Capital Share Transactions:
Proceeds from issuance of common stock		76,448		77		1,772,557			-			1,772,634
Stock dividend distribution		31,240		31		667,358			-			667,389
Repurchases of common stock		-		-		-			-			-
Offering costs		-		-		(4,365	)		-			(4,365	)
Balance at May 31, 2019		7,764,844	$	7,765	$	205,988,350		$	(19,212,414	)	$	186,783,701
Increase (Decrease) from Operations:
Net investment income		-		-		-			4,956,074			4,956,074
Net realized gain (loss) from investments		-		-		-			1,870,089			1,870,089
Net change in unrealized appreciation (depreciation) on investments		-		-		-			1,457,872			1,457,872
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			(704,263	)		(704,263	)
Decrease from Shareholder Distributions:
Distributions of investment income – net		-		-		-			(4,336,226	)		(4,336,226	)
Capital Share Transactions:
Proceeds from issuance of common stock		1,371,667		1,371		34,101,012			-			34,102,383
Stock dividend distribution		31,545		32		714,497			-			714,529
Repurchases of common stock		-		-		-			-			-
Offering costs		-		-		(507,592	)		-			(507,592	)
Balance at August 31, 2019		9,168,056	$	9,168	$	240,296,267		$	(15,968,868	)	$	224,336,567
Increase (Decrease) from Operations:
Net investment income		-		-		-			4,575,303			4,575,303
Net realized gain (loss) from investments		-		-		-			10,739,678			10,739,678
Net change in unrealized appreciation (depreciation) on investments		-		-		-			(536,151	)		(536,151	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			(1,061,608	)		(1,061,608	)
Decrease from Shareholder Distributions:
Distributions of investment income – net		-		-		-			(5,323,383	)		(5,323,383	)
Capital Share Transactions:
Proceeds from issuance of common stock		1,952,367		1,951		49,351,357			-			49,353,308
Stock dividend distribution		34,575		36		806,857			-			806,893
Repurchases of common stock		-		-		-			-			-
Offering costs		-		-		(710,257	)		-			(710,257	)
Balance at November 30, 2019		11,154,998	$	11,155	$	289,744,224		$	(7,575,029	)	$	282,180,350
Increase (Decrease) from Operations:
Net investment income		-		-		-			66,106			66,106
Net realized gain (loss) from investments		-		-		-			30,267,388			30,267,388
Net change in unrealized appreciation (depreciation) on investments		-		-		-			(5,681,765	)		(5,681,765	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-		-		-			2,141,150			2,141,150
Decrease from Shareholder Distributions:
Distributions of investment income – net		-		-		-			(6,261,839	)		(6,261,839	)
Capital Share Transactions:
Proceeds from issuance of common stock		26,865		27		676,089			-			676,116
Stock dividend distribution		35,682		36		907,645			-			907,681
Repurchases of common stock		-		-		-			-			-
Offering costs		-		-		(8,334	)		-			(8,334	)
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles		-		-		(1,842,633	)		1,842,633			-
Balance at February 29, 2020		11,217,545	$	11,218	$	289,476,991		$	14,798,644		$	304,286,853

The Company adopted Rule 3-04/Rule 8-03(a)(5) under Regulation S-X (Note 2). Pursuant to the regulation, the Company has
presented a reconciliation of the changes in each significant caption of stockholders’ equity as shown in the tables below:

   Common Stock
Capital
in Excess

Total
Distributable

   Shares    Amount    of Par Value Earnings (Loss) Net Assets
Balance at February 28, 2019
   7,657,156    $ 7,657    $ 203,552,800 $ (22,685,270 ) $ 180,875,187
Increase (Decrease) from Operations:

Net investment income
   —      —      —   3,680,788 3,680,788
Net realized gain (loss) from investments
   —      —      —   —   —
Net change in unrealized appreciation (depreciation) on investments
   —      —      —   3,989,130 3,989,130
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments
   —      —      —   (20,930 ) (20,930 )
Decrease from Shareholder Distributions:

Distributions of investment income – net
   —      —      —   (4,176,132 ) (4,176,132 )
Capital Share Transactions:

Proceeds from issuance of common stock
   76,448    77    1,772,557 —   1,772,634
Stock dividend distribution
   31,240    31    667,358 —   667,389
Repurchases of common stock
   —      —      —   —   —
Offering costs
   —      —      (4,365 ) —   (4,365 )






Balance at May 31, 2019
   7,764,844    $ 7,765    $ 205,988,350 $ (19,212,414 ) $ 186,783,701






Increase (Decrease) from Operations:

Net investment income
   —      —      —   4,956,074 4,956,074
Net realized gain (loss) from investments
   —      —      —   1,870,089 1,870,089
Net change in unrealized appreciation (depreciation) on investments
   —      —      —   1,457,872 1,457,872
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments
   —      —      —   (704,263 ) (704,263 )
Decrease from Shareholder Distributions:

Distributions of investment income – net
   —      —      —   (4,336,226 ) (4,336,226 )
Capital Share Transactions:

Proceeds from issuance of common stock
   1,371,667    1,371    34,101,012 —   34,102,383
Stock dividend distribution
   31,545    32    714,497 —   714,529
Repurchases of common stock
   —      —      —   —   —
Offering costs
   —      —      (507,592 ) —   (507,592 )






Balance at August 31, 2019
   9,168,056    $ 9,168    $ 240,296,267 $ (15,968,868 ) $ 224,336,567






Increase (Decrease) from Operations:

Net investment income
   —      —      —   4,575,303 4,575,303
Net realized gain (loss) from investments
   —      —      —   10,739,678 10,739,678
Net change in unrealized appreciation (depreciation) on investments
   —      —      —   (536,151 ) (536,151 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments
   —      —      —   (1,061,608 ) (1,061,608 )
Decrease from Shareholder Distributions:

Distributions of investment income – net
   —      —      —   (5,323,383 ) (5,323,383 )
Capital Share Transactions:

Proceeds from issuance of common stock
   1,952,367    1,951    49,351,357 —   49,353,308
Stock dividend distribution
   34,575    36    806,857 —   806,893
Repurchases of common stock
   —      —      —   —   —
Offering costs
   —      —      (710,257 ) —   (710,257 )






Balance at November 30, 2019
   11,154,998    $ 11,155    $ 289,744,224 $ (7,575,029 ) $ 282,180,350






Increase (Decrease) from Operations:

Net investment income
   —      —      —   66,106 66,106
Net realized gain (loss) from investments
   —      —      —   30,267,388 30,267,388
Net change in unrealized appreciation (depreciation) on investments
   —      —      —   (5,681,765 ) (5,681,765 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments
   —      —      —   2,141,150 2,141,150
Decrease from Shareholder Distributions:

Distributions of investment income – net
   —      —      —   (6,261,839 ) (6,261,839 )
Capital Share Transactions:

Proceeds from issuance of common stock
   26,865    27    676,089 —   676,116
Stock dividend distribution
   35,682    36    907,645 —   907,681
Repurchases of common stock
   —      —      —   —   —
Offering costs
   —      —      (8,334 ) —   (8,334 )
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles
   —      —      (1,842,633 ) 1,842,633 —






Balance at February 29, 2020
   11,217,545    $ 11,218    $ 289,476,991 $ 14,798,644 $ 304,286,853






Increase (Decrease) from Operations:

Net investment income
   —      —      —   9,018,314 9,018,314
Net realized gain (loss) from investments
   —      —      —   8,480 8,480
Net change in unrealized appreciation (depreciation) on investments
   —      —      —   (31,950,369 ) (31,950,369 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments
   —      —      —   267,740 267,740
Decrease from Shareholder Distributions:

Distributions of investment income – net
   —      —      —   —   —
Capital Share Transactions:

Proceeds from issuance of common stock
   —      —      —   —   —
Stock dividend distribution
   —      —      —   —   —
Repurchases of common stock
   —      —      —   —   —
Offering costs
   —      —      —   —   —






Balance at May 31, 2020
   11,217,545    $ 11,218    $ 289,476,991 $ (7,857,191 ) $ 281,631,018

							Capital			Total
	Common Stock						in Excess			Distributable
	Shares			Amount			of Par Value			Earnings (Loss)			Net Assets
Increase (Decrease) from Operations:
Net investment income		-			-			-			9,018,314			9,018,314
Net realized gain (loss) from investments		-			-			-			8,480			8,480
Net change in unrealized appreciation (depreciation) on investments		-			-			-			(31,950,369	)		(31,950,369	)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-			-			-			267,740			267,740
Decrease from Shareholder Distributions:
Distributions of investment income – net		-			-			-			-			-
Capital Share Transactions:
Proceeds from issuance of common stock		-			-			-			-			-
Stock dividend distribution		-			-			-			-			-
Repurchases of common stock		-			-			-			-			-
Offering costs		-			-			-			-			-
Balance at May 31, 2020		11,217,545		$	11,218		$	289,476,991		$	(7,857,191	)	$	281,631,018
Increase (Decrease) from Operations:
Net investment income		-			-			-			5,334,713			5,334,713
Net realized gain (loss) from investments		-			-			-			11,929			11,929
Net change in unrealized appreciation (depreciation) on investments		-			-			-			16,580,401			16,580,401
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-			-			-			(116,521	)		(116,521	)
Decrease from Shareholder Distributions:
Distributions of investment income – net		-			-			-			(4,487,015	)		(4,487,015	)
Capital Share Transactions:
Proceeds from issuance of common stock		-			-			-			-			-
Stock dividend distribution		47,098			46			774,944			-			774,990
Repurchases of common stock		(90,321	)		(90	)		(1,550,327	)		-			(1,550,417	)
Repurchase fees		-			-			(1,740	)		-			(1,740	)
Offering costs		-			-			-			-			-
Balance at August 31, 2020		11,174,322		$	11,174		$	288,699,868		$	9,466,316		$	298,177,358
Increase (Decrease) from Operations:
Net investment income		-			-			-			4,471,102			4,471,102
Net realized gain (loss) from investments		-			-			-			1,798			1,798
Income tax (provision) benefit from realized gain on investments											(3,895,354	)		(3,895,354	)
Net change in unrealized appreciation (depreciation) on investments		-			-			-			5,998,830			5,998,830
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		-			-			-			(210,057	)		(210,057	)
Decrease from Shareholder Distributions:
Distributions of investment income – net		-			-			-			(4,581,469	)		(4,581,469	)
Capital Share Transactions:
Proceeds from issuance of common stock		-			-			-			-			-
Stock dividend distribution		45,706			46			805,883			-			805,929
Repurchases of common stock		(50,000	)		(50	)		(914,194	)		-			(914,244	)
Repurchase fees		-			-			(1,003	)		-			(1,003	)
Offering costs		-			-			-			-			-
Balance at November 30, 2020		11,170,028		$	11,170		$	288,590,554		$	11,251,166		$	299,852,890

Note 11. Earnings Per Share

In accordance with the provisions of FASB ASC Topic 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase in net assets resulting from operations per share for the three and nine months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019 (dollars in thousands except share and per share amounts):


	For the three months ended					For the three months ended				For the nine months ended
Basic and Diluted	May 31, 2020			May 31, 2019		November 30, 2020		November 30, 2019		November 30, 2020		November 30, 2019
Net increase (decrease) in net assets resulting from operations	$	(22,656	)	$	7,649	$	6,366	$	13,717	$	5,521	$	28,946
Weighted average common shares outstanding		11,217,545			7,746,187		11,169,817		10,036,086		11,198,287		8,702,190
Weighted average earnings (loss) per common share	$	(2.02	)	$	0.99	$	0.57	$	1.37	$	0.49	$	3.33

Note 12. Dividend

On October 7, 2020, our board of directors declared a dividend of $0.41 per share, which was paid on November 10, 2020, to common stockholders of record as of October 26, 2020. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6, 9, and 10, 2020.

On July 7, 2020, our board of directors declared a dividend of $0.40 per share, which was paid on August 12, 2020, to common stockholders of record as of July 27, 2020. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.45 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.

During the three months ended May 31, 2020, there were no dividends declared.

On February 26, 2019, our board of directors declared a dividend of $0.54 per share, which was paid on March 28, 2019, to common stockholders of record as of March 14, 2019. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.36 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28, 2019.

The following table summarizes dividends declared for the ~~three~~nine months ended ~~May 31, 2019~~November 30, 2020 (dollars in thousands except per share amounts):


					Amount Per Share		Total Amount*
Date Declared	Record Date		Payment Date		Amount Per Share		Total Amount*		Record Date	Payment Date	Amount Per Share		Total Amount*
February 26, 2019		March 14, 2019		March 28, 2019	$	0.54	$	4,176

October 6, 2020									October 27, 2020	November 10, 2020	$	0.41	$	4,581
July 7, 2020									July 27, 2020	August 12, 2020		0.40		4,487
Total dividends declared					$	0.54	$	4,176			$	0.81	$	9,068

Total amount is calculated based on the number of shares outstanding at the date of record.

The following table summarizes dividends declared for the nine months ended November 30, 2019 (dollars in thousands except per share amounts):

Date Declared	Record Date	Payment Date	Amount Per Share		Total Amount*
August 27, 2019	September 13, 2019	September 26, 2019	$	0.56	$	5,323
May 28, 2019	June 13, 2019	July 27, 2019		0.55		4,336
February 26, 2019	March 14, 2019	March 28, 2019		0.54		4,176
Total dividends declared			$	1.65	$	13,835

Total amount is calculated based on the number of shares outstanding at the date of record.

Note 13. Financial Highlights

The following is a schedule of financial highlights as of and for the ~~three~~nine months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019:

Per share data
   May 31, 2020 May 31, 2019
Net asset value at beginning of period
   $ 27.13 $ 23.62
Net investment income(1)
   0.80 0.48
Net realized and unrealized gains (losses) on investments(1)
   (2.82 ) 0.51


Net increase (decrease) in net assets resulting from operations
   (2.02 ) 0.99
Distributions declared from net investment income
   —   (0.54 )


Total distributions to stockholders
   —   (0.54 )
Dilution(2)
   —   (0.01 )


Net asset value at end of period
   $ 25.11 $ 24.06


Net assets at end of period
   $ 281,631,018 $ 186,783,701
Shares outstanding at end of period
   11,217,545 7,764,844
Per share market value at end of period
   $ 15.18 $ 24.65
Total return based on market value(3)(4)
   (33.74 )% 9.69 %
Total return based on net asset value(3)(5)
   (7.45 )% 4.42 %
Ratio/Supplemental data:

Ratio of net investment income to average net assets(6)
   10.33 % 11.39 %
Expenses:

Ratio of operating expenses to average net assets(7)
   4.84 % 6.69 %
Ratio of incentive management fees expense (benefit) to average net assets(3)
   (0.63 )% 1.15 %
Ratio of interest and debt financing expenses to average net assets(7)
   3.47 % 8.37 %


Ratio of total expenses to average net assets(6)
   7.68 % 16.21 %
Portfolio turnover rate(3)(8)
   1.93 % 6.63 %
Asset coverage ratio per unit(9)
   5,694 2,389
Average market value per unit

Credit Facility(10)
   N/A N/A
SBA Debentures(10)
   N/A N/A
2023 Notes
   N/A $ 25.78
2025 Notes
   $ 22.15 $ 25.28

Per share data	November 30, 2020			November 30, 2019
Net asset value at beginning of period	$	27.13		$	23.62
Net investment income(1)		1.68			1.52
Net realized and unrealized gain and losses on investments(1)		(1.19	)		1.81
Net increase in net assets resulting from operations		0.49			3.33
Distributions declared from net investment income		(0.81	)		(1.65	)
Total distributions to stockholders		(0.81	)		(1.65	)
Issuance of common stock above net asset value (2)		-			-
Repurchases of common stock(3)		0.11			-
Dilution(4)		(0.08	)		-
Net asset value at end of period	$	26.84		$	25.30
Net assets at end of period	$	299,852,890		$	282,180,350
Shares outstanding at end of period		11,170,028			11,154,998
Per share market value at end of period	$	22.13		$	25.10
Total return based on market value(5)(6)		1.24	%		17.15	%
Total return based on net asset value(5)(7)		3.69	%		15.17	%
Ratio/Supplemental data:
Ratio of net investment income to average net assets(8)		8.66	%		9.15	%
Expenses:
Ratio of operating expenses to average net assets(9)		5.02	%		5.30	%
Ratio of incentive management fees to average net assets(5)		0.66	%		3.34	%
Ratio of interest and debt financing expenses to average net assets(9)		4.24	%		7.08	%
Ratio of total expenses to average net assets(8)		9.92	%		15.72	%
Portfolio turnover rate(5)(10)		10.07	%		21.77	%
Asset coverage ratio per unit(11)		3,773			3,099
Average market value per unit
Revolving Credit Facility(12)		N/A			N/A
SBA Debentures Payable(12)		N/A			N/A
6.75% Notes Payable 2023(13)		N/A		$	25.64
6.25% Notes Payable 2025	$	23.87		$	25.67
7.25% Notes Payable 2025(14)	$	25.53			N/A
7.75% Notes Payable 2025(12)		N/A			N/A

(1)	Per share amounts are calculated using the weighted average shares outstanding during the period.

(2)	The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date multiplied by (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding during the period.
(3)	Represents the anti-dilutive impact on the net asset value per share ("NAV") of the Company due to the repurchase of common shares. See Note 10, Stockholders' Equity.
(4)	Represents the dilutive effect of issuing common stock below net asset value per share during the period in connection with the satisfaction of the ~~Company’s~~Company's annual RIC distribution requirement and may include the impact of the different share amounts used for different items (weighted average basic common shares outstanding for the corresponding ~~period~~year and actual common shares outstanding at the end of the ~~period)~~year) in the per common share data calculation and rounding impacts. See Note 12, Dividend.

~~(3)~~(5)

Ratios are not annualized.

~~(4)~~(6)

Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions.

~~(5)~~(7)

Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions.

~~(6)~~(8)

Ratios are annualized. Incentive management fees included within the ratio are not annualized.

~~(7)~~(9)

Ratios are annualized.

~~(8)~~(10)

Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

~~(9)~~(11)

Asset coverage ratio per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage ratio per unit is expressed in terms of dollar amounts per $1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause us to be below the required amount of regulatory coverage.

~~(10)~~(12)	The Revolving Credit Facility, ~~and~~ SBA Debentures and 7.75% Notes Payable 2025 are not registered for public trading.
(13)	On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE.
(14)	Period from close of business on June 30, 2020 through November 30, 2020.

Note 14. Subsequent Events

The Company has evaluated subsequent events through the filing of this Form 10-Q and determined that there have been no events that have occurred that would require adjustments to the Company’s consolidated financial statements and disclosures in the consolidated financial statements except for the following:

On June 24, 2020, the Company issued $37.5 million in aggregate principal amount of 7.25% fixed-rate notes due 2025 (the “Second 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.2 million. The Company has granted the underwriters an option to purchase up to an additional $5.625 million in aggregate principal amount of Notes within 30 days, which they fully exercised on July 6, 2020 for additional net proceeds of $5.4 million after deducting additional underwriting commissions of approximately $0.2 million. Interest on the Second 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.25% per year, beginning August 31, 2020. The Second 2025 Notes mature on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering will be used for general corporate purposes in accordance with the Company’s investment objective and strategies. The Second 2025 Notes are expected to be listed on the New York Stock Exchange and to trade thereon within 30 days of the original issue date under the trading symbol “SAK”. The Company has received an investment grade private rating of “BBB” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency.

On ~~July 7, 2020,~~January 5, 2021, the Company declared a dividend of ~~$0.40~~$0.42 per share payable on ~~August 12, 2020,~~February 10, 2021, to common stockholders of record on ~~July 27, 2020.~~January 26, 2021. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP.

Subsequent to ~~May 31,~~November 30, 2020, the global outbreak of the coronavirus (“COVID-19”) pandemic has adversely affected some of the Company’s investments and ~~the related effect~~continues to have adverse consequences on the U.S. and global ~~economies, has had adverse consequences for the business operations of some of the Company’s portfolio companies and, as a result, has had some adverse effects on the Company’s operations.~~economies. The ultimate economic fallout from the pandemic, and the long-term impact on economies, markets, industries and individual ~~issuers, remain~~portfolio companies, remains uncertain. At the time of this filing, there is no indication of a reportable subsequent event impacting the Company’s financial statements for the quarter ended November 30, 2020. The ~~operational~~Company cannot predict the extent to which its financial condition and ~~financial performance~~results of ~~the issuers of securities in which the Company invests depends~~operations will be adversely affected at this time. The potential impact to our results will depend to a large extent on future developments ~~including~~and new information that may emerge regarding the duration and ~~spread~~severity of COVID-19. The Company continues to observe and respond to the ~~outbreak,~~evolving COVID-19 environment and ~~such uncertainty may in turn adversely affect the value and liquidity of the Company’s investments and negatively~~its potential impact ~~the Company’s performance.~~on areas across its business.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Note about Forward-Looking Statements” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended February 29, 2020.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

●

our future operating results and the impact of COVID-19 pandemic thereon;

~~our future operating results and the impact of COVID-19 pandemic thereon;~~

●

the introduction, withdrawal, success and timing of business initiatives and strategies;

●

changes in political, economic or industry conditions, the interest rate environment or financial and capital markets, which could result in changes in the value of our assets;

●

pandemics or other serious public health events, such as the recent global outbreak of COVID-19;

●

the relative and absolute investment performance and operations of our Manager;

●

the impact of increased competition;

●

our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;

●

the unfavorable resolution of any future legal proceedings;

●

our business prospects and the prospects of our portfolio companies, including our and their ability to achieve our respective objectives as a result of the current COVID-19 pandemic;

●

the impact of investments that we expect to make and future acquisitions and divestitures;

●

our contractual arrangements and relationships with third parties;

●

the dependence of our future success on the general economy and its impact on the industries in which we invest and the impact of the COVID-19 pandemic thereon;

●

the ability of our portfolio companies to achieve their objectives;

●

our expected financings and investments;

●

our regulatory structure and tax status, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiaries, and to continue to qualify to be taxed as a regulated investment company (“RIC”);

●

the adequacy of our cash resources and working capital;

●

the timing of cash flows, if any, from the operations of our portfolio companies and the impact of the COVID-19 pandemic thereon;

●

the impact of interest rate volatility on our results, particularly because we use leverage as part of our investment strategy;

●

the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our Manager;

●

the impact of changes to tax legislation and, generally, our tax position;

●

our ability to access capital and any future financings by us;

●

the ability of our Manager to attract and retain highly talented professionals; and

●

the ability of our Manager to locate suitable investments for us and to monitor and effectively administer our investments and the impacts of the COVID-19 pandemic thereon.

~~the introduction, withdrawal, success~~The following statements are not guarantees of future performance and ~~timing~~are subject to risks, uncertainties, and other factors, some of ~~business initiatives~~which are beyond our control and ~~strategies;~~

~~changes in political, economic~~difficult to predict and could cause actual results to differ materially from those expressed or ~~industry conditions, the interest rate environment or financial and capital markets, which could result in changes~~forecasted in the ~~value of our assets;~~forward-looking statements, including without limitation:

~~pandemics or other serious public health events, such as the recent global outbreak of COVID-19;~~

●

changes in laws and regulations, changes in political, economic or industry conditions, and changes in the interest rate environment, including with respect to the anticipated discontinuation of LIBOR, or other conditions affecting the financial and capital markets, including with respect to changes resulting from or in response to, or potentially even the absence of changes as a result of, the impact of the COVID-19 pandemic;

~~the relative and absolute investment performance and operations of our Manager;~~

●

the length and duration of the COVID-19 outbreak in the United States as well as worldwide, and the magnitude of its impact and time required for economic recovery, including with respect to the impact of travel restrictions and other isolation and quarantine measures on the ability of the Manager’s investment professionals to conduct in-person diligence on, and otherwise monitor, existing and future investments;

~~the impact of increased competition;~~

●

an economic downturn and the time period required for robust economic recovery therefrom, including the current economic downturn as a result of the impact of the COVID-19 pandemic, which may have a material impact on our portfolio companies’ results of operations and financial condition, which could lead to the loss of some or all of our investments in certain portfolio companies and have a material adverse effect on our results of operations and financial condition;

~~our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;~~

●

a contraction of available credit, an inability or unwillingness of our lenders to fund their commitments to us and/or an inability to access capital markets or additional sources of liquidity, including as a result of the impact and duration of the COVID-19 pandemic, could have a material adverse effect on our results of operations and financial condition and impair our lending and investment activities;

~~the unfavorable resolution of any future legal proceedings;~~

●

risks associated with possible disruption in our portfolio companies’ operations due to wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics; and

~~our business prospects and the prospects of our portfolio companies, including our and their ability to achieve our respective objectives as a result of the current COVID-19 pandemic;~~

●

the risks, uncertainties and other factors we identify in “Risk Factors” in our most recent Annual Report on Form 10-K under Part I, Item 1A, in our quarterly reports on Form 10-Q, including this report, and in our other filings with the SEC that we make from time to time.

~~the impact of investments that we expect to make and future acquisitions and divestitures;~~

~~our contractual arrangements and relationships with third parties;~~

~~the dependence of our future success on the general economy and its impact on the industries in which we invest and the impact of the COVID-19 pandemic thereon;~~

~~the ability of our portfolio companies to achieve their objectives;~~

~~our expected financings and investments;~~

~~the adequacy of our cash resources and working capital;~~

~~the timing of cash flows, if any, from the operations of our portfolio companies and the impact of the COVID-19 pandemic thereon;~~

~~the impact of interest rate volatility on our results, particularly because we use leverage as part of our investment strategy;~~

~~the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our Manager;~~

~~the impact of changes to tax legislation and, generally, our tax position;~~

~~our ability to access capital and any future financings by us;~~

~~the ability of our Manager to attract and retain highly talented professionals; and~~

~~the ability of our Manager to locate suitable investments for us and to monitor and effectively administer our investments.~~

Such forward-looking statements may include statements preceded by, followed by or that otherwise include terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “will” and “would” or the negative of these terms or other comparable terminology.

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report on Form 10-Q, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law or SEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this quarterly report on Form 10-Q.

OVERVIEW

We are a Maryland corporation that has elected to be treated as a BDC under the 1940 Act. Our investment objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from our investments. We invest primarily in senior and unitranche leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having earnings before interest, tax, depreciation and amortization (“EBITDA”) of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15.0% of its net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Code.

COVID-19 Update

On March 11, 2020, the World Health Organization declared the novel coronavirus, or COVID-19, as a pandemic, and on March 13, 2020 the United States declared a national emergency with respect to COVID-19. The outbreak of COVID-19 has ~~and continues, to~~ severely ~~impact~~impacted global economic activity and ~~cause~~caused significant volatility and negative pressure in financial markets. The global impact of the outbreak has been rapidly evolving and many countries, including the United States, have reacted by instituting quarantines, ~~mandating business~~restricting travel and ~~school closures~~hospitality, and ~~restricting travel.~~temporarily closing or limiting operations at many corporate offices, retail stores, restaurants, fitness clubs and manufacturing facilities and factories in affected jurisdictions. Such actions are creating disruption in global supply chains and adversely impacting a number of industries. The outbreak could have a continued adverse impact on economic and market conditions and trigger a period of global economic slowdown. The rapid development and fluidity of this situation precludes any prediction as to the ultimate adverse impact of COVID-19. Nevertheless, COVID-19 presents material uncertainty and risks with respect to the underlying value of the Company’s portfolio companies, the Company’s business, financial condition, results of operations and cash flows, such as the potential negative impact to financing arrangements, company decisions to delay, defer and/or modify the character of dividends in order to preserve liquidity, increased costs of operations, changes in law and/or regulation, and uncertainty regarding government and regulatory policy.

We have evaluated subsequent events from ~~June~~December 1, 2020 through ~~July 8, 2020.~~January 6, 2021. However, as the discussion in this Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations relates to the Company’s financial statements for the quarter-ended ~~May 31,~~November 30, 2020, the analysis contained herein may not fully account for impacts relating to the COVID-19 pandemic. In that regard, for example, as of ~~May 31,~~November 30, 2020, the Company valued its portfolio investments in conformity with U.S. GAAP based on the facts and circumstances known by the Company at that time, or reasonably expected to be known at that time. Due to the overall volatility that the COVID-19 pandemic has caused during the months that followed our November 30, 2020 valuation, any valuations conducted now or in the future in conformity with U.S. GAAP could result in a lower fair value of our portfolio. The potential impact to our results going forward will depend to a large extent on future developments and new information that may emerge regarding the duration and severity of COVID- 19 and the actions taken by authorities and other entities to contain the coronavirus or treat its impact, all of which are beyond our control. Accordingly, the Company cannot predict the extent to which its financial condition and results of operations will be affected at this time.

Corporate History

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, which indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business as Saratoga Investment Corp.

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

In January 2011, we registered for public resale of the 986,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received an SBIC license from the Small Business Administration (“SBA”). On August 14, 2019, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), also received an SBIC license from the SBA.

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% fixed-rate unsecured notes due 2020 (the “2020 Notes”) for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. The 2020 Notes were listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share. The 2020 Notes were redeemed in full on January 13, ~~2017.~~2017 and are no longer listed on the NYSE.

On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. Prior to the 2020 Notes being redeemed in full, the Company sold 539,725 bonds with a principal of $13.5 million at an average price of $25.31 for aggregate net proceeds of $13.4 million (net of transaction costs).

On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 6.75% fixed-rate unsecured notes due 2023 (the “2023Notes”) for net proceeds of $71.7 million after deducting underwriting commissions of approximately $2.3 million and offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. The 2023 Notes were listed on the NYSE under the trading symbol “SAB” with a par value of $25.00 per share. On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes.

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered through this offering was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. As of ~~May 31,~~November 30, 2020, the Company sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs). During the ~~three~~nine months ended ~~May 31,~~November 30, 2020, there was no activity related to the ATM offering.

On December 14, 2018, the Company completed the third refinancing of the Saratoga CLO (the “2013-1 Reset CLO Notes”). This refinancing, among other things, extended the Saratoga CLO reinvestment period to January 2021, and extended its legal maturity to January 2030. A non-call period of January 2020 was also added. In addition to and as part of the refinancing, the Saratoga CLO has also been upsized from $300 million in assets to approximately $500 million. As part of this refinancing and upsizing, the Company invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $2.5 million in aggregate principal amount of the Class F-R-2 Notes tranche and $7.5 million in aggregate principal amount of the Class G-R-2 Notes tranche at par. Concurrently, the existing $4.5 million of Class F notes were repaid.

the underwriters’ option to purchase an additional $2.5 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate, interest payment dates and maturity remain unchanged from the existing 6.25% 2025 Notes issued in August 2018. The net proceeds from this offering were used for general corporate purposes in accordance with our investment objective and strategies. The financing costs and discount of $1.0 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes. As of ~~May 31,~~November 30, 2020, the total 6.25% 2025 Notes outstanding was $60.0 million. The 6.25% 2025 Notes are listed on the NYSE under the trading symbol “SAF” with a par value of $25.00 per share.

On August 14, 2019, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), also received an SBIC license from the SBA. The new license will provide up to $175.0 million in additional long-term capital in the form of SBA debentures.

On February 11, 2020, the Company entered into an unsecured loan agreement ~~(“CLO 2013-1 Warehouse 2 Loan”)~~ with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, ~~Ltd (“CLO 2013-1 Warehouse 2”)~~Ltd., a wholly-owned subsidiary of Saratoga Investment Corp. CLO ~~pursuant~~2013-1, Ltd. Pursuant to which CLO 2013-1 Warehouse 2 may borrow from time to time up to $20.0 million from the Company in order to provide capital necessary to support warehouse activities. ~~The~~On October 23, 2020, the CLO 2013-1 Warehouse 2 Loan was increased to $25.0 million availability, which was immediately fully drawn and, which expires on August 20, ~~2021, bears~~2021. The interest rate was also amended to be based on a pricing grid, starting at an annual rate of 3M USD LIBOR ~~+7.5%~~+ 4.46%. As of November 30, 2020, the Company’s investment in the CLO 2013-1 Warehouse 2 had a fair value of $24.8 million.

On June 24, 2020, the Company issued $37.5 million in aggregate principal amount of our 7.25% fixed-rate notes due 2025 (the ~~“Second~~“7.25% 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately ~~$0.2~~$0.3 million. ~~The Company has granted~~On July 6, 2020, the underwriters anexercised their option in full to purchase ~~up to~~ an additional $5.625 million in aggregate principal amount of ~~Notes within 30 days, which they fully exercised on July 6, 2020 for additional net~~its 7.25% unsecured notes due 2025. Net proceeds ofto the Company were $5.4 million after deducting ~~additional~~ underwriting commissions of approximately $0.2 million. Interest on the ~~Second~~7.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.25% per year, beginning August 31, 2020. The ~~Second~~7.25% 2025 Notes mature on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering ~~will be~~were used for general corporate purposes in accordance with ~~the Company’s~~our investment objective and strategies. ~~The Second~~Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and are ~~expected to be listed on~~being amortized over the ~~New York Stock Exchange and to trade thereon within 30 days~~term of the ~~original issue date under the trading symbol “SAK”.~~7.25% 2025 Notes. The Company has received an investment grade private rating of “BBB” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency. As of November 30, 2020, the total 7.25% 2025 Notes outstanding was $43.1 million. The 7.25% 2025 Notes are listed on the NYSE under the trading symbol “SAK” with a par value of $25.00 per share.

On July 9, 2020, the Company issued $5.0 million aggregate principal amount of our 7.75% fixed-rate Notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% Notes 2025 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year, beginning August 31, 2020. The 7.75% Notes 2025 mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% Notes 2025 have been capitalized and are being amortized over the term of the Notes. As of November 30, 2020, the total 7.25% 2025 Notes outstanding was $5.0 million. The 7.75% 2025 Notes are unlisted and has a par value of $25.00 per share.

Critical Accounting Policies

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These

estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820,Fair Value Measurement and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold or its liabilities are to be transferred at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisors, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

●

An independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. We use a third-party independent valuation firm to value our investment in the subordinated notes of Saratoga CLO and the Class F-R-2 Notes and Class G-R-2 Notes tranches of the Saratoga CLOs every quarter.

In addition, all our investments are subject to the following valuation process:

The audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

●

Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by Saratoga Investment Advisors and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Payment-in-Kind Interest

The Company holds debt and preferred equity investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt or preferred equity investments may provide for a portion or all of the interest to be PIK. To the extent interest is PIK, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity or common equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 with its reinvestment period extended to October 2016. On November 15, 2016, we completed a second refinancing of the Saratoga CLO with its reinvestment period extended to October 2018.

On December 14, 2018, we completed a third refinancing and upsize of the Saratoga CLO. The third Saratoga CLO refinancing, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030. A non-call period of January 2020 was also added. Following this refinancing, the Saratoga CLO portfolio increased from approximately $300.0 million in aggregate principal amount to approximately $500.0 million of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO and also purchased $2.5 million in aggregate principal amount of the Class F-R-2 and $7.5 million in aggregate principal amount of the Class G-R-2 notes tranches at par, with a coupon of LIBOR plus 8.75% and LIBOR plus 10.00%, respectively. As part of this refinancing, we also redeemed our existing $4.5 million aggregate amount of the Class F notes tranche at par.

On February 11, 2020, the Company entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, ~~Ltd~~Ltd. (“CLO 2013-1 Warehouse 2”), a wholly-owned subsidiary of Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), pursuant to which CLO 2013-1 Warehouse 2 may borrow from time to time up to $20.0 million from the Company in order to provide capital necessary to support warehouse activities. ~~The~~On October 23, 2020, the CLO 2013-1 Warehouse 2 Loan was increased to $25.0 million availability, which was immediately fully drawn and, which expires on August 20, ~~2021, bears~~2021. The interest rate was also amended to be based on a pricing grid, starting at an annual rate of 3M USD LIBOR + ~~7.5%~~4.46%. ~~For the three months ended May 31,~~As of November 30, 2020, the ~~maximum amount invested by us~~Company’s investment in the CLO 2013-1 Warehouse 2 ~~amounted to $5.0 million. As of May 31, 2020, the~~had a fair value of ~~our investment in CLO 2013-1 Warehouse 2 was $4.0~~ $24.8 million.

The Saratoga CLO remains effectively 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Prior to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, we received a base management fee of 0.25% per annum and a subordinated management fee of 0.25% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds.

Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, we are no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our Manager for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

●

organization;

~~organization;~~

●

calculating our net asset value (including the cost and expenses of any independent valuation firm);

~~calculating our net asset value (including the cost and expenses of any independent valuation firm);~~

●

expenses incurred by our Manager payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

●

expenses incurred by our Manager payable for travel and due diligence on our prospective portfolio companies;

~~expenses incurred by our Manager payable for travel and due diligence on our prospective portfolio companies;~~

●

interest payable on debt, if any, incurred to finance our investments;

~~interest payable on debt, if any, incurred to finance our investments;~~

●

offerings of our common stock and other securities;

~~offerings of our common stock and other securities;~~

●

investment advisory and management fees;

~~investment advisory and management fees;~~

●

fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

~~fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;~~

●

transfer agent and custodial fees;

~~transfer agent and custodial fees;~~

●

federal and state registration fees;

~~federal and state registration fees;~~

●

all costs of registration and listing our common stock on any securities exchange;

~~all costs of registration and listing our common stock on any securities exchange;~~

●

federal, state and local taxes;

~~federal, state and local taxes;~~

●

independent directors’ fees and expenses;

~~independent directors’ fees and expenses;~~

●

costs of preparing and filing reports or other documents required by governmental bodies (including the U.S. Securities and Exchange Commission (“SEC”) and the SBA);

~~costs of preparing and filing reports or other documents required by governmental bodies (including the U.S. Securities and Exchange Commission (“SEC”) and the SBA);~~

●

costs of any reports, proxy statements or other notices to common stockholders including printing costs;

~~costs of any reports, proxy statements or other notices to common stockholders including printing costs;~~

●

our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

~~our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;~~

●

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

~~direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and~~

●

administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an Administration Agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters and an incentive fee.

The incentive fee had two parts:

●

A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our former investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

●

A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis on each investment in the Company’s portfolio, less the aggregate amount of capital gains incentive fees paid to our former investment adviser through such date.

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007 and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Quarterly Report.

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

●

Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

●

We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

~~We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.~~

Capital Gains Incentive Fee

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its Manager when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the Manager if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

New Accounting Pronouncements

~~There~~

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (“ASU 2020-04”). The amendments in ASU 2020-04 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are ~~currently no new accounting pronouncements that would have~~met. The standard is effective as of March 12, 2020 through December 31, 2022. Management does not believe this optional guidance has a material impact on the ~~Company.~~

Company’s consolidated financial statements and disclosures.
SEC Rule 12b-2 Update
In March 2020, the SEC adopted a final rule under SEC Release No. 34-88365 (the “Final Rule”), amending the accelerated filer and large accelerated filer definitions in Exchange Act Rule 12b-2. The amendments include a provision under which a BDC will be excluded from the “accelerated filer” and “large accelerated filer” definitions if the BDC has (1) a public float of $75 million or more, but less than $700 million, and (2) has annual investment income of less than $100 million. In addition, BDCs are subject to the same transition provisions for accelerated filer and large accelerated filer status as other issuers, but instead substituting investment income for revenue. The amendments will reduce the number of issuers required to comply with the auditor attestation on the internal control over financial reporting requirement provided under Section 404(b) of the Sarbanes-Oxley Act of 2002. The Final Rule applies to annual report filings due on or after April 27, 2020. The Company has assessed the Final Rule, and believes that effective February 28, 2021, it will no longer be an accelerated filer. As a result, the Company will file its Annual Report on Form 10-K for the fiscal year ending February 28, 2021 as a non-accelerated filer.

Portfolio and Investment Activity
Investment Portfolio Overview

   May 31, 2020 February 29, 2020 November 30,
2020 February 29,
2020
   ($ in millions) ($ in millions)
Number of investments(1)
   76 74 83 74
Number of portfolio companies(2)
   39 35 42 35
Average investment per portfolio company(2)
   $ 11.6 $ 12.9 $ 11.7 $ 12.9
Average investment size(1)
   $ 6.1 $ 6.3 $ 6.3 $ 6.3
Weighted average maturity(3)
   2.9yrs 3.1 yrs 2.6 yrs 3.1 yrs
Number of industries
   9 9 32 28
Non-performing or delinquent investments (fair value)
   $ 3.9 $ 2.1 $ 6.2 $ 2.1
Fixed rate debt (% of interest earning portfolio)(3)
   $ 28.6(6.5%) $ 29.7(6.8%) $ 31.3(6.3 )% $ 29.7(6.8 )%
Fixed rate debt (weighted average current coupon)(3)
   8.7% 9.3% 8.8 % 9.3 %
Floating rate debt (% of interest earning portfolio)(3)
   $ 410.3(93.5%) $ 404.4(93.2%) $ 463.0(93.7 )% $ 404.4(93.2 )%
Floating rate debt (weighted average current spread over LIBOR)(3)(4)
   7.9 % 8.0 % 7.5 % 8.0 %

(1)
Excludes our investment in the subordinated notes of Saratoga CLO.
(2)
Excludes our investment in the subordinated notes of Saratoga CLO, Class F-R-2 Notes and Class G-R-2 Notes tranches of Saratoga CLO and loan to Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd.
(3)
Excludes our investment in the subordinated notes of Saratoga CLO and equity interests.
(4)
Calculation uses either 1-month or 3-month LIBOR, depending on the contractual terms, and after factoring in any existing LIBOR floors.
During the three months ended ~~May 31,~~November 30, 2020, we invested ~~$39.0~~$51.3 million in new or existing portfolio companies and had ~~$9.4~~$18.3 million in aggregate amount of exits and repayments resulting in net investments of ~~$29.6~~$33.0 million for the period. During the three months ended ~~May 31,~~November 30, 2019, we invested ~~$27.4~~$40.8 million in new or existing portfolio companies and had ~~$26.9~~$51.2 million in aggregate amount of exits and repayments resulting in net exits and repayments of $10.4 million for the period.
During the nine months ended November 30, 2020, we invested $122.0 million in new or existing portfolio companies and had $50.9 million in aggregate amount of exits and repayments resulting in net investments of ~~$0.5~~$71.1 million for the period. During the nine months ended November 30, 2019, we invested $160.7 million in new or existing portfolio companies and had $97.2 million in aggregate amount of exits and repayments resulting in net investments of $63.5 million for the period.

Portfolio Composition
Our portfolio composition at ~~May 31,~~November 30, 2020 and February 29, 2020 at fair value was as follows:

   May 31, 2020 February 29, 2020 November 30, 2020 February 29, 2020
   Percentage
of Total
Portfolio Weighted
Average
Current
Yield Percentage
of Total
Portfolio Weighted
Average
Current
Yield Percentage
of Total
Portfolio Weighted
Average
Current
Yield Percentage
of Total
Portfolio Weighted
Average
Current
Yield
First lien term loans
   73.4 % 9.9 % 71.3 % 9.6 % 74.5 % 9.5 % 71.3 % 9.6 %
Second lien term loans
   14.4 11.1 15.1 10.7 9.2 11.5 15.1 10.7
Unsecured term loans
   1.2 6.7 0.9 9.3 4.9 4.4 0.9 9.3
Structured finance securities
   5.6 11.7 6.7 11.4 5.7 17.6 6.7 11.4
Equity interests
   5.4 —   6.0 —   5.7 - 6.0 -


Total
   100.0 % 9.6 % 100.0 % 9.3 % 100.0 % 9.4 % 100.0 % 9.3 %


At ~~May 31,~~November 30, 2020, our investment in the subordinated notes of Saratoga CLO, a collateralized loan obligation fund, had a fair value of ~~$18.1~~$21.6 million and constituted ~~3.7%~~3.9% of our portfolio. This investment constitutes a first loss position in a portfolio that, as of ~~May 31,~~November 30, 2020 and February 29, 2020, was composed of ~~$519.0~~$540.0 million and $528.4 million, respectively, in aggregate principal amount of primarily senior secured first lien term loans. In addition, as of ~~May 31,~~November 30, 2020, we also own $2.5 million in aggregate principal of the F-R-2 Notes and $7.5 million in aggregate principal of the G-R-2 Notes in the Saratoga CLO, that only rank senior to the subordinated notes. At ~~May 31,~~November 30, 2020, our investment in CLO 2013-1 Warehouse 2, a wholly-owned subsidiary of Saratoga CLO, had a fair value of ~~$4.0~~$24.8 million and constituted ~~0.8%~~4.5% of our portfolio.
This investment is subject to unique risks. (See “Part 1. Item 1A. Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our Annual Report on Form 10-K for the fiscal year ended February 29, 2020).
We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at ~~May 31,~~November 30, 2020, ~~$449.0~~$512.7 million or ~~98.1%~~99.2% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and ~~seven~~five Saratoga CLO portfolio investments were in default with a fair value of ~~$3.6~~$1.7 million. At February 29, 2020, $494.2 million or 98.6% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and two Saratoga CLO portfolio investments were in default with a fair value of $1.4 million. For more information relating to the Saratoga CLO, see the audited financial statements for Saratoga in our Annual Report on Form 10-K for the fiscal year ended February 29, 2020.
Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—performing credit; (Yellow)—underperforming credit; (Red)—in principal payment default and/or expected loss of principal.

Portfolio CMR distribution
The CMR distribution for our investments at ~~May 31,~~November 30, 2020 and February 29, 2020 was as follows:
Saratoga Investment Corp.

   May 31, 2020 February 29, 2020 November 30, 2020 February 29, 2020
Color Score
   Investments
at
Fair Value    Percentage
of Total
Portfolio Investments
at
Fair Value    Percentage
of Total
Portfolio Investments
at
Fair Value Percentage
of Total
Portfolio Investments
at
Fair Value Percentage
of Total
Portfolio
   ($ in thousands) ($ in thousands)
Green
   $ 396,777    82.2 % $ 429,784    88.5 % $ 458,469 83.8 % $ 429,784 88.5 %
Yellow
   40,148    8.3 2,141    0.5 35,836 6.6 2,141 0.5
Red
   2,029    0.4 2,137    0.4 - 0.0 2,137 0.4
N/A(1)
   43,993    9.1 51,570    10.6 52,639 9.6 51,570 10.6






Total
   $ 482,947    100.0 % $ 485,632    100.0 % $ 546,944 100.0 % $ 485,632 100.0 %






(1)
Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.
The change in reserve from $1.2 million as of February 29, 2020 to ~~$1.5~~$2.0 million as of ~~May 31,~~November 30, 2020 was primarily related to the additional interest accruals reserved on My Alarm Center, LLC, Roscoe Medical, Inc. and TMAC Acquisition Co., LLC.
The CMR distribution of Saratoga CLO investments at ~~May 31,~~November 30, 2020 and February 29, 2020 was as follows:
Saratoga CLO

   May 31, 2020 February 29, 2020 November 30, 2020 February 29, 2020
Color Score
   Investments
at
Fair Value    Percentage
of Total
Portfolio Investments
at
Fair Value    Percentage
of Total
Portfolio Investments
at
Fair Value Percentage
of Total
Portfolio Investments
at
Fair Value Percentage
of Total
Portfolio
   ($ in thousands) ($ in thousands)
Green
   $ 381,793    83.4 % $ 456,767    91.1 % $ 439,472 85.0 % $ 456,767 91.1 %
Yellow
   67,179    14.7 37,446    7.5 73,185 14.2 37,446 7.5
Red
   8,772    1.9 6,787    1.4 3,912 0.8 6,787 1.4
N/A(1)
   0    0.0 0    0.0 145 0.0 0 0.0






Total
   $ 457,744    100.0 % $ 501,000    100.0 % $ 516,714 100.0 % $ 501,000 100.0 %






(1)
Comprised of Saratoga CLO’s equity interests.

Portfolio composition by industry grouping at fair value
The following table shows our portfolio composition by industry grouping at fair value at ~~May 31,~~November 30, 2020 and February 29, 2020:
Saratoga Investment Corp.

November 30, 2020 February 29, 2020*
   May 31, 2020 February 29, 2020 Investments
At
Fair Value Percentage
of Total
Portfolio Investments
At
Fair Value Percentage
of Total
Portfolio
   Investments
At
Fair Value    Percentage
of Total
Portfolio Investments
At
Fair Value    Percentage
of Total
Portfolio ($ in thousands)
   ($ in thousands)
Business Services
   $ 294,092    60.9 % $ 285,356    58.8 %
Education Software $ 84,613 15.5 % $ 96,055 19.8 %
IT Services 81,556 14.9 62,541 12.9
Structured Finance Securities(1) 56,131 10.3 34,675 7.1
Education Services 32,358 5.9 36,365 7.5
Healthcare Services
   71,864    14.9 69,072    14.2 30,468 5.4 28,455 5.9
Education
   70,070    14.5 77,341    15.9
Structured Finance Securities(1)
   31,269    6.5 34,675    7.1
Healthcare Software 28,910 5.3 30,764 6.3
Sports Management 24,521 4.5 25,740 5.3
Dental Practice Management Software 22,931 4.2 - 0.0
Payroll Services 19,089 3.5 19,055 3.9
Marketing Services 17,200 3.1 14,200 2.9
Hospitality/Hotel 15,088 2.8 14,894 3.1
Real Estate Services 14,859 2.7 - 0.0
Construction Management Services 14,135 2.6 4,284 0.9
Property Management
   9,981    2.0 11,503    2.4 12,973 2.4 11,503 2.4
Cyber Security 12,868 2.4 9,982 2.1
Corporate Governance 9,522 1.7 9,090 1.9
Industrial Products 9,502 1.7 10,779 2.2
Waste Services 8,969 1.6 9,000 1.9
Healthcare Products Manufacturing 8,153 1.5 7,717 1.6
HVAC Services and Sales 6,930 1.3 - 0.0
Facililties Maintenance 6,538 1.2 5,375 1.1
Dental Practice Management 6,489 1.2 - 0.0
Non-profit Services 5,525 1.0 5,555 1.1
Healthcare Supply 4,338 0.8 2,137 0.4
Field Service Management 3,952 0.7 2,970 0.6
Office Supplies 3,527 0.6 3,799 0.8
Metals 1,998 0.4 3,130 0.6
Restaurant 1,985 0.4 2,140 0.4
Staffing Services 693 0.1 922 0.2
Financial Services 425 0.1 32,090 6.6
Consumer Products 392 0.1 418 0.1
Consumer Services
   1,997    0.4 1,997    0.4 306 0.1 1,997 0.4
Food and Beverage
   1,848    0.4 2,141    0.4
Metals
   1,417    0.3 3,130    0.7
Consumer Products
   409    0.1 417    0.1






Total
   $ 482,947    100.0 % $ 485,632    100.0 % $ 546,944 100.0 % $ 485,632 100.0 %






* Certain reclassifications have been made to previously reported industry groupings to show results on a consistent basis across periods.
(1)
Comprised of our investment in the subordinated notes, Class F-R-2 Notes and Class G-R-2 Notes of Saratoga CLO and Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd.

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at ~~May 31,~~November 30, 2020 and February 29, 2020:
Saratoga CLO

   May 31, 2020 February 29, 2020 November 30, 2020 February 29, 2020
   Investments
at
Fair Value    Percentage
of Total
Portfolio Investments
at
Fair Value    Percentage
of Total
Portfolio Investments
at
Fair Value Percentage
of Total
Portfolio Investments
at
Fair Value Percentage
of Total
Portfolio
   ($ in thousands) ($ in thousands)
Banking Finance Insurance & Real Estate
   $ 86,039    18.8 % $ 87,957    17.6 % $ 96,062 18.6 % $ 87,957 17.6 %
Services: Business
   37,308    8.2 45,735    9.1 44,988 8.7 45,735 9.1
Healthcare & Pharmaceuticals
   33,988    7.4 39,978    8.0 38,770 7.5 39,978 8.0
High Tech Industries
   30,372    6.6 32,897    6.6 38,413 7.4 32,897 6.6
Telecommunications
   28,033    6.1 28,317    5.6 29,327 5.8 28,317 5.6
Services: Consumer
   25,015    5.5 28,327    5.6 24,105 4.7 28,327 5.6
Aerospace & Defense
   24,320    5.3 25,093    5.0 23,741 4.6 25,093 5.0
Beverage Food & Tobacco
   20,588    4.5 21,637    4.3
Media: Advertising Printing & Publishing
   18,085    4.0 19,808    4.0 21,752 4.2 19,808 4.0
Chemicals Plastics & Rubber
   16,401    3.6 14,689    2.9 18,945 3.7 14,689 2.9
Beverage Food & Tobacco 17,512 3.4 21,637 4.3
Consumer goods: Non-durable
   15,409    3.4 15,700    3.1 17,694 3.4 15,700 3.1
Containers Packaging & Glass
   15,050    3.3 15,753    3.1
Hotel Gaming & Leisure
   12,752    2.8 16,883    3.4 17,024 3.3 16,883 3.4
Automotive
   10,976    2.4 13,820    2.8 14,997 2.9 13,820 2.8
Containers Packaging & Glass 12,467 2.4 15,753 3.1
Media: Broadcasting & Subscription 12,573 2.4 7,959 1.6
Retail
   10,511    2.3 14,538    2.9 11,901 2.3 14,538 2.9
Media: Broadcasting & Subscription
   9,826    2.1 7,959    1.6
Capital Equipment
   9,616    2.1 9,551    1.9 10,784 2.1 9,551 1.9
Consumer goods: Durable
   9,528    2.1 11,674    2.3 8,383 1.6 11,674 2.3
Utilities: Oil & Gas
   6,501    1.4 7,306    1.5 7,952 1.5 7,306 1.5
Transportation: Cargo
   6,432    1.4 7,054    1.4 7,095 1.4 7,054 1.4
Construction & Building
   6,175    1.3 7,617    1.5
Forest Products & Paper
   5,056    1.1 5,385    1.1 7,375 1.4 5,385 1.1
Metals & Mining
   3,721    0.8 4,112    0.8 7,352 1.4 4,112 0.8
Transportation: Consumer 6,148 1.2 1,914 0.4
Construction & Building 4,393 0.9 7,617 1.5
Utilities: Electric
   2,683    0.6 4,752    1.0 4,262 0.8 4,752 1.0
Media: Diversified & Production 3,058 0.6 2,711 0.5
Wholesale 2,833 0.5 1,928 0.4
Energy: Oil & Gas
   2,553    0.6 3,559    0.7 2,135 0.4 3,559 0.7
Media: Diversified & Production
   2,478    0.5 2,711    0.5
Transportation: Consumer
   1,937    0.4 1,914    0.4
Energy: Electricity
   1,873    0.4 3,357    0.7 1,990 0.4 3,357 0.7
Utilities
   1,835    0.4 —      0.0 1,708 0.3 - 0.0
Wholesale
   1,727    0.4 1,928    0.4
Environmental Industries
   956    0.2 989    0.2 975 0.2 989 0.2






Total
   $ 457,744    100.0 % $ 501,000    100.0 % $ 516,714 100.0 % $ 501,000 100.0 %






Portfolio composition by geographic location at fair value
The following table shows our portfolio composition by geographic location at fair value at ~~May 31,~~November 30, 2020 and February 29, 2020. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

   May 31, 2020 February 29, 2020 November 30, 2020 February 29, 2020
   Investments
at
Fair Value    Percentage
of Total
Portfolio Investments
at
Fair Value    Percentage
of Total
Portfolio Investments
at
Fair Value Percentage
of Total
Portfolio Investments
at
Fair Value Percentage
of Total
Portfolio
   ($ in thousands) ($ in thousands)
Southeast
   $ 159,280    33.0 % $ 165,353    34.0 % $ 170,188 31.1 % $ 165,353 34.0 %
West
   117,808    24.4 99,390    20.5 130,903 23.9 99,390 20.5
Midwest
   73,130    15.1 75,528    15.5 101,415 18.5 75,528 15.5
Southwest
   53,609    11.1 61,456    12.7
Other 76,867 14.1 55,877 11.5
Northeast
   18,018    3.7 18,047    3.7 22,968 4.2 18,047 3.7
Northwest
   9,623    2.0 9,981    2.1 12,868 2.4 9,981 2.1
Other(1)
   51,479    10.7 55,877    11.5






Southwest(1) 31,735 5.8 61,456 12.7
Total
   $ 482,947    100.0 % $ 485,632    100.0 % $ 546,944 100.0 % $ 485,632 100.0 %






(1)
Comprised of our investment in the subordinated notes, Class F-R-2 Notes and Class G-R-2 Notes of Saratoga CLO, Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd and foreign investments.
Results of operations
Operating results for the three and nine months ended ~~May 31,~~November 30, 2020 and ~~May~~November 30, 2019 was as follows:

   For the three months ended For the three months ended For the nine months ended
   May 31, 2020    May 31, 2019 November 30,
2020 November 30,
2019 November 30,
2020 November 30,
2019
   ($ in thousands) ($ in thousands)
Total investment income
   $ 13,297    $ 12,751 $ 14,283 $ 14,196 $ 41,435 $ 40,835
Total operating expenses
   4,279    9,070 9,812 9,621 22,611 27,623




Net investment income
   9,018    3,681 4,471 4,575 18,824 13,212
Net realized gain (loss) from investments
   8    —   2 10,740 22 12,610
Income tax (provision) benefit from realized gain on investments (3,895 ) - (3,895 ) -
Net change in unrealized appreciation (depreciation) on investments
   (31,950 )    3,989 5,999 (536 ) (9,371 ) 4,911
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments
   268    (21 ) (210 ) (1,062 ) (59 ) (1,787 )




Net increase (decrease) in net assets resulting from operations
   $ (22,656 )    $ 7,649 $ 6,367 $ 13,717 $ 5,521 $ 28,946




Investment income
The composition of our investment income for three and nine months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019 was as follows:

   For the three months ended For the three months ended For the nine months ended
   May 31, 2020    May 31, 2019 November 30,
2020 November 30,
2019 November 30,
2020 November 30,
2019
   ($ in thousands) ($ in thousands)
Interest from investments
   $ 12,150    $ 11,603 $ 12,804 $ 12,899 $ 37,215 $ 36,244
Interest from cash and cash equivalents
   12    51 1 120 14 317
Management fee income
   635    630 624 630 1,884 1,889
Structuring and advisory fee income*
   313    316 545 511 1,798 1,875
Other income*
   187    151 309 36 524 510




Total investment income
   $ 13,297    $ 12,751 $ 14,283 $ 14,196 $ 41,435 $ 40,835




*
Certain prior period amounts have been reclassified to conform to current period presentation.
For the three months ended ~~May 31,~~November 30, 2020, total investment income increased ~~$0.5~~$0.1 million, or ~~4.3%~~0.6% to ~~$13.3~~$14.3 million from $14.2 million for the three months ended November 30, 2019. Interest income from investments decreased $0.1 million, or 0.7%, to $12.8 million for the three months ended ~~May 31, 2019. Interest income~~November 30, 2020 from ~~investments increased $0.6 million, or 4.7%, to $12.2~~$12.9 million for the three months ended ~~May 31, 2020 from $11.6 million for the three months ended May 31,~~November 30, 2019. This reflects the impact of the increase of ~~$73.4~~$59.9 million, or ~~17.9%~~12.3% in total investments at ~~May 31,~~November 30, 2020 from ~~$409.5~~$487.0 million at ~~May 31,~~November 30, 2019, offset by the reduction in LIBOR during this same period. At ~~May 31,~~November 30, 2020, the weighted average current yield on investments was ~~9.6%~~9.4% compared to ~~10.6%~~9.8% at ~~May 31,~~November 30, 2019, which offset ~~some~~most of the increase in investments.
For the nine months ended November 30, 2020, total investment income increased $0.6 million, or 1.5% to $41.4 million from $40.8 million for the nine months ended November 30, 2019. Interest income from investments increased $1.0 million, or 2.7%, to $37.2 million for the nine months ended November 30, 2020 from $36.2 million for the nine months ended November 30, 2019. This reflects the partial period impact of the increase of $59.9 million, or 12.3% in total investments at November 30, 2020 from $487.0 million at November 30, 2019, offset by the reduction in LIBOR during the same period.
For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, total PIK income was ~~$0.7~~$0.3 million and ~~$1.2~~$1.5 million, respectively. For the nine months ended November 30, 2020 and November 30, 2019, total PIK income was $1.4 million and $3.9 million, respectively. This decrease was primarily due to the sale of our investment in Easy Ice, LLC during the fourth quarter of the fiscal year ended February 29, 2020, which primarily generated PIK income.
Management fee income reflects the fee income received for managing the Saratoga CLO. For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, total management fee income was $0.6 million and $0.6 million, respectively. For the nine months ended November 30, 2020 and November 30, 2019, total management fee income was $1.9 million and $1.9 million, respectively.

Operating expenses
The composition of our operating expenses for the three and nine months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019 was as follows:

   For the three months ended
   May 31, 2020    May 31, 2019
   ($ in thousands)
Interest and debt financing expenses
   $ 2,564    $ 3,864
Base management fees
   2,160    1,812
Incentive management fees expense (benefit)
   (1,858 )    2,113
Professional fees
   387    395
Administrator expenses
   556    500
Insurance
   68    65
Directors fees and expenses
   60    60
General & administrative and other expenses
   351    259
Income tax expense (benefit)
   (9 )    2




Total operating expenses
   $ 4,279    $ 9,070




For the three months ended For the nine months ended
November 30,
2020 November 30,
2019 November 30,
2020 November 30,
2019
($ in thousands)
Interest and debt financing expenses $ 3,560 $ 3,897 $ 9,452 $ 11,628
Base management fees 2,324 2,147 6,694 5,956
Incentive management fees expense (benefit) 2,295 3,102 1,966 7,301
Professional fees 503 401 1,258 1,181
Administrator expenses 694 556 1,852 1,575
Insurance 67 64 203 193
Directors fees and expenses 60 60 195 218
General & administrative and other expenses 279 395 963 1,036
Income tax expense (benefit) 30 (1,001 ) 28 (1,465 )
Total operating expenses $ 9,812 $ 9,621 $ 22,611 $ 27,623
For the three months ended ~~May 31,~~November 30, 2020, total operating expenses ~~decreased $4.8~~increased $0.2 million, or ~~52.8%~~2.0% compared to the three months ended ~~May 31,~~November 30, 2019. For the nine months ended November 30, 2020, total operating expenses decreased $5.0 million, or 18.1% compared to the nine months ended November 30, 2019.
For the three months ended ~~May 31,~~November 30, 2020, interest and debt financing expenses decreased ~~$1.3~~$0.3 million, or ~~33.7%~~8.7% compared to the three months ended ~~May 31,~~November 30, 2019. The decrease is primarily attributable to a decrease in average outstanding debt from ~~$284.5~~$286.6 million for the three months ended ~~May 31,~~November 30, 2019 to ~~$217.4~~$278.4 million for the three months ended ~~May 31,~~November 30, 2020, primarily reflecting the redemption of our 2023 Notes during the fiscal quarter ended February 29, 2020.
For the nine months ended November 30, 2020, interest and debt financing expenses decreased $2.2 million, or 18.7% compared to the nine months ended November 30, 2019. The decrease is primarily attributable to a decrease in average outstanding debt from $284.6 million for the nine months ended November 30, 2019 to $253.6 million for the nine months ended November 30, 2020, primarily reflecting the redemption of our 2023 Notes during the fiscal quarter ended February 29, 2020.
For the three months ended ~~May 31,~~November 30, 2020, the weighted average interest rate on our outstanding indebtedness was ~~4.01%~~4.42% compared to ~~4.80%~~4.79% for the three months ended ~~May 31,~~November 30, 2019. The decrease in weighted average interest rate was primarily driven by the redemption of the 2023 Notes during the fiscal quarter ended February 29, 2020 which carried a fixed rate of 6.75%.
For the nine months ended November 30, 2020, the weighted average interest rate on our outstanding indebtedness was 6.41% compared to 4.81% for the nine months ended November 30, 2019. The decrease in weighted average interest rate was primarily driven by the redemption of the 2023 Notes during the fiscal quarter ended February 29, 2020 which carried a fixed rate of 6.75%.
As of ~~May 31,~~November 30, 2020 and February 29, 2020, the SBA debentures represented ~~73.9%~~61.9% and 71.4% of overall debt, respectively.
For the three months ended ~~May 31,~~November 30, 2020, base management fees increased ~~$0.3~~$0.2 million, or ~~19.2%~~8.3% from $2.1 million to $2.3 million compared to the three months ended ~~May 31,~~November 30, 2019. The increase in base management fees results from the ~~18.9%~~8.0% increase in the average value of our total assets, less cash and cash equivalents, from ~~$412.0~~$493.3 million for the three months ended ~~May 31,~~November 30, 2019 to ~~$489.8~~$532.8 million for the three months ended ~~May 31,~~November 30, 2020. For the nine months ended November 30, 2020, base management fees increased $0.7 million, or 12.4% from $6.0 million to $6.7 million compared to the nine months ended November 30, 2019. The increase in base management fees results from the 12.1% increase in the average value of our total assets, less cash and cash equivalents, from $452.9 million for the nine months ended November 30, 2019 to $507.7 million for the nine months ended November 30, 2020.
For the three months ended ~~May 31,~~November 30, 2020, incentive management fees decreased ~~$4.0~~$0.8 million, or ~~187.9%~~26.0%, compared to the three months ended ~~May 31,~~November 30, 2019. The first part of the incentive management fees ~~increased~~decreased from $1.5 million for the three months ended November 30, 2019 to $1.2 million for the three months ended ~~May 31, 2019 to $1.4 million for the three months ended May 31,~~November 30, 2020, as ~~higher average total assets led~~net equity increased by 32.9% during this period resulting in an increase to ~~increased~~the net investment income ~~above the~~ hurdle rate pursuant to the Management Agreement. The incentive management fees related to capital gains decreased from a ~~$1.0~~$1.6 million expense for the three months ended ~~May 31,~~November 30, 2019 to a ~~$(3.3)~~$1.1 million ~~benefit~~expense for the three months ended ~~May 31,~~November 30, 2020, with the incentive fee expense on unrealized gains on the Company’s Censis and Easy Ice investments last year offsetting the incentive fee expense on this quarter’s unrealized appreciation across numerous investments.

For the nine months ended November 30, 2020, incentive management fees decreased $5.3 million, or 73.1%, compared to the nine months ended November 30, 2019. The first part of the incentive management fees decreased from $4.1 million for the nine months ended November 30, 2019 to $4.0 million for the nine months ended November 30, 2020, as higher average net equity during this period resulted in an increase to the net investment income hurdle rate pursuant to the Management Agreement. The incentive management fees related to capital gains decreased from a $3.2 million expense for the nine months ended November 30, 2019 to a $(2.0) million benefit for the nine months ended November 30, 2020, reflecting a reversal of incentive fee accrual due to an increase in unrealized depreciation on investments ~~as of May 31,~~during the nine months ended November 30, 2020.
For the three and nine months ended ~~May 31,~~November 30, 2020, professional fees ~~decreased $0.01~~increased $0.1 million, or ~~2.1%~~25.4%, and increased $0.08 million, or 6.5%, respectively, compared to the three and nine months ended ~~May 31,~~November 30, 2019.
For the three and nine months ended ~~May 31,~~November 30, 2020, administrator expenses increased $0.1 million, or ~~11.3%~~24.7%, and increased $0.3 million, or 17.6%, respectively, compared to the three and nine months ended ~~May 31,~~November 30, 2019. These increases during the period are primarily attributable to an increase to the cap on the payment or reimbursements of expenses by the Company from $2.0 million to $2.225 million, effective August 1, ~~2019.~~2019, and from $2.225 million to $2.775 million, effective August 1, 2020.
As discussed above, the decrease in interest and debt financing expenses for the three months ended ~~May 31,~~November 30, 2020 compared to the three months ended ~~May 31,~~November 30, 2019 is primarily attributable to a decrease in the average dollar amount of outstanding debt. During the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, ~~there were no~~the average borrowings outstanding under the Credit ~~Facility.~~Facility was $0.0 million and $2.1 million, respectively. For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, the average borrowings outstanding of SBA debentures was ~~$157.4~~$170.3 million and $150.0 million, respectively. For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, the weighted average interest rate on the outstanding borrowings of the SBA debentures was ~~3.16%~~2.97% and ~~3.25%~~3.21%, respectively. During the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, the average dollar amount of our 6.25% fixed-rate 2025 Notes outstanding was $60.0 million and $60.0 million, respectively. On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes. During the three months ended ~~May 31,~~November 30, 2020 and November 30, 2019, the weighted average dollar amount of our 7.25% fixed-rate 2025 Notes outstanding was $43.1 million and $0.0 million, respectively. During the three months ended November 30, 2020 and November 30, 2019, the weighted average dollar amount of our 7.75% fixed-rate 2025 Notes outstanding was $5.0 million and $0.0 million, respectively. During the three months ended November 30, 2020 and November 30, 2019, the average dollar amount of our 6.75% fixed-rate 2023 Notes outstanding was $0.0 million and $74.5 ~~million.~~million, respectively.
As discussed above, the decrease in interest and debt financing expenses for the nine months ended November 30, 2020 compared to the nine months ended November 30, 2019 is primarily attributable to a decrease in the average dollar amount of outstanding debt. During the nine months ended November 30, 2020 and November 30, 2019, the average borrowings outstanding under the Credit Facility was $0.0 million and $0.8 million, respectively. For the nine months ended November 30, 2020 and November 30, 2019, the average borrowings outstanding of SBA debentures was $165.9 million and $150.0 million, respectively. For the nine months ended November 30, 2020 and November 30, 2019, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 4.57% and 3.24%, respectively. During the nine months ended November 30, 2020 and November 30, 2019, the average dollar amount of our 6.25% fixed-rate 2025 Notes outstanding was $60.0 million and $60.0 million, respectively. During the nine months ended November 30, 2020 and November 30, 2019, the weighted average dollar amount of our 7.25% fixed-rate 2025 Notes outstanding was $43.1 million and $0.0 million, respectively. During the nine months ended November 30, 2020 and November 30, 2019, the weighted average dollar amount of our 7.75% fixed-rate 2025 Notes outstanding was $5.0 million and $0.0 million, respectively. During the nine months ended November 30, 2020 and November 30, 2019, the average dollar amount of our 6.75% fixed-rate 2023 Notes outstanding was $0.0 million and $74.5 million, respectively.
For the three months ended ~~May 31,~~November 30, 2020 and ~~May 31,~~November 30, 2019, there were income tax expense (benefits) of ~~$0.01~~$0.03 million and ~~$0.0~~$1.0 million, respectively. For the nine months ended November 30, 2020 and November 30, 2019, there were income tax expense (benefits) of $0.03 million and $1.5 million, respectively. This relates to net deferred federal and state income tax expense (benefit) with respect to operating gains and losses and income derived from equity investments held in the taxable blockers.
Net realized gains (losses) on sales of investments
For the three months ended ~~May 31,~~November 30, 2020, the Company had ~~$9.4~~$18.3 million of sales, repayments, exits or restructurings resulting in ~~$0.01~~$0.0 million of net realized gains.
For the ~~three~~nine months ended ~~May 31, 2019,~~November 30, 2020, the Company had ~~$26.9~~$50.9 million of sales, repayments, exits or ~~restructurings. There were no~~restructurings resulting in $0.02 million of net realized gains. In addition, for the three and nine months ended November 30, 2020, the Company recognized an income tax expense of $3.9 million representing federal tax paid on the Company’s undistributed net realized capital gains as of February 29, 2020.

For the three months ended November 30, 2019, the Company had $51.2 million of sales, repayments, exits or restructurings resulting in $10.7 million of net realized gains. For the nine months ended November 30, 2019, the Company had $97.2 million of sales, repayments, exits or restructurings resulting in $12.6 million of net realized gains. The most significant realized gains and losses during the ~~three~~nine months ended ~~May 31, 2019.~~
November 30, 2019 were as follows (dollars in thousands):
Nine Months ended November 30, 2019
Issuer Asset Type Gross Proceeds Cost Net
Realized
Gain
Censis Technologies, Inc. Equity Interests $ 12,280 $ 999 $ 11,281
Fancy Chap, Inc. First Lien Term Loan & Equity Interests 8,175 6,865 1,310
Net change in unrealized appreciation (depreciation) on investments
For the three months ended ~~May 31,~~November 30, 2020, our investments had a net change in unrealized appreciation of $6.0 million versus a net change in unrealized depreciation of $0.5 million for the three months ended November 30, 2019. For the nine months ended November 30, 2020, our investments had a net change in unrealized depreciation of ~~$32.0~~$9.4 million versus a net change in unrealized appreciation of ~~$4.0~~$4.9 million for the ~~three~~nine months ended ~~May 31,~~November 30, 2019. The most significant cumulative net change in unrealized appreciation (depreciation) for the ~~three~~nine months ended ~~May 31,~~November 30, 2020 were the following (dollars in ~~thousands)~~thousands):

Three Months ended May 31, 2020
Issuer

Asset Type
   Cost    Fair Value    Total
Unrealized
Appreciation
(Depreciation) YTD Change in
Unrealized
Appreciation
(Depreciation)
Knowland Group, LLC

Second Lien Term Loans
   $ 15,379    $ 11,445    $ (3,934 ) $ (3,827 )
C2 Educational Systems

First Lien Term Loan
   15,987    12,872    (3,115 ) (3,134 )
Saratoga Investment Corp. CLO 2013-1, Ltd.

Structured Finance Securities
   22,160    18,085    (4,075 ) (3,112 )
Elyria Foundry Company, L.L.C.

Second Lien Term Loan & Equity Interests
   10,921    1,417    (9,504 ) (1,759 )
Destiny Solutions Inc.

First Lien Term Loan & Equity Interests
   38,178    37,077    (1,101 ) (1,640 )
ArbiterSports, LLC

First Lien Term Loan
   26,777    25,126    (1,651 ) (1,625 )
Village Realty Holdings LLC

First Lien Term Loan
   11,025    9,763    (1,262 ) (1,390 )
Texas Teachers of Tomorrow, LLC

First Lien Term Loan & Equity Interests
   19,533    18,520    (1,013 ) (1,144 )
Identity Automation Systems

First Lien Term Loan & Equity Interests
   17,742    17,546    (196 ) (959 )
Kev Software Inc.

First Lien Term Loan
   21,047    20,210    (837 ) (952 )
EMS LINQ, Inc.

First Lien Term Loan
   14,771    13,875    (896 ) (939 )
inMotionNow, Inc.

First Lien Term Loan
   14,084    13,273    (811 ) (935 )
CLEO Communications Holding, LLC

First Lien Term Loan
   33,882    33,728    (154 ) (924 )
Nine Months ended November 30, 2020
Issuer Asset Type Cost Fair Value Total
Unrealized
Appreciation
(Depreciation) YTD Change in
Unrealized
Appreciation
(Depreciation)
Knowland Group, LLC Second Lien Term Loan $ 15,768 $ 12,118 $ (3,650 ) $ (3,544 )
C2 Educational Systems First Lien Term Loan 15,993 12,987 (3,006 ) (3,024 )
ArbiterSports, LLC First Lien Term Loan 26,793 24,521 (2,272 ) (2,246 )
Roscoe Medical, Inc. Second Lien Term Loan & Equity Interests 4,708 4,338 (370 ) 2,201
My Alarm Center, LLC Equity Interests 4,867 306 (4,561 ) (1,691 )
Elyria Foundry Company, L.L.C. Second Lien Term Loan & Equity Interests 11,019 1,998 (9,021 ) (1,276 )
The net changes in unrealized depreciation for the nine months ended November 30, 2020 noted above primarily relate to the impact of COVID-19, resulting in changes to market spreads, EBITDA multiples and/or revised portfolio company performance, following the events since March 2020.
The most significant cumulative net change in unrealized appreciation ~~(depreciation)~~ for the ~~three~~nine months ended ~~May 31,~~November 30, 2019 were the following (dollars in thousands):

Three Months ended May 31, 2019
Issuer

Asset Type
   Cost    Fair Value    Total
Unrealized
Appreciation
(Depreciation) YTD Change in
Unrealized
Appreciation
(Depreciation)
Censis Technologies, Inc.

Equity Interests
   $ 999    $ 4,018    $ 3,019 $ 1,631
My Alarm Center, LLC

Equity Interests
   4,811    2,372    (2,439 ) (794 )
Saratoga Investment Corp. CLO 2013-1, Ltd.

Structured Finance Securities
   24,899    28,024    3,125 1,248
Nine Months ended November 30, 2019
Issuer Asset Type Cost Fair Value Total
Unrealized
Appreciation YTD Change in
Unrealized
Appreciation
Easy Ice, LLC Second Term Lien Loan & Equity Interests $ 37,822 $ 47,316 $ 9,494 $ 5,626
Saratoga Investment Corp. CLO 2013-1, Ltd. Structured Finance Securities 24,268 24,497 229 (1,648 )

The ~~$1.6~~$5.6 million net change in unrealized appreciation in our investment in ~~Censis Technologies, Inc.~~Easy Ice, LLC was driven by a continued ~~outperformance~~increase in the scale and earnings of the ~~business as well as the completion of a strategic acquisition.~~business.
The ~~$0.8~~$1.6 million net change in unrealized depreciation in our investment in ~~My Alarm Center, LLC was driven by the issuance of new securities senior to existing investments.~~
~~The $1.2 million net change in unrealized appreciation in our investment in~~ Saratoga Investment Corp., CLO 2013-1, Ltd. was driven by ~~continued outperformance of~~ the ~~Saratoga CLO.~~actual cash distribution received by the Company in the quarter ended November 30, 2019, coupled with an increase in the discount rate.
Changes in net assets resulting from operations
For the three months ended ~~May 31,~~November 30, 2020, we recorded a net ~~decrease~~increase in net assets resulting from operations of ~~$22.7~~$6.4 million. Based on ~~11,217,545~~11,169,817 weighted average common shares outstanding as of ~~May 31,~~November 30, 2020, our per share net ~~decrease~~increase in net assets resulting from operations was ~~$2.02~~$0.57 for the three months ended ~~May 31,~~November 30, 2020. For the three months ended ~~May 31,~~November 30, 2019, we recorded a net increase in net assets resulting from operations of ~~$7.6~~$13.7 million, or ~~$0.99~~$1.37 per share based on ~~7,746,187~~10,036,086 weighted average common shares outstanding as of ~~May 31,~~November 30, 2019.
For the nine months ended November 30, 2020, we recorded a net increase in net assets resulting from operations of $5.5 million. Based on 11,198,287 weighted average common shares outstanding as of November 30, 2020, our per share net increase in net assets resulting from operations was $0.49 for the nine months ended November 30, 2020. For the nine months ended November 30, 2019, we recorded a net increase in net assets resulting from operations of $28.9 million, or $3.33 per share based on 8,702,190 weighted average common shares outstanding as of November 30, 2019.
FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES
We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.
Although we expect to fund the growth of our investment portfolio through the net proceeds from future equity offerings, including our dividend reinvestment plan (“DRIP”), and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital.
In addition, we intend to distribute to our stockholders substantially all of our operating taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, in accordance with certain applicable provisions of the Code and the Treasury regulations and a revenue procedure issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution. We may rely on the revenue procedure in future periods to satisfy our RIC distribution requirement.
Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200.0%, reduced to 150.0% effective April 16, 2019 following the approval received from the non-interested board of directors on April 16, 2018. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was ~~569.4%~~377.3% as of ~~May 31,~~November 30, 2020 and 607.1% as of February 29, 2020. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.
Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies, to pay dividends or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Madison revolving credit facility
Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding LLC (the “Credit Facility”) on June 30, 2010, which was most recently amended on ~~April 24,~~September 14, 2020. (See Recent Developments).
Availability. The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.
The Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.
Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).
Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 1.00%, plus an applicable margin of 4.75%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.00%, and the applicable margin over such alternative base rate is 3.75%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility.
Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.
Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

•●
Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Credit Facility for the last 6 payment periods must equal at least 175.0%.

•●
Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

•●
Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.
The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.
Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.
Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.
Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.
Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:

● an Interest Coverage Ratio of less than 150.0%;
~~an Interest Coverage Ratio of less than 150.0%;~~
● an Overcollateralization Ratio of less than 175.0%;
● the filing of certain ERISA or tax liens;
● the occurrence of certain “Manager Events” such as:
● failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5.0 million at any time prior to the third anniversary of the closing date;
● failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;
● indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

~~an Overcollateralization Ratio of less than 175.0%;~~

● resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

~~the filing of certain ERISA or tax liens;~~
● occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

~~the occurrence of certain “Manager Events” such as:~~
failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5.0 million at any time prior to the third anniversary of the closing date;
~~failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;~~
indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;
resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or
occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.
Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.
Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital Funding LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding LLC in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.
On February 24, 2012, we ~~amended our senior secured revolving credit facility with Madison Capital Funding LLC~~entered into a first amendment to the Credit Facility to, among other things:

~~expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;~~
● expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;

● extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and
extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and
● remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.
~~remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.~~
On September 17, 2014, we entered into a second amendment to the ~~Revolving~~Credit Facility, ~~with Madison Capital Funding LLC to,~~ among other things:

~~extend the commitment termination date from February 24, 2015 to September 17, 2017;~~
● extend the commitment termination date from February 24, 2015 to September 17, 2017;

~~extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);~~
● extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

~~reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and~~
● reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

● reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.
~~reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.~~
On May 18, 2017, we entered into a third amendment to the Credit Facility ~~with Madison Capital Funding LLC~~ to, among other things:

~~extend the commitment termination date from September 17, 2017 to September 17, 2020;~~
● extend the commitment termination date from September 17, 2017 to September 17, 2020;

~~extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025;~~
● extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025;

~~reduce the floor on base rate borrowings from 2.25% to 2.00%;~~
● reduce the floor on base rate borrowings from 2.25% to 2.00%;

~~reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and~~
● reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and

● reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.
~~reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.~~
On April 24, 2020, we entered into a fourth amendment to the Credit Facility ~~with Madison Capital Funding LLC~~ to, among other things:

● permit certain amendments related to the Paycheck Protection Program (“Permitted PPP Amendment”) to Loan Asset Documents;

● exclude certain debt and interest amounts allowed by the Permitted PPP Amendments from certain calculations related to Net Leverage Ratio, Interest Coverage Ratio and EBITDA; and
● exclude such Permitted PPP Amendments from constituting a Material Modification.
On September 14, 2020, we entered into a fifth amendment to the ~~Paycheck Protection Program (“Permitted PPP Amendment”)~~Credit Facility to, ~~Loan Asset Documents;~~among other things:

~~exclude certain debt and interest amounts allowed by the Permitted PPP Amendments from certain calculations related to Net Leverage Ratio, Interest Coverage Ratio and EBITDA; and~~
● extend the commitment termination date of the Credit Facility from September 17, 2020 to September 17, 2021, with no change to the maturity date of September 17, 2025.

● provide for the transition away from the LIBOR Rate in the market, and
~~exclude such Permitted PPP Amendments from constituting a Material Modification.~~
● expand the definition of “Eligible Loan Asset” to allow investments with certain recurring revenue features to qualify as Collateral and be included in the borrowing base.
As of ~~May 31,~~November 30, 2020, we had no outstanding borrowings under the Credit Facility and ~~$170.0~~$176.0 million of SBA-guaranteed debentures outstanding (which are discussed below). As of February 29, 2020, we had no outstanding borrowings under the Credit Facility and $150.0 million of SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at ~~May 31,~~November 30, 2020 and February 29, 2020 was ~~$36.8~~$46.4 million and $35.6 million, respectively.
Our asset coverage ratio, as defined in the 1940 Act, was ~~569.4%~~377.3% as of ~~May 31,~~November 30, 2020 and 607.1% as of February 29, 2020.
SBA-guaranteed debentures
In addition, we, through two wholly-owned subsidiaries, sought and obtained licenses from the SBA to operate an SBIC. In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958 and on August 14, 2019, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC II LP, also received a license. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.
The SBIC licenses allows our SBIC subsidiaries to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.
SBA regulations previously limited the amount that our SBIC subsidiary may borrow to a maximum of $150.0 million when it has at least $75.0 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. This maximum has been increased by SBA regulators for new licenses to $175.0 million of SBA debentures when it has at least $87.5 million in regulatory capital. The new license will provide up to $175.0 million in additional long-term capital in the form of SBA-guaranteed debentures. The SBIC LP and SBIC II LP are regulated by the SBA. As a result of the 2016 omnibus spending bill signed into law in December 2015, the maximum amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding was increased from $225.0 million to $350.0 million. Our wholly-owned SBIC subsidiaries are able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. With this license approval, Saratoga ~~will~~can grow its SBA relationship from $150.0 million to $325.0 million of committed capital.
We received exemptive relief from the SEC to permit us to exclude the debt of our SBIC subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows us increased flexibility under the asset coverage test by permitting us to borrow up to $325.0 million more than we would otherwise be able to absent the receipt of this exemptive relief. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our non-interested board of directors approved of our becoming subject to a minimum asset coverage ratio of 150.0% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150.0% asset coverage ratio became effective on April 16, 2019.
As of ~~May 31,~~November 30, 2020, our SBIC LP subsidiary had $75.0 million in regulatory capital and $150.0 million in SBA-guaranteed debentures outstanding and our SBIC II LP subsidiary had ~~$50.0~~$69.0 million in regulatory capital and ~~$20.0~~$26.0 million in SBA-guaranteed debentures outstanding.

Unsecured notes
In May 2013, wethe Company issued $48.3 million in aggregate principal amount of ~~our~~7.50% fixed-rate notes due 2020 Notes for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these 2020 Notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The 2020 Notes mature on May 31, 2020 and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at our option. In connection with the issuance of the 2020 Notes, we agreed to the following covenants for the period of time during which the 2020 Notes are outstanding:
we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200.0% after such borrowings.
we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under the Code. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200.0% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.
(the “2020 Notes”). The 2020 Notes were redeemed in full on January 13, 2017 and are no longer listed on the NYSE.
On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an ATM offering. Prior to the 2020 Notes being redeemed in full, the Company had sold 539,725 bonds with a principal of $13.5 million at an average price of $25.31 for aggregate net proceeds of $13.4 million (net of transaction costs).
On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 2023 Notes for net proceeds of $71.7 million after deducting underwriting commissions of approximately $2.3 million and offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 2023 Notes is paid quarterly in arrears on March 15, June 15, September 15 and December 15, at a rate of 6.75% per year, beginning March 30, 2017. The 2023 Notes mature on December 30, 2023, and commencing December 21, 2019, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used to repay all of the outstanding indebtedness under the 2020 Notes on January 13, 2017, which amounted to $61.8 million, and for general corporate purposes in accordance with our investment objective and strategies. On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE.
On August 28, 2018, the Company issued $40.0 million in aggregate principal amount of our 6.25% fixed-rate notes due 2025 (the ~~“2025~~“6.25% 2025 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.3 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $5.0 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest on the 6.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning November 30, 2018. The 6.25% 2025 Notes mature on August 31, 2025 and commencing August 28, 2021, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes. The 6.25% 2025 Notes are listed on the NYSE under the trading symbol “SAF” with a par value of $25.00 per share.
On February 5, 2019, the Company completed a re-opening and up-sizing of its existing 6.25% 2025 Notes by issuing an additional $20.0 million in aggregate principal amount for net proceeds of $19.2 million after deducting underwriting commissions of approximately $0.6 million and discount of $0.2 million. Offering costs incurred were approximately $0.2 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $2.5 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate, interest payment dates and maturity remain unchanged from the existing 6.25% 2025 Notes issued in August 2018. The net proceeds from this offering were used for general corporate purposes in accordance with our investment objective and strategies. The financing costs and discount of $1.0 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes.
At ~~May 31,~~November 30, 2020, the total 6.25% 2025 Notes outstanding was $60.0 million.
In connection with the issuance of the 6.25% 2025 Notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

● we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. These provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings, or, if we obtain the required approvals from our independent directors and/or stockholders, 150% (after deducting the amount of such dividend, distribution or purchase price, as the case may be).
we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. These provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings, or, if we obtain the required approvals from our independent directors and/or stockholders, 150% (after deducting the amount of such dividend, distribution or purchase price, as the case may be).
● we will not declare any dividend (except a dividend payable in our stock), or declare any other distribution, upon a class of our capital stock, or purchase any such capital stock, unless, in every such case, at the time of the declaration of any such dividend or distribution, or at the time of any such purchase, we have an asset coverage (as defined in the 1940 Act) of at least 150.0%, as such obligation may be amended or superseded, after deducting the amount of such dividend, distribution or purchase price, as the case may be, and in each case giving effect to (i) any exemptive relief granted to us by the SEC, and (ii) any SEC no-action relief granted by the SEC to another BDC (or to us if we determine to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by such provisions of Section 61(a) of the 1940 Act as may be applicable to us from time to time, as such obligation may be amended or superseded, in order to maintain such BDC’s status as a regulated investment company under Subchapter M of the Code.

we will not declare any dividend (except a dividend payable in our stock), or declare any other distribution, upon a class of our capital stock, or purchase any such capital stock, unless, in every such case, at the time of the declaration of any such dividend or distribution, or at the time of any such purchase, we have an asset coverage (as defined in the 1940 Act) of at least 150.0%, as such obligation may be amended or superseded, after deducting the amount of such dividend, distribution or purchase price, as the case may be, and in each case giving effect to (i) any exemptive relief granted to us by the SEC, and (ii) any SEC no-action relief granted by the SEC to another BDC (or to us if we determine to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by such provisions of Section 61(a) of the 1940 Act as may be applicable to us from time to time, as such obligation may be amended or superseded, in order to maintain such BDC’s status as a regulated investment company under Subchapter M of the Code.

● if, at any time, we are not subject to the reporting requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, to file any periodic reports with the SEC, we agree to furnish to holders of the 6.25% 2025 Notes and the Trustee, for the period of time during which the 6.25% 2025 Notes are outstanding, our audited annual consolidated financial statements, within 90 days of our fiscal year end, and unaudited interim consolidated financial statements, within 45 days of our fiscal quarter end (other than our fourth fiscal quarter). All such financial statements will be prepared, in all material respects, in accordance with applicable United States generally accepted accounting principles.

if, at any time, we are not subject to the reporting requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, to file any periodic reports with the SEC, we agree to furnish to holders of the 2025 Notes and the Trustee, for the period of time during which the 2025 Notes are outstanding, our audited annual consolidated financial statements, within 90 days of our fiscal year end, and unaudited interim consolidated financial statements, within 45 days of our fiscal quarter end (other than our fourth fiscal quarter). All such financial statements will be prepared, in all material respects, in accordance with applicable United States generally accepted accounting principles.
On June 24, 2020, the Company issued $37.5 million in aggregate principal amount of our 7.25% fixed-rate notes due 2025 (the ~~“Second~~“7.25% 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately ~~$0.2~~$0.3 million. ~~The Company has granted~~On July 6, 2020, the underwriters anexercised their option in full to purchase ~~up to~~ an additional $5.625 million in aggregate principal amount of ~~Notes within 30 days, which they fully exercised on July 6, 2020 for additional net~~its 7.25% unsecured notes due 2025. Net proceeds ofto the Company were $5.4 million after deducting ~~additional~~ underwriting commissions of approximately $0.2 million. Interest on the ~~Second~~7.25% 2025 Notes is paid quarterly in arrears on
February 28, May 31, August 31 and November 30, at a rate of 7.25% per year, beginning August 31, 2020. The ~~Second~~7.25% 2025 Notes mature on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering ~~will be~~were used for general corporate purposes in accordance with ~~the Company’s~~our investment objective and strategies. ~~The Second~~Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and are ~~expected to be listed on~~being amortized over the ~~New York Stock Exchange and to trade thereon within 30 days~~term of the ~~original issue date under the trading symbol “SAK”.~~7.25% 2025 Notes. The Company has received an investment grade private rating of “BBB” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency. The 7.25% 2025 Notes are listed on the NYSE under the trading symbol “SAK” with a par value of $25.00 per share. At November 30, 2020, the total 7.25% 2025 Notes outstanding was $43.1 million.
On July 9, 2020, the Company issued $5.0 million aggregate principal amount of our 7.75% fixed-rate Notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% Notes 2025 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year, beginning August 31, 2020. The 7.75% Notes 2025 mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% Notes 2025 have been capitalized and are being amortized over the term of the Notes. The 7.75% 2025 Notes are unlisted and have a par value of $25.00 per share.

At ~~May 31, 2020 and February 29,~~November 30, 2020, the ~~fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts were as follows:~~total 7.75% 2025 Notes outstanding was $5.0 million.

   May 31, 2020 February 29, 2020
   Fair Value    Percentage of
Total Fair Value    Percentage of
Total
   ($ in thousands)
Cash and cash equivalents
   $ 12,843    2.5 % $ 24,599    4.7 %
Cash and cash equivalents, reserve accounts
   12,952    2.6 14,851    2.8
First lien term loans
   354,435    69.6 346,233    66.0
Second lien term loans
   69,487    13.7 73,570    14.0
Unsecured term loans
   5,811    1.1 4,346    0.8
Structured finance securities
   27,306    5.4 32,470    6.2
Equity interests
   25,908    5.1 29,013    5.5






Total
   $ 508,742    100.0 % $ 525,082    100.0 %






On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised.
At November 30, 2020 and February 29, 2020, the fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts were as follows:
November 30, 2020 February 29, 2020
Fair Value Percentage
of Total Fair Value Percentage
of Total
($ in thousands)
Cash and cash equivalents $ 21,060 3.6 % $ 24,599 4.7 %
Cash and cash equivalents, reserve accounts 12,837 2.3 14,851 2.8
First lien term loans 407,698 70.1 346,233 66.0
Second lien term loans 50,027 8.6 73,570 14.0
Unsecured term loans 26,817 4.6 4,346 0.8
Structured finance securities 31,299 5.4 32,470 6.2
Equity interests 31,102 5.4 29,013 5.5
Total $ 580,840 100.0 % $ 525,082 100.0 %

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered through this offering was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. As of ~~May 31,~~November 30, 2020, the Company sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs). During the ~~three~~nine months ended ~~May 31,~~November 30, 2020, there was no activity related to the ATM offering.
On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial ~~statements.~~statements (the “Share Repurchase Plan”). On October 7, 2015, ~~the Company’s~~our board of directors extended the ~~open market share repurchase plan~~Share Repurchase Plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. On October 5, 2016, ~~the Company’s~~our board of directors extended the ~~open market share repurchase plan~~Share Repurchase Plan for another year to October 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. On October 10, 2017, January 8, 2019 and January 7, 2020, ~~the Company’s~~our board of directors extended the ~~open market share repurchase plan~~Share Repurchase Plan for another year to October 15, 2018, January 15, 2020 and January 15, 2021, respectively, each time leaving the number of shares unchanged at 600,000 shares of its common stock. On May 4, 2020, ~~the Board~~our board of ~~Directors~~directors increased the ~~share repurchase plan~~Share Repurchase Plan to 1.3 million shares of common stock. On January 5, 2021, our board of directors extended the Share Repurchase Plan for another year to January 15, 2022, leaving the number of shares unchanged at 1.3 million shares of common stock. As of ~~May 31,~~November 30, 2020, the Company purchased ~~218,491~~358,812 shares of common stock, at the average price of ~~$16.87~~$17.14 for approximately ~~$3.7~~$6.2 million pursuant to ~~this repurchase plan.~~the Share Repurchase Plan. During the three months ended ~~May 31,~~November 30, 2020, ~~there was no activity~~the Company purchased 50,000 shares of common stock, at the average price of $18.28 for approximately $0.9 million pursuant to ~~this repurchase plan.~~the Share Repurchase Plan. During the nine months ended November 30, 2020, the Company purchased 140,321 shares of common stock, at the average price of $17.56 for approximately $2.5 million pursuant to the Share Repurchase Plan.
On October 7, 2020, our board of directors declared a dividend of $0.41 per share, which was paid on November 10, 2020, to common stockholders of record as of October 26, 2020. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6, 9 and 10, 2020.
On July 7, 2020, the Company declared a dividend of $0.40 per share payable on August 12, 2020, to common stockholders of record on July 27, 2020. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.45 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.
On January 7, 2020, the Company declared a dividend of $0.56 per share, which was paid on February 6, 2020, to common stockholders of record on January 24, 2020. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $5.4 million in cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.44 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 24, 27, 28, 29, 30, 31 and February 3, 4, 5 and 6, 2020.
On August 27, 2019, the Company declared a dividend of $0.56 per share, which was paid on September 26, 2019, to common stockholders of record on September 13, 2019. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.34 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25 and 26, 2019.
On May 28, 2019, our board of directors declared a dividend of $0.55 per share, which was paid on June 27, 2019, to common stockholders of record as of June 13, 2019. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 31,545 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.65 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2019.

On February 26, 2019, our board of directors declared a dividend of $0.54 per share, which was paid on March 28, 2019, to common stockholders of record as of March 14, 2019. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.36 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28, 2019.
On November 27, 2018, our board of directors declared a dividend of $0.53 per share, which was paid on January 2, 2019, to common stockholders of record on December 17, 2018. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $18.88 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 18, 19, 20, 21, 24, 26, 27, 28, 31, 2018 and January 2, 2019.
On August 28, 2018, our board of directors declared a dividend of $0.52 per share, which was paid on September 27, 2018, to common stockholders of record as of September 17, 2018. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 25,862 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.35 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2018.
On May 30, 2018, our board of directors declared a dividend of $0.51 per share, which was paid on June 27, 2018, to common stockholders of record as of June 15, 2018. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.7 million in cash and 21,562 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.72 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2018.
On February 26, 2018, our board of directors declared a dividend of $0.50 per share, which was paid on March 26, 2018, to common stockholders of record as of March 14, 2018. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.6 million in cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $19.91 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 13, 14, 15, 16, 19, 20, 21, 22, 23 and 26, 2018.
On November 29, 2017, our board of directors declared a dividend of $0.49 per share, which was paid on December 27, 2017, to common stockholders of record on December 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.
On August 28, 2017, our board of directors declared a dividend of $0.48 per share, which was paid on September 26, 2017, to common stockholders of record on September 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.
On May 30, 2017, our board of directors declared a dividend of $0.47 per share, which was paid on June 27, 2017, to common stockholders of record on June 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

On February 28, 2017, our board of directors declared a dividend of $0.46 per share, which was paid on March 28, 2017, to common stockholders of record as of March 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.
On January 12, 2017, our board of directors declared a dividend of $0.45 per share, which was paid on February 9, 2017, to common stockholders of record as of January 31, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.
On October 5, 2016, our board of directors declared a dividend of $0.44 per share, which was paid on November 9, 2016, to common stockholders of record as of October 31, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.
On August 8, 2016, our board of directors declared a special dividend of $0.20 per share, which was paid on September 5, 2016, to common stockholders of record as of August 24, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.
On July 7, 2016, our board of directors declared a dividend of $0.43 per share, which was paid on August 9, 2016, to common stockholders of record as of July 29, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.
On March 31, 2016, our board of directors declared a dividend of $0.41 per share, which was paid on April 27, 2016, to common stockholders of record as of April 15, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.
On January 12, 2016, our board of directors declared a dividend of $0.40 per share, which was paid on February 29, 2016, to common stockholders of record as of February 1, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.
On October 7, 2015, our board of directors declared a dividend of $0.36 per share, which was paid on November 30, 2015, to common stockholders of record as of November 2, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.

On July 8, 2015, our board of directors declared a dividend of $0.33 per share, which was paid on August 31, 2015, to common stockholders of record as of August 3, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.
On May 14, 2015, our board of directors declared a special dividend of $1.00 per share, which was paid on June 5, 2015, to common stockholders of record on as of May 26, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4 and 5, 2015.
On April 9, 2015, our board of directors declared a dividend of $0.27 per share, which was paid on May 29, 2015, to common stockholders of record as of May 4, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.
On September 24, 2014, our board of directors declared a dividend of $0.22 per share, which was paid on February 27, 2015, to common stockholders of record on February 2, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.
Also, on September 24, 2014, our board of directors declared a dividend of $0.18 per share, which was paid on November 28, 2014, to common stockholders of record on November 3, 2014. Shareholders had the option to receive payment of the dividend in cash or receive shares of common stock pursuant to ~~our~~the DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.
On October 30, 2013, our board of directors declared a dividend of $2.65 per share, which was paid on December 27, 2013, to common stockholders of record as of November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which 95% of equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.
On November 9, 2012, our board of directors declared a dividend of $4.25 per share, which was paid on December 31, 2012, to common stockholders of record as of November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

On November 15, 2011, our board of directors declared a dividend of $3.00 per share, which was paid on December 30, 2011, to common stockholders of record as of November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.
On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010. Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.
On November 13, 2009, our board of directors declared a dividend of $18.25 per share, which was paid on December 31, 2009, to common stockholders of record as of November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.
We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.
Contractual obligations
The following table shows our payment obligations for repayment of debt and other contractual obligations at ~~May 31,~~November 30, 2020:

      Payment Due by Period Payment Due by Period
Long-Term Debt Obligations
   Total    Less Than
1 Year    1 - 3
Years    3 - 5
Years    More Than
5 Years Total Less Than
1 Year 1 - 3
Years 3 - 5
Years More Than
5 Years
   ($ in thousands) ($ in thousands)
Revolving credit facility
   $ —      $ —      $ —      $ —      $ —   $ - $ - $ - $ - $ -
SBA debentures
   170,000    —      40,000    39,000    91,000 176,000 - 40,000 39,000 97,000
2025 Notes
   60,000    —      —      —      60,000










6.25% 2025 Notes 60,000 - - 60,000 -
7.25% 2025 Notes 43,125 - - 43,125 -
7.75% 2025 Notes 5,000 - 5,000 -
Total Long-Term Debt Obligations
   $ 230,000    $ —      $ 40,000    $ 39,000    $ 151,000 $ 284,125 $ - $ 40,000 $ 147,125 $ 97,000










94
Off-balance sheet arrangements
As of ~~May 31,~~November 30, 2020 and February 29, 2020, the Company’s off-balance sheet arrangements consisted of ~~$48.3~~$49.8 million and $64.1 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.
A summary of the unfunded commitments outstanding as of ~~May 31,~~November 30, 2020 and February 29, 2020 is shown in the table below (dollars in thousands):

   May 31, 2020    February 29, 2020 November 30,
2020 February 29,
2020
At Company’s discretion

CLEO Communications Holding, LLC $ 630 $ -
inMotionNow, Inc.
   $ 3,000    $ 3,000 - 3,000
Omatic Software, LLC
   —      1,000 - 1,000
Passageways, Inc.
   5,000    5,000 5,000 5,000
PDDS Buyer, LLC
   3,000    5,000 - 5,000
Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd.
   15,000    17,500 - 17,500
Top Gun Pressure Washing, LLC
   3,175    5,000 3,175 5,000
Village Realty Holdings LLC
   10,000    10,000 10,000 10,000




18,805 46,500
   39,175    46,500




At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required

ArbiterSports, LLC
   —      1,000 - 1,000
Axiom Purchaser, Inc.
   —      1,000 - 1,000
CoConstruct, LLC
   —      3,500 6,500 3,500
Davisware, LLC
   1,022    2,000 1,022 2,000
GoReact
   2,000    2,000 2,000 2,000
Granite Comfort, LP 8,000 -
HemaTerra Holding Company, LLC
   2,000    4,000 2,000 4,000
New England Dental Partners 7,445 -
Passageways, Inc.
   3,000    3,000 3,000 3,000
Procurement Partners, LLC 1,000 -
Village Realty Holdings LLC
   1,124    1,124 - 1,124




30,967 17,624
   9,146    17,624




Total
   $ 48,321    $ 64,124 $ 49,772 $ 64,124




Recent Developments
On ~~June 24, 2020,~~January 5, 2021, the Company ~~issued $37.5 million in aggregate principal amount~~declared a dividend of ~~7.25% fixed-rate notes due 2025 (the “Second 2025 Notes”) for net proceeds~~$0.42 per share payable on February 10, 2021, to common stockholders of ~~$36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.2 million. The Company has granted~~record on January 26, 2021. Shareholders have the ~~underwriters an~~ option to ~~purchase up~~receive payment of the dividend in cash, or receive shares of common stock, pursuant to an additional $5.625 million in aggregate principal amount of Notes within 30 days, which they fully exercised on July 6, 2020 for additional net proceeds of $5.4 million after deducting additional underwriting commissions of approximately $0.2 million. Interest on the Second 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.25% per year, beginning August 31, 2020. The Second 2025 Notes mature on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering will be used for general corporate purposes in accordance with the Company’s investment objective and strategies. The Second 2025 Notes are expected to be listed on the New York Stock Exchange and to trade thereon within 30 days of the original issue date under the trading symbol “SAK”. The Company has received an investment grade private rating of “BBB” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency.DRIP.
Subsequent to ~~May 31,~~November 30, 2020, the global outbreak of the ~~coronavirus, or~~ COVID-19 pandemic has adversely affected some of the Company’s investments and ~~the related effect~~continues to have adverse consequences on the U.S. and global ~~economies, has had adverse consequences for the business operations of some of the Company’s portfolio companies and, as a result, has had some adverse effects on the Company’s operations.~~economies. The ultimate economic fallout from the pandemic, and the long-term impact on economies, markets, industries and individual ~~issuers,~~portfolio companies, remains uncertain. At the time of this filing, there is ~~uncertain.~~no indication of a reportable subsequent event impacting the Company’s financial statements for the quarter ended November 30, 2020. The ~~operational~~Company cannot predict the extent to which its financial condition and ~~financial performance~~results of ~~the issuers of securities in which the Company invests depends~~operations will be adversely affected at this time. The potential impact to our results will depend to a large extent on future developments ~~including~~and new information that may emerge regarding the duration and ~~spread~~severity of COVID-19. The Company continues to observe and respond to the ~~outbreak,~~evolving COVID-19 environment and ~~such uncertainty may in turn adversely affect the value and liquidity of the Company’s investments and negatively~~its potential impact ~~the Company’s performance.~~on areas across its business.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Our business activities contain elements of market risk. We consider our principal market risk to be the fluctuation in interest rates. Managing this risk is essential to our business. Accordingly, we have systems and procedures designed to identify and analyze our risks, to establish appropriate policies and thresholds and to continually monitor this risk and thresholds by means of administrative and information technology systems and other policies and processes. In addition, U.S. and global capital markets and credit markets have experienced a higher level of stress due to the global COVID-19 pandemic, which has resulted in an increase in the level of volatility across such markets and a general decline in value of the securities held by us.
Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, including relative changes in different interest rates, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest-bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire leveraged loans, high yield bonds and other debt investments and the value of our investment portfolio.
Our investment income is affected by fluctuations in various interest rates, including LIBOR and the prime rate. A large portion of our portfolio is, and we expect will continue to be, comprised of floating rate investments that utilize LIBOR. In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in LIBOR are not offset by a corresponding increase in the spread over LIBOR that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities tied to LIBOR. Our interest expense is affected by fluctuations in LIBOR only on our revolving credit facility. At ~~May 31,~~November 30, 2020, we had ~~$230.0~~$284.0 million of borrowings outstanding. There were no borrowings outstanding on the revolving credit facility as of ~~May 31,~~November 30, 2020.
We have analyzed the potential impact of changes in interest rates on interest income from investments. Assuming that our investments as of ~~May 31,~~November 30, 2020 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of a 1.0% increase in interest rates would cause a corresponding increase of approximately ~~$0.6~~$0.7 million to our interest income. Conversely, a hypothetical change of a 1.0% decrease in interest rates would cause a corresponding decrease of approximately ~~$0.05~~$0.08 million to our interest income.
Changes in interest rates would have no impact to our current interest and debt financing expense, as all our borrowings except for our credit facility are fixed rate, and our credit facility is currently undrawn.
Although management believes that this measure is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in credit quality, size and composition of the assets on the statements of assets and liabilities and other business developments that could magnify or diminish our sensitivity to interest rate changes, nor does it account for divergences in LIBOR and the commercial paper rate, which have historically moved in tandem but, in times of unusual credit dislocations, have experienced periods of divergence. Accordingly, no assurances can be given that actual results would not materially differ from the potential outcome simulated by this estimate.

For further information, the following table shows the approximate annualized increase or decrease in the components of net investment income due to hypothetical base rate changes in interest rates, assuming no changes in our investments and borrowings as of ~~May 31,~~November 30, 2020.

Basis
Point
Change
Increase
(Decrease)
in Interest
Income (Increase)
Decrease
in Interest
Expense Increase
(Decrease) in Net
Investment
Income Increase
(Decrease) in Net
Investment
Income per Share
($ in thousands)
-100 $ (52 ) $ —   $ (52 ) $ (0.00 )
-50 (52 ) —   (52 ) (0.00 )
-25 (38 ) —   (38 ) (0.00 )
25 38 —   38 0.00
50 75 —   75 0.01
100 618 —   618 0.06
200 3,277 —   3,277 0.29
300 7,470 —   7,470 0.67
400 11,814 —   11,814 1.05
Basis
Point
Change Increase
(Decrease)
in Interest
Income (Increase)
Decrease
in Interest
Expense Increase
(Decrease) in Net
Investment
Income Increase
(Decrease) in Net
Investment
Income per Share
($ in thousands)
-100 $ (80 ) $          - $      (80 ) $ (0.01 )
-50 (80 ) - (80 ) (0.01 )
-25 (80 ) - (80 ) (0.01 )
25 88 - 88 0.01
50 190 - 190 0.02
100 727 - 727 0.06
200 3,379 - 3,379 0.30
300 7,824 - 7,824 0.70
400 12,567 - 12,567 1.12
ITEM 4. CONTROLS AND PROCEDURES

(a)
As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

(b)
There have been no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) of Exchange Act) that occurred during the quarter ended ~~May 31,~~November 30, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Neither we nor our wholly-owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP and Saratoga Investment Corp. SBIC II LP, are currently subject to any material legal proceedings.
Item 1A. Risk Factors
In addition to information set forth in this report, you should carefully consider the “Risk Factors” discussed in our most recent Annual Report on Form 10-K filed with the SEC, which could materially affect our business, financial condition and/or operating results. Other than as set forth below, there have been no material changes during the ~~three~~nine months ended ~~May 31,~~November 30, 2020 to the risk factors discussed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K. Additional risks or uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results.
Changes relating to the LIBOR calculation process may adversely affect the value of our portfolio of LIBOR-indexed, floating-rate debt securities.
LIBOR, the London Interbank Offered Rate, is the basic rate of interest used in lending transactions between banks on the London interbank market and is widely used as a reference for setting the interest rate on loans globally. We typically use LIBOR as a reference rate in floating-rate loans we extend to portfolio companies such that the interest due to us pursuant to a term loan extended to a portfolio company is calculated using LIBOR. The terms of our debt investments generally include minimum interest rate floors which are calculated based on LIBOR. Further, the borrowings of the ~~senior secured revolving credit facility entered into with Madison Capital Funding LLC (the “Credit Facility”)~~Credit Facility typically use LIBOR as a reference rate.
In the recent past, concerns have been publicized that some of the member banks surveyed by the British Bankers’ Association (“BBA”) in connection with the calculation of LIBOR across a range of maturities and currencies may have been under-reporting or otherwise manipulating the inter-bank lending rate applicable to them in order to profit on their derivative positions or to avoid an appearance of capital insufficiency or adverse reputational or other consequences that may have resulted from reporting inter-bank lending rates higher than those they actually submitted. A number of BBA member banks entered into settlements with their regulators and law enforcement agencies with respect to alleged manipulation of LIBOR, and investigations by regulators and governmental authorities in various jurisdictions are ongoing.
Actions by the ICE Benchmark Administration, regulators or law enforcement agencies as a result of these or future events, may result in changes to the manner in which LIBOR is determined. Potential changes, or uncertainty related to such potential changes may adversely affect the market for LIBOR-based securities, including our portfolio of LIBOR-indexed, floating-rate debt securities. In addition, any further changes or reforms to the determination or supervision of LIBOR may result in a sudden or prolonged increase or decrease in reported LIBOR, which could have an adverse impact on the market for LIBOR-based securities or the value of our portfolio of LIBOR-indexed, floating-rate debt securities, loans, and other financial obligations or extensions of credit held by or due to us.
On July 27, 2017, the U.K. Financial Conduct Authority (the “FCA”), which regulates LIBOR, announced that it intends to stop persuading or compelling banks to submit LIBOR rates after 2021. In addition, on March 25, 2020, the FCA stated that although the central assumption that firms cannot rely on LIBOR being published after the end of 2021 has not changed, the outbreak of COVID-19 has impacted the timing of many firms’ transition planning, and the FCA will continue to assess the impact of the COVID-19 pandemic on transition timelines and update the marketplace as soon as possible. It is unclear if after 2021 LIBOR will cease to exist or if new methods of calculating LIBOR will be established such that it continues to exist after 2021. We have exposure to LIBOR, including in financial instruments that mature after 2021. Our exposure arises from the value of our portfolio of LIBOR-indexed, floating-rate debt securities.
In the United States, the Federal Reserve Board and the Federal Reserve Bank of New York, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, is considering replacing U.S. dollar LIBOR with a new index calculated by short-term repurchase agreements, backed by Treasury securities called the Secured Overnight Financing Rate (“SOFR”). The Federal Reserve Bank of New York began publishing SOFR in April 2018. Whether or not SOFR attains market traction as a LIBOR replacement remains a question and the future of LIBOR at this time is uncertain, including whether the COVID-19 pandemic will have further effect on LIBOR transition plans.
The elimination of LIBOR or any other changes or reforms to the determination or supervision of LIBOR could have an adverse impact on the market for or value of any LIBOR-indexed, floating-rate debt securities, loans, and other financial obligations or extensions of credit held by or due to us or on our overall financial condition or results of operations. If LIBOR ceases to exist, we may need to renegotiate the credit agreements extending beyond 2021 with our portfolio companies that utilize LIBOR as a factor in determining the interest rate to replace LIBOR with the new standard that is established. In the event that the LIBOR Rate is no longer available or published on a current basis or no longer made available or used for determining the interest rate of loans, our administrative agent that manages our loans will generally select a comparable successor rate; provided that (i) to the extent a comparable or successor rate is approved by the administrative agent, the approved rate shall be applied in a manner consistent with market practice; and (ii) to the extent such market practice is not administratively feasible for the administrative agent, such approved rate shall be applied as otherwise reasonably determined by the administrative agent.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
~~Not applicable.~~
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
Effective January 5, 2021, our board of directors amended and restated the Company’s Second Amended and Restated Bylaws (the “Third Amended and Restated Bylaws”) to change the stockholder vote requirement to elect directors to the Company’s board of directors. Previously, the affirmative vote of the holders of a majority of the shares of the Company’s stock outstanding and entitled to vote thereon was required to elect a director to our board of directors. The Third Amended and Restated Bylaws modify such requirement to provide that a plurality of the votes cast at a meeting of the Company’s stockholders duly called and at which a quorum is present will be required to elect a director to the Company’s board of directors.
The foregoing description of the Third Amended and Restated Bylaws is qualified in its entirety by reference to the complete text of the Third Amended and Restated Bylaws, a copy of which is attached as Exhibit 3.2 to this Quarterly Report on Form 10-Q.

ITEM 6. EXHIBITS
Listed below are the exhibits which are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):
EXHIBIT INDEX

Exhibit
Number

Description

3.1(a) Articles of Incorporation of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Form 10-Q for the quarterly period ended May 31, 2007).
3.1(b) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 3, 2010).
3.1(c) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 13, 2010).
  ~~3.2~~
3.2* ~~Second~~Third Amended and Restated Bylaws of Saratoga Investment Corp. ~~(incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on June 14, 2011).~~

4.1 Specimen certificate of Saratoga Investment Corp.’s common stock, par value $0.001 per share. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-169135, filed on September 1, 2010).
4.2 Registration Rights Agreement dated July 30, 2010 between GSC Investment Corp., GSC CDO III L.L.C., and the investors party thereto (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
4.3 Dividend Reinvestment Plan (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 24, 2014).
4.4 Form of Indenture by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 2 to the Registration Statement on Form N-2, File No. 333-186323 filed April 30, 2013).
4.5 Form of Second Supplemental Indenture between the Company and U.S. Bank National Association (incorporated by reference to Amendment No. 2 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-214182, filed on December 12, 2016).
4.6 Form of Global Note (incorporated by reference to Exhibit 4.5 hereto, and Exhibit A therein).

4.7 Form of Third Supplemental Indenture between the Company and U.S. Bank National Association (incorporated by reference to Post- Effective Amendment No. 9 to the Registrant’s Registration Statement on Form N-2, File No. 333-216344, filed on August 28, 2018).
4.8 Form of Global Note (incorporated by reference to Exhibit 4.7 hereto, and Exhibit A therein).

4.9 Form of Articles Supplementary Establishing and Fixing the Rights and Preferences of Preferred Stock (incorporated by reference to Saratoga Investment Corp.’s registration statement on Form N-2 Pre-Effective Amendment No. 1, File No. 333-196526, filed on December 5, 2014).
4.10 Description of ~~Securities~~Securities. (incorporated by reference to Saratoga Investment Corp.’s Annual Report on Form 10-K filed on May 6, 2020).

4.11 Fourth Supplemental Indenture between the Company and U.S. Bank National Association, as trustee, relating to the 7.25%  Note due 2025 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No. 814-00732) filed on June 24, 2020).
4.12 Form of 7.25% Notes due 2025 (incorporated by reference to Exhibit 4.11 hereto).
10.1 Investment Advisory and Management Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.2 Custodian Agreement dated March 21, 2007 between GSC Investment LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Form 10-Q for the quarterly period ended May 31, 2007).
10.3 Administration Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.4 Trademark License Agreement dated July 30, 2010 between Saratoga Investment Advisors, LLC and GSC Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.5 Credit, Security and Management Agreement dated July 30, 2010 by and among GSC Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.6 Form of Indemnification Agreement between Saratoga Investment Corp. and each officer and director of Saratoga Investment Corp. (incorporated by reference to Amendment No. 2 to Saratoga Investment Corp.’s Registration Statement on Form N-2 filed on January 12, 2007).
10.7 Amendment No. 1 to Credit, Security and Management Agreement dated February 24, 2012 by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on February 29, 2012).
10.8 Amended and Restated Indenture, dated as of November 15, 2016, among Saratoga Investment Corp. CLO 2013-1, Ltd., Saratoga Investment Corp. CLO 2013-1, Inc. and U.S. Bank National Association. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-216344, filed on February 28, 2017).
10.9 Amended and Restated Collateral Management Agreement, dated October 17, 2013, by and between Saratoga Investment Corp. and Saratoga Investment Corp. CLO 2013-1, Ltd. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-196526, filed on December 5, 2014).
10.10 Amendment No. 2 to Credit, Security and Management Agreement dated September 17, 2014 by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 18, 2014).
10.11 Amendment No. 3 to Credit, Security and Management Agreement, dated May 18, 2017, by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on May 18, 2017).
10.12 Equity Distribution Agreement dated March 16, 2017, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc. and BB&T Capital Markets, a division of BB&T Securities, LLC (incorporated by reference to Saratoga Investment Corp.’s Post-Effective Amendment No. 1 to the Registration Statement on Form N-2, File No. 333-216344, filed on March 16, 2017).
101
10.13 Amendment No. 1 to the Equity Distribution Agreement dated October 12, 2017, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, and FBR Capital Markets & Co. (incorporated by reference to Saratoga Investment Corp.’s Post-Effective Amendment No. 2 to the Registration Statement on Form N-2, File No. 333-216344, filed on October 12, 2017).
10.14 Amendment No. 2 to the Equity Distribution Agreement dated January 11, 2018, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, and FBR Capital Markets & Co. (incorporated by reference to Saratoga Investment Corp.’s Post-Effective Amendment No. 3 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-216344, filed on January 11, 2018).
10.15 Amendment No. 3 to the Equity Distribution Agreement dated October 16, 2018, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, and B. Riley FBR, Inc. (incorporated by reference to Post-Effective Amendment No. 1 to the registrant’s Registration Statement on Form N-2, File No. 333-227116, filed on October 16, 2018).
10.16 Amendment No. 4 to the Equity Distribution Agreement dated July 11, 2019, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, and B. Riley FBR, Inc. (incorporated by reference to Post-Effective Amendment No. 5 to the registrant’s Registration Statement on Form N-2, File No. 333-227116, filed on July 12, 2019).
10.17 Amendment No. 5 to the Equity Distribution Agreement dated October 10, 2019, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division BB&T Securities, LLC, and B. Riley FBR, Inc. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on October 10, 2019).
10.18 Amendment No. 4 to Credit, Security and Management Agreement, dated April 24, 2020, by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on April 29, 2020).
10.19 Amendment No. 5 to Credit, Security and Management Agreement, dated September 14, 2020, by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 17, 2020).
11 Computation of Per Share Earnings (included in Note 11 to the consolidated financial statements contained in this report)..
14 Code of Ethics of the Company adopted under Rule 17j-1 (incorporated by reference to Amendment No.7 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-138051, filed on March 22, 2007).
21.1 List of Subsidiaries (incorporated by reference to Saratoga Investment Corp.’s Annual Report on Form 10-K filed on May 6, 2020).
31.1* Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
31.2* Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
32.1* Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 ~~U.S.C 1350)~~U.S.C.1350)
32.2* Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

*
Filed herewith
102
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SARATOGA INVESTMENT CORP.

~~SARATOGA INVESTMENT CORP.~~
Date: ~~July 8, 2020~~ January 6, 2021 By:
/s/ CHRISTIAN L. OBERBECK
Christian L. Oberbeck

Chief Executive Officer

By:
/s/ HENRI J. STEENKAMP
Henri J. Steenkamp
Chief Financial Officer and Chief Compliance Officer

81
103


Maryland		20-8700615
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer
~~incorporation or organization)~~		Identification Number)


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	SAR	The New York Stock Exchange
6.25% Notes due 2025	SAF	The New York Stock Exchange
7.25% Notes due 2025	SAK	The New York Stock Exchange


	May 31, 2020			February 29, 2020			November 30, 2020			February 29, 2020
	(unaudited)						(unaudited)
ASSETS
Investments at fair value
Non-control/Non-affiliate investments (amortized cost of $442,916,804 and $418,006,725, respectively)	$	420,930,113		$	420,442,928
Affiliate investments (amortized cost of $25,998,569 and $23,998,917, respectively)		18,041,254			18,485,854
Control investments (amortized cost of $46,649,515 and $44,293,619, respectively)		43,975,865			46,703,192

Total investments at fair value (amortized cost of $515,564,888 and $486,299,261, respectively)		482,947,232			485,631,974
Non-control/Non-affiliate investments (amortized cost of $463,588,455 and $418,006,725, respectively)							$	456,552,179		$	420,442,928
Affiliate investments (amortized cost of $28,338,471 and $23,998,917, respectively)								21,403,802			18,485,854
Control investments (amortized cost of $65,055,003 and $44,293,619, respectively)								68,987,521			46,703,192
Total investments at fair value (amortized cost of $556,981,929 and $486,299,261, respectively)								546,943,502			485,631,974
Cash and cash equivalents		12,842,608			24,598,905			21,060,224			24,598,905
Cash and cash equivalents, reserve accounts		12,952,393			14,851,447			12,836,663			14,851,447
Interest receivable (net of reserve of $1,500,123 and $1,238,049, respectively)		4,308,981			4,810,456
Interest receivable (net of reserve of $1,982,033 and $1,238,049, respectively)								4,192,177			4,810,456
Management fee receivable		285,588			272,207			284,256			272,207
Other assets		660,775			701,007			740,361			701,007

Total assets	$	513,997,577		$	530,865,996		$	586,057,183		$	530,865,996

LIABILITIES
Revolving credit facility	$	—		$	—		$	-		$	-
Deferred debt financing costs, revolving credit facility		(489,361	)		(512,628	)		(674,638	)		(512,628	)
SBA debentures payable		170,000,000			150,000,000			176,000,000			150,000,000
Deferred debt financing costs, SBA debentures payable		(2,892,760	)		(2,561,495	)		(2,725,309	)		(2,561,495	)
2025 Notes payable		60,000,000			60,000,000
Deferred debt financing costs, 2025 notes payable		(1,953,054	)		(2,046,735	)
6.25% Notes Payable 2025								60,000,000			60,000,000
Deferred debt financing costs, 6.25% notes payable 2025								(1,766,709	)		(2,046,735	)
7.25% Notes Payable 2025								43,125,000			-
Deferred debt financing costs, 7.25% notes payable 2025								(1,480,977	)		-
7.75% Notes Payable 2025								5,000,000			-
Deferred debt financing costs, 7.75% notes payable 2025								(252,746	)		-
Base management and incentive fees payable		3,552,457			15,800,097			4,775,801			15,800,097
Deferred tax liability		1,070,678			1,347,363			1,434,505			1,347,363
Accounts payable and accrued expenses		1,580,913			1,713,157			1,514,585			1,713,157
Interest and debt fees payable		994,956			2,234,042			931,938			2,234,042
Directors fees payable		63,000			61,500			44,500			61,500
Due to manager		439,730			543,842			278,343			543,842

Total liabilities		232,366,559			226,579,143			286,204,293			226,579,143

Commitments and contingencies (See Note 8)

NET ASSETS
Common stock, par value $0.001, 100,000,000 common shares authorized, 11,217,545 and 11,217,545 common shares issued and outstanding, respectively		11,218			11,218
Common stock, par value $0.001, 100,000,000 common shares authorized, 11,170,028 and 11,217,545 common shares issued and outstanding, respectively								11,170			11,218
Capital in excess of par value		289,476,991			289,476,991			288,590,554			289,476,991
Total distributable earnings (loss)		(7,857,191	)		14,798,644

Total distributable earnings								11,251,166			14,798,644
Total net assets		281,631,018			304,286,853			299,852,890			304,286,853

Total liabilities and net assets	$	513,997,577		$	530,865,996		$	586,057,183		$	530,865,996

NET ASSET VALUE PER SHARE	$	25.11		$	27.13		$	26.84		$	27.13


	For the three months ended						For the three months ended						For the nine months ended
	May 31, 2020			May 31, 2019			November 30, 2020			November 30, 2019			November 30, 2020			November 30, 2019
INVESTMENT INCOME
Interest from investments
Interest income:
Non-control/Non-affiliate investments	$	9,955,562		$	8,527,740		$	10,422,586		$	9,749,294		$	30,585,868		$	26,862,643
Affiliate investments		398,370			249,325			418,418			356,958			1,204,840			873,816
Control investments		1,133,584			1,648,146			1,654,359			1,300,923			4,037,915			4,627,395
Payment-in-kind interest income:
Non-control/Non-affiliate investments		581,946			151,897			214,422			198,984			1,125,306			530,728
Affiliate investments		46,223			40,150			49,333			42,397			143,574			123,812
Control investments		34,782			985,869			44,896			1,250,824			117,449			3,226,060

Total interest from investments		12,150,467			11,603,127			12,804,014			12,899,380			37,214,952			36,244,454
Interest from cash and cash equivalents		11,796			51,359			770			119,539			14,176			316,691
Management fee income		634,572			629,516			623,817			629,671			1,883,825			1,888,932
Structuring and advisory fee income*		313,306			316,375			545,354			511,500			1,798,660			1,875,225
Other income*		187,000			150,807			308,802			35,665			523,862			509,850

Total investment income		13,297,141			12,751,184			14,282,757			14,195,755			41,435,475			40,835,152

OPERATING EXPENSES
Interest and debt financing expenses		2,563,876			3,864,576			3,559,870			3,896,968			9,452,193			11,628,266
Base management fees		2,160,528			1,812,169			2,324,564			2,146,214			6,694,144			5,955,623
Incentive management fees expense (benefit)		(1,858,310	)		2,113,169			2,295,000			3,102,139			1,966,367			7,300,794
Professional fees		386,888			395,126			502,979			401,010			1,257,420			1,181,010
Administrator expenses		556,250			500,000			693,750			556,250			1,852,083			1,575,000
Insurance		67,726			64,619			67,010			63,936			202,463			193,174
Directors fees and expenses		60,000			60,000			60,000			60,000			195,000			217,500
General & administrative		350,814			258,601			278,734			395,024			963,372			1,036,498
Income tax expense (benefit)		(8,945	)		2,136			29,748			(1,001,089	)		28,304			(1,464,878	)

Total operating expenses		4,278,827			9,070,396			9,811,655			9,620,452			22,611,346			27,622,987

NET INVESTMENT INCOME		9,018,314			3,680,788			4,471,102			4,575,303			18,824,129			13,212,165

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS
Net realized gain (loss) from investments:
Non-control/Non-affiliate investments		8,480			—			1,798			10,739,678			22,207			12,609,767

Net realized gain (loss) from investments		8,480			—			1,798			10,739,678			22,207			12,609,767

Income tax (provision) benefit from realized gain on investments								(3,895,354	)		-			(3,895,354	)		-
Net change in unrealized appreciation (depreciation) on investments:
Non-control/Non-affiliate investments		(24,422,894	)		2,393,191			4,348,888			(4,322,305	)		(9,472,477	)		(1,563,573	)
Affiliate investments		(2,444,252	)		169,944			385,414			(41,295	)		(1,421,606	)		859,953
Control investments		(5,083,223	)		1,425,995			1,264,528			3,827,449			1,522,945			5,614,471

Net change in unrealized appreciation (depreciation) on investments		(31,950,369	)		3,989,130			5,998,830			(536,151	)		(9,371,138	)		4,910,851
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments		267,740			(20,930	)		(210,057	)		(1,061,608	)		(58,838	)		(1,786,801	)

Net realized and unrealized gain (loss) on investments		(31,674,149	)		3,968,200			1,895,217			9,141,919			(13,303,123	)		15,733,817

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	$	(22,655,835	)	$	7,648,988		$	6,366,319		$	13,717,222		$	5,521,006		$	28,945,982

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE	$	(2.02	)	$	0.99
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING—BASIC AND DILUTED		11,217,545			7,746,187
WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE							$	0.57		$	1.37		$	0.49		$	3.33
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED								11,169,817			10,036,086			11,198,287			8,702,190

		Page
PART I.	FINANCIAL INFORMATION			1
				~~Page~~

~~PART I.~~		~~FINANCIAL INFORMATION~~

Item 1.		Consolidated Financial Statements	1
		3

		Consolidated Statements of Assets and Liabilities as of ~~May 31,~~November 30, 2020 (unaudited) and February 29, 2020	1
		3

		Consolidated Statements of Operations for the three and nine months ended ~~May 31,~~November 30, 2020 (unaudited) and ~~May 31,~~November 30, 2019 (unaudited)	2
		4

		Consolidated Statements of Changes in Net Assets for three and nine months ended ~~May 31,~~November 30, 2020 (unaudited) and ~~May 31,~~November 30, 2019 (unaudited)	3
		5

		Consolidated Statements of Cash Flows for the three and nine months ended ~~May 31,~~November 30, 2020 (unaudited) and ~~May 31,~~November 30, 2019 (unaudited)	4
		6

		Consolidated Schedules of Investments as of ~~May 31,~~November 30, 2020 (unaudited) and February 29, 2020	5
		7

		Notes to Consolidated Financial Statements as of ~~May 31,~~November 30, 2020 (unaudited)	16
		11

Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations	64
		49

Item 3.		Quantitative and Qualitative Disclosures About Market Risk	96
		76

Item 4.		Controls and Procedures	97
		77
PART II.	OTHER INFORMATION	98
~~PART II.~~		~~OTHER INFORMATION~~			78

Item 1.		Legal Proceedings	98
		78

Item 1A.		Risk Factors	98
		78

Item 2.		Unregistered Sales of Equity Securities and Use of Proceeds	99
		78

Item 3.		Defaults Upon Senior Securities	99
		78

Item 4.		Mine Safety Disclosures	99
		78

Item 5.		Other Information	99
		78
Item 6.	Exhibits	100
~~Item 6.~~		~~Exhibits~~			79

Signatures					81	103


Company	Industry		Investment Interest Rate/ Maturity	Original Acquisition Date		Principal/ Number of Shares		Cost		Fair Value (c)			% of Net Assets
Non-control/Non-affiliate investments—149.5% (b)
Apex Holdings Software Technologies, LLC		Business Services	First Lien Term Loan (3M USD LIBOR+8.00%), 9.00% Cash, 9/21/2021		9/21/2016	$	18,000,000	$	17,958,108	$	17,220,600			6.1	%
Apex Holdings Software Technologies, LLC		Business Services	Delayed Draw Term Loan (3M USD LIBOR+8.00%), 9.00% Cash, 9/21/2021		10/1/2018	$	1,500,000		1,493,070		1,435,050			0.5	%
ArbiterSports, LLC (d)		Business Services	First Lien Term Loan (3M USD LIBOR+6.50%), 8.25% Cash, 2/21/2025		2/21/2020	$	26,000,000		25,776,666		24,195,600			8.6	%
Arbiter Sports, LLC (d)		Business Services	Delayed Draw Term Loan (3M USD LIBOR+6.50%), 8.25% Cash, 2/21/2025		2/21/2020	$	1,000,000		1,000,000		930,600			0.3	%
Avionte Holdings, LLC (h)		Business Services	Class A Units		1/8/2014		100,000		100,000		652,755			0.2	%
CLEO Communications Holding, LLC (d)		Business Services	First Lien Term Loan (3M USD LIBOR+8.00%), 9.00% Cash/2.00% PIK, 3/31/2022		3/31/2017	$	13,862,297		13,845,633		13,748,626			4.9	%
CLEO Communications Holding, LLC (d)		Business Services	Delayed Draw Term Loan (3M USD LIBOR+8.00%), 9.00% Cash/2.00% PIK, 3/31/2022		3/31/2017	$	20,144,170		20,036,042		19,978,987			7.1	%
CoConstruct, LLC		Business Services	First Lien Term Loan (3M USD LIBOR+7.50%), 10.00% Cash, 7/5/2024		7/5/2019	$	4,200,000		4,163,653		4,082,400			1.4	%
CoConstruct, LLC		Business Services	Delayed Draw Term Loan (3M USD LIBOR+7.50%), 10.00% Cash, 7/5/2024		7/5/2019	$	3,500,000		3,467,047		3,402,000			1.2	%
Davisware, LLC		Business Services	First Lien Term Loan (3M USD LIBOR+7.00%), 9.00% Cash, 7/31/2024		9/6/2019	$	3,000,000		2,973,420		2,844,300			1.0	%
Davisware, LLC (j)		Business Services	Delayed Draw Term Loan (3M USD LIBOR+7.00%), 9.00% Cash, 7/31/2024		9/6/2019	$	977,790		968,436		873,990			0.3	%
Destiny Solutions Inc. (d)		Business Services	First Lien Term Loan (3M USD LIBOR+7.25%), 9.25% Cash, 10/23/2024		5/16/2018	$	36,000,000		35,709,234		34,311,600			12.2	%
Destiny Solutions Inc. (h), (i)		Business Services	Limited Partner Interests		5/16/2018		2,342		2,468,464		2,765,313			1.0	%
Emily Street Enterprises, L.L.C.		Business Services	Senior Secured Note (3M USD LIBOR+8.50%), 10.00% Cash, 12/31/2020		12/28/2012	$	3,300,000		3,299,985		3,230,700			1.1	%
Emily Street Enterprises, L.L.C. (h)		Business Services	Warrant Membership Interests Expires 12/28/2022		12/28/2012		49,318		400,000		307,450			0.1	%
Erwin, Inc. (d)		Business Services	Second Lien Term Loan (3M USD LIBOR+11.50%), 12.50% Cash/1.00% PIK, 8/28/2021		2/29/2016	$	16,090,374		16,042,089		16,021,185			5.7	%
FMG Suite Holdings, LLC (d)		Business Services	Second Lien Term Loan (1M USD LIBOR+8.00%), 9.00% Cash, 11/16/2023		5/16/2018	$	23,000,000		22,875,335		22,896,500			8.1	%
GDS Software Holdings, LLC (h)		Business Services	Common Stock Class A Units		8/23/2018		250,000		250,000		416,431			0.1	%
Identity Automation Systems (h)		Business Services	Common Stock Class A-2 Units		8/25/2014		232,616		232,616		697,848			0.2	%
Identity Automation Systems (h)		Business Services	Common Stock Class A-1 Units		3/6/2020		43,715		171,571		174,870			0.1	%
Identity Automation Systems (d)		Business Services	First Lien Term Loan (3M USD LIBOR+9.24%), 10.99% Cash, 5/8/2024		8/25/2014	$	17,378,750		17,338,112		16,673,173			5.9	%
inMotionNow, Inc.		Business Services	First Lien Term Loan (3M USD LIBOR+7.25), 9.75% Cash, 5/15/2024		5/15/2019	$	12,200,000		12,100,642		11,403,340			4.0	%
inMotionNow, Inc. (j)		Business Services	Delayed Draw Term Loan (3M USD LIBOR+7.25) 9.75% Cash, 5/15/2024		5/15/2019	$	2,000,000		1,982,887		1,869,400			0.7	%
Knowland Group, LLC		Business Services	Second Lien Term Loan (3M USD LIBOR+8.00%), 10.00% Cash, 5/9/2024		11/9/2018	$	15,379,167		15,379,167		11,445,176			4.1	%
LogicMonitor, Inc.		Business Services	First Lien Term Loan (3M USD LIBOR+5.00), 6.00% Cash, 5/17/2023		3/20/2020	$	18,000,000		17,872,544		17,305,200			6.1	%
National Waste Partners (d)		Business Services	Second Lien Term Loan 10.00% Cash, 2/13/2022		2/13/2017	$	9,000,000		8,965,278		8,805,600			3.1	%
Omatic Software, LLC		Business Services	First Lien Term Loan (3M USD LIBOR+8.00%), 9.75% Cash, 5/29/2023		5/29/2018	$	5,500,000		5,463,118		5,358,650			2.0	%
Passageways, Inc.		Business Services	First Lien Term Loan (3M USD LIBOR+7.00%), 8.75% Cash, 7/5/2023		7/5/2018	$	5,000,000		4,963,510		4,849,500			1.8	%
Passageways, Inc. (j)		Business Services	Delayed Draw Term Loan (3M USD LIBOR+7.00%), 8.75% Cash, 7/5/2023		1/3/2020	$	2,000,000		1,991,661		1,849,500			0.7	%
Passageways, Inc. (h)		Business Services	Series A Preferred Stock		7/5/2018		2,027,205		1,000,000		2,105,112			0.8	%
Sceptre Hospitality Resources, LLC		Business Services	First Lien Term Loan (1M USD LIBOR+9.00%), 10.00% Cash, 4/27/2025		4/27/2020	$	3,000,000		2,970,794		2,970,000			1.1	%
Vector Controls Holding Co., LLC (d)		Business Services	First Lien Term Loan 10.50% (9.00% Cash/1.50% PIK), 3/6/2022		3/6/2013	$	7,849,846		7,849,770		7,649,675			2.7	%
Vector Controls Holding Co., LLC (d), (h)		Business Services	Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027		5/31/2015		343		—		2,289,966			0.8	%

			Total Business Services						271,108,852		264,761,097			94.0	%

Targus Holdings, Inc. (d), (h)		Consumer Products	Common Stock		12/31/2009		210,456		1,589,630		409,172			0.1	%

			Total Consumer Products						1,589,630		409,172			0.1	%

My Alarm Center, LLC (k)		Consumer Services	Preferred Equity Class A Units 8.00% PIK		7/14/2017		2,227		2,357,879		—			0.0	%
My Alarm Center, LLC (h)		Consumer Services	Preferred Equity Class B Units		7/14/2017		1,797		1,796,880		—			0.0	%
My Alarm Center, LLC (h)		Consumer Services	Preferred Equity Class Z Units		9/12/2018		676		712,343		1,997,158			0.6	%
My Alarm Center, LLC (h)		Consumer Services	Common Stock		7/14/2017		96,224		—		—			0.0	%

			Total Consumer Services						4,867,102		1,997,158			0.6	%

C2 Educational Systems (d)		Education	First Lien Term Loan (3M USD LIBOR+7.00%), 8.50% Cash, 5/31/2020		5/31/2017	$	16,000,000		15,987,433		12,872,000			4.6	%
EMS LINQ, Inc.		Education	First Lien Term Loan (1M USD LIBOR+8.50%), 9.75% Cash, 8/9/2024		8/9/2019	$	14,887,500		14,771,175		13,875,150			4.9	%
GoReact		Education	First Lien Term Loan (3M USD LIBOR+7.50%), 9.50% Cash, 1/17/2025		1/17/2020	$	5,000,000		4,934,208		4,709,000			1.7	%
GoReact (j)		Education	Delayed Draw Term Loan (3M USD LIBOR+7.50%), 9.50% Cash, 1/17/2025		1/17/2020	$	—		—		(116,400	)		0.0	%
Kev Software Inc. (a)		Education	First Lien Term Loan (1M USD LIBOR+8.63%), 9.63% Cash, 9/13/2023		9/13/2018	$	21,178,171		21,046,716		20,210,328			7.2	%
Texas Teachers of Tomorrow, LLC (h), (i)		Education	Common Stock		12/2/2015		750,000		750,000		648,428			0.2	%
Texas Teachers of Tomorrow, LLC (d)		Education	First Lien Term Loan (3M USD LIBOR+7.25%), 9.75% Cash, 6/28/2024		6/28/2019	$	18,945,824		18,782,577		17,871,596			6.3	%

			Total Education						76,272,109		70,070,102			24.9	%

TMAC Acquisition Co., LLC (k)		Food and Beverage	Unsecured Term Loan 8.00% PIK, 9/01/2023		3/1/2018	$	2,261,017		2,261,017		1,848,422			0.7	%

			Total Food and Beverage						2,261,017		1,848,422			0.7	%

Axiom Parent Holdings, LLC (h)		Healthcare Services	Common Stock Class A Units		6/19/2018		400,000		400,000		331,445			0.1	%
Axiom Purchaser, Inc. (d)		Healthcare Services	First Lien Term Loan (3M USD LIBOR+6.00%), 7.75% Cash, 6/19/2023		6/19/2018	$	10,000,000		9,940,487		9,488,000			3.4	%
Axiom Purchaser, Inc. (d)		Healthcare Services	Delayed Draw Term Loan (3M USD LIBOR+6.00%), 7.75% Cash, 6/19/2023		6/19/2018	$	4,000,000		3,970,740		3,795,200			1.3	%
ComForCare Health Care		Healthcare Services	First Lien Term Loan (3M USD LIBOR+7.50%), 8.50% Cash, 1/31/2022		1/31/2017	$	15,000,000		14,936,996		14,737,500			5.2	%
HemaTerra Holding Company, LLC		Healthcare Services	First Lien Term Loan (3M USD LIBOR+6.75%), 9.25% Cash, 4/15/2024		4/15/2019	$	6,000,000		5,947,515		5,868,000			2.1	%
HemaTerra Holding Company, LLC (d), (j)		Healthcare Services	Delayed Draw Term Loan (3M USD LIBOR+6.75%), 9.25% Cash, 4/15/2024		4/15/2019	$	12,000,000		11,896,667		11,692,000			4.2	%
TRC HemaTerra, LLC (h)		Healthcare Services	Class D Membership Interests		4/15/2019		2,000,000		2,000,000		2,289,018			0.8	%
Ohio Medical, LLC (h)		Healthcare Services	Common Stock		1/15/2016		5,000		500,000		743,607			0.3	%
Ohio Medical, LLC		Healthcare Services	Senior Subordinated Note 12.00% Cash, 6/30/2022		1/15/2016	$	7,300,000		7,279,283		7,300,000			2.6	%
PDDS Buyer, LLC		Healthcare Services	First Lien Term Loan (3M USD LIBOR+7.00%), 9.50% Cash, 7/15/2024		7/15/2019	$	12,000,000		11,894,752		11,648,400			4.1	%


Company	Purchases		Sales		Total Interest from Investments		Management Fee Income		Net Realized Gain (Loss) from Investments		Net Change in Unrealized Appreciation (Depreciation)
Elyria Foundry Company, L.L.C.	$	—	$	—	$	46,223	$	—	$	—	$	(1,758,988	)
GreyHeller LLC		—		—		230,371		—		—		(363,252	)
Top Gun Pressure Washing, LLC		1,806,750		—		167,999		—		—		(244,777	)
TG Pressure Washing Holdings, LLC		138,148		—		—		—		—		(77,235	)

	$	1,944,898	$	—	$	444,593	$	—	$	—	$	(2,444,252	)

	Number of Shares		Cost		Fair Value		% of Net Assets
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 11.3% (b)
U.S. Bank Money Market (l)		33,896,887	$	33,896,887	$	33,896,887		11.3	%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts		33,896,887	$	33,896,887	$	33,896,887		11.3	%

Company	Industry	Investment Interest Rate/ Maturity	Original Acquisition Date	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Non-control/Non-affiliate investments - 138.2% (b)
CoConstruct, LLC	Construction Management Services	First Lien Term Loan (3M USD LIBOR+7.50%), 10.00% Cash, 7/5/2024	7/5/2019	$	4,200,000		4,161,917		4,284,000		1.4	%
CoConstruct, LLC (j)	Construction Management Services	Delayed Draw Term Loan (3M USD LIBOR+7.50%), 10.00% Cash, 7/5/2024	7/5/2019	$	-		-		-		0.0	%
		Total Construction Management Services					4,161,917		4,284,000		1.4	%
Targus Holdings, Inc. (h)	Consumer Products	Common Stock	12/31/2009		210,456		1,589,630		417,619		0.1	%
		Total Consumer Products					1,589,630		417,619		0.1	%
My Alarm Center, LLC (k)	Consumer Services	Preferred Equity Class A Units 8.00% PIK	7/14/2017		2,227		2,357,879		-		0.0	%
My Alarm Center, LLC (h)	Consumer Services	Preferred Equity Class B Units	7/14/2017		1,797		1,796,880		-		0.0	%
My Alarm Center, LLC (h)	Consumer Services	Preferred Equity Class Z Units	9/12/2018		676		712,343		1,997,158		0.6	%
My Alarm Center, LLC (h)	Consumer Services	Common Stock	7/14/2017		96,224		-		-		0.0	%
		Total Consumer Services					4,867,102		1,997,158		0.60	%
Passageways, Inc.	Corporate Governance	First Lien Term Loan (3M USD LIBOR+7.00%), 8.75% Cash, 7/5/2023	7/5/2018	$	5,000,000		4,961,214		5,034,500		1.7	%
Passageways, Inc. (j)	Corporate Governance	Delayed Draw Term Loan (3M USD LIBOR+7.00%), 8.75% Cash, 7/5/2023	1/3/2020	$	2,000,000		1,991,001		2,013,800		0.7	%
Passageways, Inc. (h)	Corporate Governance	Series A Preferred Stock	7/5/2018		2,027,205		1,000,000		2,042,180		0.8	%
		Total Corporate Governance					7,952,215		9,090,480		0.03
C2 Educational Systems (d)	Education Services	First Lien Term Loan (3M USD LIBOR+7.00%), 8.50% Cash, 5/31/2020	5/31/2017	$	16,000,000		15,981,853		16,000,000		5.3	%
Texas Teachers of Tomorrow, LLC (h), (i)	Education Services	Common Stock	12/2/2015		750,000		750,000		703,910		0.2	%
Texas Teachers of Tomorrow, LLC (d)	Education Services	First Lien Term Loan (3M USD LIBOR+7.25%), 9.75% Cash, 6/28/2024	6/28/2019	$	19,661,200		19,483,213		19,661,200		6.5	%
		Total Education Services					36,215,066		36,365,110		12.0	%
Destiny Solutions Inc. (d)	Education Software	First Lien Term Loan (3M USD LIBOR+7.25%), 9.25% Cash, 10/23/2024	5/16/2018	$	36,000,000		35,686,318		35,888,400		11.8	%
Destiny Solutions Inc. (h), (i)	Education Software	Limited Partner Interests	5/16/2018		2,342		2,468,464		2,805,839		0.9	%
Identity Automation Systems (h)	Education Software	Common Stock Class A Units	8/25/2014		232,616		232,616		860,269		0.4	%
Identity Automation Systems (d)	Education Software	First Lien Term Loan (3M USD LIBOR+9.24%), 10.99% Cash, 5/8/2024	8/25/2014	$	15,422,500		15,389,090		15,524,289		5.1	%
EMS LINQ, Inc.	Education Software	First Lien Term Loan (1M USD LIBOR+8.50%), 10.02% Cash, 8/9/2024	8/9/2019	$	14,925,000		14,780,293		14,823,510		4.8	%
GoReact	Education Software	First Lien Term Loan (3M USD LIBOR+7.50%), 9.50% Cash, 1/17/2025	1/17/2020	$	5,000,000		4,930,819		4,950,000		1.6	%
GoReact (j)	Education Software	Delayed Draw Term Loan (3M USD LIBOR+7.50%), 9.50% Cash, 1/17/2025	1/17/2020	$	-		-		-		0.0	%
Kev Software Inc. (a)	Education Software	First Lien Term Loan (1M USD LIBOR+8.63%), 10.15% Cash, 9/13/2023	9/13/2018	$	21,231,923		21,086,573		21,202,198		7.0	%
		Total Education Software					94,574,173		96,054,505		31.6	%
Davisware, LLC	Field Service Management	First Lien Term Loan (3M USD LIBOR+7.00%), 9.00% Cash, 7/31/2024	9/6/2019	$	3,000,000		2,971,896		2,970,000		1.0	%
Davisware, LLC (j)	Field Service Management	Delayed Draw Term Loan (3M USD LIBOR+7.00%), 9.00% Cash, 7/31/2024	9/6/2019	$	-		-		-		0.0	%
		Total Field Service Management					2,971,896		2,970,000		1.0	%

	Number of Shares		Cost		Fair Value		% of Net Assets
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 13.0% (b)
U.S. Bank Money Market (l)		39,450,352	$	39,450,352	$	39,450,352		13.0	%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts		39,450,352	$	39,450,352	$	39,450,352		13.0	%


	May 31, 2020		May 31, 2019		November 30, 2020		November 30, 2019
Cash and cash equivalents	$	12,842,608	$	37,183,604	$	21,060,224	$	51,646,844
Cash and cash equivalents, reserve accounts		12,952,393		23,812,643		12,836,663		29,465,785

Total cash and cash equivalents and cash and cash equivalents, reserve accounts	$	25,795,001	$	60,996,247	$	33,896,887	$	81,112,629


	Fair Value Measurements								Fair Value Measurements
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
First lien term loans	$	—	$	—	$	354,435	$	354,435	$	-	$	-	$	407,699	$	407,699
Second lien term loans		—		—		69,487		69,487		-		-		50,027		50,027
Unsecured term loans		—		—		5,811		5,811		-		-		26,817		26,817
Structured finance securities		—		—		27,306		27,306		-		-		31,299		31,299
Equity interests		—		—		25,908		25,908		-		-		31,102		31,102

Total	$	—	$	—	$	482,947	$	482,947	$	-	$	-	$	546,944	$	546,944


	First lien term loans			Second lien term loans			Unsecured term loans			Structured finance securities			Equity interests			Total			First lien term loans			Second lien term loans			Unsecured term loans			Structured finance securities			Equity interests			Total
Balance as of February 29, 2020	$	346,233		$	73,570		$	4,346		$	32,470		$	29,013		$	485,632		$	346,233		$	73,570		$	4,346		$	32,470		$	29,013		$	485,632
Payment-in-kind and other adjustments to cost		191			466			—			(1,361	)		—			(704	)		625			1,034			-			(3,061	)		-			(1,402	)
Net accretion of discount on investments		279			33			—			—			—			312			772			193			-			-			-			965
Net change in unrealized appreciation (depreciation) on investments		(19,115	)		(4,582	)		(1,035	)		(3,803	)		(3,415	)		(31,950	)		(7,915	)		(1,770	)		(29	)		1,890			(1,547	)		(9,371	)
Purchases		36,189			—			2,500			—			310			38,999			95,891			-			22,500			-			3,636			122,027
Sales and repayments		(9,350	)		—			—			—			—			(9,350	)		(27,929	)		(23,000	)		-			-			-			(50,929	)
Net realized gain (loss) from investments		8			—			—			—			—			8			22			-			-			-			-			22

Balance as of May 31, 2020	$	354,435		$	69,487		$	5,811		$	27,306		$	25,908		$	482,947

Balance as of November 30, 2020																			$	407,699		$	50,027		$	26,817		$	31,299		$	31,102		$	546,944
Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period	$	(18,880	)	$	(4,583	)	$	(1,034	)	$	(3,804	)	$	(3,414	)	$	(31,715	)	$	(7,636	)	$	(1,722	)	$	(29	)	$	1,889		$	(1,546	)	$	(9,044	)


	Investments at Amortized Cost		Amortized Cost Percentage of Total Portfolio			Investments at Fair Value		Fair Value Percentage of Total Portfolio			Investments at Amortized Cost		Amortized Cost Percentage of Total Portfolio			Investments at Fair Value		Fair Value Percentage of Total Portfolio
First lien term loans	$	370,417		71.9	%	$	354,435		73.4	%	$	412,481		74.1	%	$	407,699		74.5	%
Second lien term loans		75,978		14.7			69,487		14.4			53,704		9.6			50,027		9.2
Unsecured term loans		7,261		1.4			5,811		1.2			27,261		4.9			26,817		4.9
Structured finance securities		32,160		6.2			27,306		5.6			30,460		5.5			31,299		5.7
Equity interests		29,749		5.8			25,908		5.4			33,076		5.9			31,102		5.7

Total	$	515,565		100.0	%	$	482,947		100.0	%	$	556,982		100.0	%	$	546,944		100.0	%


Issuer Name	Industry	Asset Name	Asset Type		Reference Rate/ Spread		x			LIBOR Floor			Current Rate (All In)			Maturity Date		Principal/ Number of Shares		Cost		Fair Value
Education Management II LLC (b)	Services: Consumer	Education Management II A-2 Preferred Shares		Equity		—		0.00	%		0.00	%		0.00	%		—		18,975	$	1,897,538	$	—
Education Management II LLC (b)	Services: Consumer	Education Management II A-1 Preferred Shares		Equity		—		0.00	%		0.00	%		0.00	%		—		6,692		669,214		—
1011778 B.C. Unlimited Liability Company	Beverage Food & Tobacco	Term Loan B4		Loan		1M USD LIBOR+		1.75	%		0.00	%		1.93	%		11/19/2026	$	1,496,250		1,453,849		1,434,530
24 Hour Fitness Worldwide Inc.	Services: Consumer	Term Loan (5/18)		Loan		3M USD LIBOR+		3.50	%		0.00	%		3.84	%		5/30/2025		2,952,437		2,942,983		826,682
ABB Con-Cise Optical Group LLC	Consumer goods: Non-durable	Term Loan B		Loan		6M USD LIBOR+		5.00	%		1.00	%		6.00	%		6/15/2023		2,076,547		2,058,435		1,654,323
ADMI Corp.	Services: Consumer	Term Loan B		Loan		3M USD LIBOR+		2.75	%		0.00	%		3.09	%		4/30/2025		1,965,276		1,957,855		1,798,719
Advantage Sales & Marketing Inc.	Services: Business	First Lien Term Loan		Loan		3M USD LIBOR+		3.25	%		1.00	%		4.25	%		7/23/2021		2,364,874		2,364,078		2,119,850
Advantage Sales & Marketing Inc.	Services: Business	Term Loan B Incremental		Loan		3M USD LIBOR+		3.25	%		1.00	%		4.25	%		7/23/2021		488,693		485,128		438,114
Advisor Group Holdings Inc	Banking Finance Insurance & Real Estate	Term Loan (7/19)		Loan		1M USD LIBOR+		5.00	%		0.00	%		5.18	%		7/31/2026		498,750		497,545		462,177
Aegis Toxicology Sciences Corporation	Healthcare & Pharmaceuticals	Term Loan		Loan		3M USD LIBOR+		5.50	%		1.00	%		6.50	%		5/9/2025		3,940,000		3,911,716		3,299,750
Agiliti Health Inc.	Healthcare & Pharmaceuticals	Term Loan (1/19)		Loan		3M USD LIBOR+		3.00	%		0.00	%		3.34	%		1/5/2026		495,000		495,000		480,150
Agrofresh Inc.	Beverage Food & Tobacco	Term Loan		Loan		1M USD LIBOR+		4.75	%		1.00	%		5.75	%		7/30/2021		2,881,923		2,879,786		2,633,357
AI Convoy (Luxembourg) S.a.r.l.	Aerospace & Defense	AI Convoy (Luxembourg) USD T/L B		Loan		6M USD LIBOR+		3.50	%		1.00	%		4.50	%		1/15/2027		1,500,000		1,492,592		1,428,750
AI Mistral (Luxembourg) Subco Sarl	High Tech Industries	Term Loan		Loan		1M USD LIBOR+		3.00	%		1.00	%		4.00	%		3/11/2024		485,000		485,000		366,175
AIS Holdco LLC	Services: Business	Term Loan		Loan		3M USD LIBOR+		5.00	%		0.00	%		5.34	%		8/15/2025		2,406,250		2,396,870		1,973,125
Alchemy US Holdco 1 LLC	Metals & Mining	Term Loan		Loan		1M USD LIBOR+		5.50	%		0.00	%		5.68	%		10/10/2025		1,937,500		1,914,018		1,724,375
Alion Science and Technology Corporation	Aerospace & Defense	Term Loan B (1st Lien)		Loan		1M USD LIBOR+		4.50	%		1.00	%		5.50	%		8/19/2021		3,377,293		3,374,207		3,337,880
Allen Media LLC	Media: Advertising Printing & Publishing	Allen Media T/L B (1/20)		Loan		2M USD LIBOR+		5.50	%		0.00	%		5.78	%		2/10/2027		3,000,000		2,986,071		2,827,500
Altisource S.a r.l.	Banking Finance Insurance & Real Estate	Term Loan B (03/18)		Loan		3M USD LIBOR+		4.00	%		1.00	%		5.00	%		4/3/2024		1,454,005		1,446,990		1,066,265
Altra Industrial Motion Corp.	Capital Equipment	Term Loan		Loan		1M USD LIBOR+		2.00	%		0.00	%		2.18	%		10/1/2025		1,767,163		1,763,700		1,678,805
American Greetings Corporation	Media: Advertising Printing & Publishing	Term Loan		Loan		1M USD LIBOR+		4.50	%		1.00	%		5.50	%		4/5/2024		4,780,845		4,777,921		4,398,377
American Residential Services LLC	Services: Consumer	Term Loan B		Loan		3M USD LIBOR+		4.00	%		1.00	%		5.00	%		6/30/2022		3,915,488		3,907,173		3,641,404
Amerilife Holdings LLC	Banking Finance Insurance & Real Estate	AmeriLife T/L		Loan		1M USD LIBOR+		4.00	%		0.00	%		4.18	%		3/18/2027		886,364		884,237		815,454
Amerilife Holdings LLC (a)	Banking Finance Insurance & Real Estate	Unfunded Commitment		Loan		1M USD LIBOR+		4.00	%		0.00	%		4.18	%		3/18/2027		—		—		—
Amynta Agency Borrower Inc.	Banking Finance Insurance & Real Estate	Term Loan		Loan		1M USD LIBOR+		4.50	%		0.00	%		4.68	%		2/28/2025		3,453,572		3,418,544		3,194,554
Anastasia Parent LLC	Consumer goods: Non-durable	Term Loan		Loan		3M USD LIBOR+		3.75	%		0.00	%		4.09	%		8/11/2025		985,000		981,157		317,249
Anchor Glass Container Corporation	Containers Packaging & Glass	Term Loan (07/17)		Loan		3M USD LIBOR+		2.75	%		1.00	%		3.75	%		12/7/2023		483,819		482,396		360,750
Api Group DE Inc	Services: Business	Term Loan B		Loan		1M USD LIBOR+		2.50	%		0.00	%		2.68	%		10/1/2026		997,500		992,795		957,181
APLP Holdings Limited Partnership	Utilities	APLP Holdings T/L B (01/20)		Loan		1M USD LIBOR+		2.50	%		1.00	%		3.50	%		4/11/2025		1,894,737		1,894,737		1,834,939
Aramark Services Inc.	Services: Consumer	Term Loan		Loan		1M USD LIBOR+		1.75	%		0.00	%		1.93	%		1/15/2027		2,500,000		2,410,516		2,374,224
Arctic Glacier U.S.A. Inc.	Beverage Food & Tobacco	Term Loan (3/18)		Loan		3M USD LIBOR+		3.50	%		1.00	%		4.50	%		3/20/2024		3,350,967		3,333,558		2,587,583
Aretec Group Inc.	Banking Finance Insurance & Real Estate	Term Loan (10/18)		Loan		1M USD LIBOR+		4.25	%		0.00	%		4.43	%		10/1/2025		1,975,000		1,971,083		1,817,000
Aristocrat International PTY Ltd	Hotel Gaming & Leisure	Term Loan (5/20)		Loan		3M USD LIBOR+		3.75	%		1.00	%		4.75	%		10/21/2024		1,000,000		980,043		993,750
ASG Technologies Group Inc.	High Tech Industries	Term Loan		Loan		1M USD LIBOR+		3.50	%		1.00	%		4.50	%		7/31/2024		465,137		463,621		406,028
AssetMark Financial Holdings Inc.	Banking Finance Insurance & Real Estate	Term Loan		Loan		3M USD LIBOR+		3.00	%		0.00	%		3.34	%		11/14/2025		1,237,500		1,235,709		1,206,563
Asurion LLC	Banking Finance Insurance & Real Estate	Term Loan B-4 (Replacement)		Loan		1M USD LIBOR+		3.00	%		0.00	%		3.18	%		8/4/2022		870,960		868,920		852,888
Asurion LLC	Banking Finance Insurance & Real Estate	Term Loan B6		Loan		1M USD LIBOR+		3.00	%		0.00	%		3.18	%		11/3/2023		491,477		488,707		478,271
Athenahealth Inc.	Healthcare & Pharmaceuticals	Term Loan B		Loan		3M USD LIBOR+		4.50	%		0.00	%		4.84	%		2/11/2026		1,980,000		1,946,688		1,905,750
Avaya Inc.	Telecommunications	Term Loan B		Loan		1M USD LIBOR+		4.25	%		0.00	%		4.43	%		12/16/2024		3,169,156		3,140,053		2,944,146
Avison Young (Canada) Inc.	Services: Business	Term Loan		Loan		3M USD LIBOR+		5.00	%		0.00	%		5.34	%		1/30/2026		3,467,443		3,412,554		3,097,953
Avolon TLB Borrower 1 (US) LLC	Capital Equipment	Term Loan B3		Loan		1M USD LIBOR+		1.75	%		0.75	%		2.50	%		1/15/2025		1,000,000		847,650		942,860
B&G Foods Inc.	Beverage Food & Tobacco	Term Loan		Loan		1M USD LIBOR+		2.50	%		0.00	%		2.68	%		10/10/2026		248,750		247,605		245,081
Ball Metalpack Finco LLC	Containers Packaging & Glass	Term Loan		Loan		3M USD LIBOR+		4.50	%		0.00	%		4.84	%		7/31/2025		3,934,925		3,919,453		3,478,474
Berry Global Inc.	Chemicals Plastics & Rubber	Term Loan Y		Loan		1M USD LIBOR+		2.00	%		0.00	%		2.18	%		7/1/2026		4,974,969		4,969,626		4,850,593
Blackstone Mortgage Trust Inc.	Banking Finance Insurance & Real Estate	Term Loan B-2		Loan		1M USD LIBOR+		4.75	%		1.00	%		5.75	%		4/23/2026		500,000		485,055		487,500
Blount International Inc.	Forest Products & Paper	Term Loan B (09/18)		Loan		1M USD LIBOR+		3.75	%		1.00	%		4.75	%		4/12/2023		3,445,038		3,442,502		3,279,951
Blucora Inc.	Services: Consumer	Term Loan (11/17)		Loan		3M USD LIBOR+		3.00	%		1.00	%		4.00	%		5/22/2024		955,134		953,335		907,377
Bombardier Recreational Products Inc.	Consumer goods: Durable	Term Loan (1/20)		Loan		1M USD LIBOR+		2.00	%		0.00	%		2.18	%		5/24/2027		992,513		983,756		917,011
Bracket Intermediate Holding Corp.	Healthcare & Pharmaceuticals	Term Loan		Loan		3M USD LIBOR+		4.25	%		0.00	%		4.59	%		9/5/2025		985,000		981,186		896,350
Broadstreet Partners Inc.	Banking Finance Insurance & Real Estate	Term Loan B3		Loan		1M USD LIBOR+		3.25	%		0.00	%		3.43	%		1/27/2027		2,024,614		2,022,906		1,940,248
Brookfield Property REIT Inc.	Banking Finance Insurance & Real Estate	Term Loan B		Loan		1M USD LIBOR+		2.50	%		0.00	%		2.68	%		8/27/2025		4,000,000		3,112,644		3,024,280
Brookfield WEC Holdings Inc.	Energy: Electricity	Term Loan 1/20		Loan		1M USD LIBOR+		3.00	%		0.75	%		3.75	%		8/1/2025		496,231		495,158		484,292
Buckeye Partners L.P.	Utilities: Oil & Gas	Term Loan		Loan		1M USD LIBOR+		2.75	%		0.00	%		2.93	%		11/2/2026		1,000,000		995,596		970,000
BW Gas & Convenience Holdings LLC	Beverage Food & Tobacco	Term Loan		Loan		1M USD LIBOR+		6.25	%		0.00	%		6.43	%		11/18/2024		2,962,500		2,853,893		2,784,750
Calceus Acquisition Inc.	Consumer goods: Non-durable	Term Loan B		Loan		3M USD LIBOR+		5.50	%		0.00	%		5.84	%		2/12/2025		968,750		958,753		900,938
Callaway Golf Company	Retail	Term Loan B		Loan		1M USD LIBOR+		4.50	%		0.00	%		4.68	%		1/2/2026		695,625		683,433		685,191
CareerBuilder LLC	Services: Business	Term Loan		Loan		3M USD LIBOR+		6.75	%		1.00	%		7.75	%		7/31/2023		1,393,388		1,373,831		1,247,082
Casa Systems Inc.	Telecommunications	Term Loan		Loan		1M USD LIBOR+		4.00	%		1.00	%		5.00	%		12/20/2023		1,451,250		1,443,042		1,310,363
Castle US Holding Corporation	Media: Advertising Printing & Publishing	Term Loan B (USD)		Loan		1M USD LIBOR+		3.75	%		0.00	%		3.93	%		1/29/2027		500,000		497,688		462,710
CCS-CMGC Holdings Inc.	Healthcare & Pharmaceuticals	Term Loan		Loan		3M USD LIBOR+		5.50	%		0.00	%		5.84	%		10/1/2025		2,468,750		2,448,592		2,147,813
Cengage Learning Inc.	Media: Advertising Printing & Publishing	Term Loan		Loan		3M USD LIBOR+		4.25	%		1.00	%		5.25	%		6/7/2023		1,443,708		1,432,362		1,162,907
CenturyLink Inc.	Telecommunications	Term Loan B (1/20)		Loan		1M USD LIBOR+		2.25	%		0.00	%		2.43	%		3/15/2027		2,992,500		2,989,209		2,867,653
Chemours Company The	Chemicals Plastics & Rubber	Term Loan		Loan		1M USD LIBOR+		1.75	%		0.00	%		1.93	%		4/3/2025		997,455		938,747		930,955
Citadel Securities LP	Banking Finance Insurance & Real Estate	Term Loan (2/20)		Loan		1M USD LIBOR+		2.75	%		0.00	%		2.93	%		2/27/2026		990,019		988,954		968,159

Issuer Name	Industry	Asset Name	Asset Type	Reference Rate/Spread			LIBOR Floor			Current Rate (All In)			Maturity Date	Principal/ Number of Shares		Cost		Fair Value
Education Management II LLC	Services: Consumer	Education Management II A-2 Preferred Shares	Equity	-	0.00	%		0.00	%		0.00	%	-		18,975	$	1,897,538	$	190
Education Management II LLC	Services: Consumer	Education Management II A-1 Preferred Shares	Equity	-	0.00	%		0.00	%		0.00	%	-		6,692		669,214		67
1011778 B.C. Unlimited Liability Company	Beverage Food & Tobacco	Term Loan B4	Loan	1M USD LIBOR+	1.75	%		0.00	%		3.27	%	11/19/2026	$	500,000.00		498,790		491,665
24 Hour Fitness Worldwide Inc.	Services: Consumer	Term Loan (5/18)	Loan	1M USD LIBOR+	3.50	%		0.00	%		5.02	%	5/30/2025		2,959,950		2,949,872		1,943,710
ABB Con-Cise Optical Group LLC	Consumer goods: Non-durable	Term Loan B	Loan	1M USD LIBOR+	5.00	%		1.00	%		6.52	%	6/15/2023		2,081,927		2,062,239		1,969,149
ADMI Corp.	Services: Consumer	Term Loan B	Loan	1M USD LIBOR+	2.75	%		0.00	%		4.27	%	4/30/2025		1,970,000		1,962,286		1,924,848
Advantage Sales & Marketing Inc.	Services: Business	First Lien Term Loan	Loan	1M USD LIBOR+	3.25	%		1.00	%		4.77	%	7/23/2021		2,371,131		2,370,010		2,286,173
Advantage Sales & Marketing Inc.	Services: Business	Term Loan B Incremental	Loan	1M USD LIBOR+	3.25	%		1.00	%		4.77	%	7/23/2021		489,950		485,523		470,352
Advisor Group Holdings Inc	Banking Finance Insurance & Real Estate	Term Loan (7/19)	Loan	1M USD LIBOR+	5.00	%		0.00	%		6.52	%	7/31/2026		500,000		498,753		486,875
Aegis Toxicology Sciences Corporation	Healthcare & Pharmaceuticals	Term Loan	Loan	3M USD LIBOR+	5.50	%		1.00	%		6.96	%	5/9/2025		3,950,000		3,919,494		3,695,225
Agiliti Health Inc.	Healthcare & Pharmaceuticals	Term Loan (1/19)	Loan	1M USD LIBOR+	3.00	%		0.00	%		4.52	%	1/5/2026		496,250		496,250		486,325
Agrofresh Inc.	Beverage Food & Tobacco	Term Loan	Loan	1M USD LIBOR+	4.75	%		1.00	%		6.27	%	7/30/2021		2,889,487		2,886,790		2,677,601
AI Convoy Bidco Limited	Aerospace & Defense	AI Convoy Bidco T/L B (USD)	Loan	3M USD LIBOR+	3.50	%		1.00	%		4.96	%	1/29/2027		1,500,000		1,492,500		1,483,125
AI Mistral (Luxembourg) Subco Sarl	High Tech Industries	Term Loan	Loan	1M USD LIBOR+	3.00	%		1.00	%		4.52	%	3/11/2024		486,250		486,250		384,138
AIS Holdco LLC	Services: Business	Term Loan	Loan	3M USD LIBOR+	5.00	%		0.00	%		6.46	%	8/15/2025		2,421,875		2,411,617		2,228,125
Alchemy US Holdco 1 LLC	Metals & Mining	Term Loan	Loan	1M USD LIBOR+	5.50	%		0.00	%		7.02	%	10/10/2025		1,950,000		1,925,236		1,945,125
Alion Science and Technology Corporation	Aerospace & Defense	Term Loan B (1st Lien)	Loan	1M USD LIBOR+	4.50	%		1.00	%		6.02	%	8/19/2021		3,377,293		3,373,263		3,373,071
Allen Media LLC	Media: Advertising Printing & Publishing	Allen Media T/L B (1/20)	Loan	3M USD LIBOR+	5.50	%		0.00	%		6.96	%	2/10/2027		3,000,000		2,985,000		2,936,250
Altisource S.a r.l.	Banking Finance Insurance & Real Estate	Term Loan B (03/18)	Loan	3M USD LIBOR+	4.00	%		1.00	%		5.46	%	4/3/2024		1,454,005		1,446,493		1,353,141
Altra Industrial Motion Corp.	Capital Equipment	Term Loan	Loan	1M USD LIBOR+	2.00	%		0.00	%		3.52	%	10/1/2025		1,767,163		1,763,366		1,748,943
American Dental Partners Inc.	Healthcare & Pharmaceuticals	Term Loan B	Loan	3M USD LIBOR+	4.25	%		1.00	%		5.71	%	3/24/2023		990,000		982,019		982,575
American Greetings Corporation	Media: Advertising Printing & Publishing	Term Loan	Loan	1M USD LIBOR+	4.50	%		1.00	%		6.02	%	4/5/2024		4,889,524		4,886,331		4,788,702
American Residential Services LLC	Services: Consumer	Term Loan B	Loan	1M USD LIBOR+	4.00	%		1.00	%		5.52	%	6/30/2022		3,925,767		3,916,564		3,896,324
AmeriLife Group LLC	Banking Finance Insurance & Real Estate	AmeriLife T/L	Loan	3M USD LIBOR+	4.00	%		0.00	%		5.46	%	2/5/2027		838,710		836,613		832,419
AmeriLife Group LLC(a)	Banking Finance Insurance & Real Estate	Unfunded Commitment	Loan	3M USD LIBOR+	4.00	%		0.00	%		4.00	%	2/5/2027		-		-		-
Amex GBT (2/20) T/L	Banking Finance Insurance & Real Estate	Term Loan	Loan	3M USD LIBOR+	4.00	%		0.00	%		5.46	%	2/26/2027		2,993,363		2,933,496		2,926,012
Amex GBT 2/20 D/T/L(a)	Banking Finance Insurance & Real Estate	Unfunded Commitment	Loan	3M USD LIBOR+	4.00	%		0.00	%		5.46	%	2/26/2027		-		-		-
Amynta Agency Borrower Inc.	Banking Finance Insurance & Real Estate	Term Loan	Loan	1M USD LIBOR+	4.50	%		0.00	%		6.02	%	2/28/2025		3,462,357		3,425,731		3,224,320

	Number of Shares		Cost		Fair Value
Cash and cash equivalents
U.S. Bank Money Market (c)		9,081,041	$	9,081,041	$	9,081,041
Total cash and cash equivalents		9,081,041	$	9,081,041	$	9,081,041

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company